Sentence,class,file
"Moreover, MarkerMiner is freely available via the iPlant   cloud computing infrastructure ( http://www.iplantcollaborative.org/ci/atmosphere ;  Goff et al., 2011  [also available at  https://bitbucket.org/srikarchamala/markerminer ]), pro viding a working solution for researchers with limited or  no access to high- performance computing resources.",OADS,/arxiv_data1/oa_pdf/6e/be/apps.1400115.PMC4406834.pdf
"2 ; see also the user   manual [available at https://bitbucket.org/srikarchamala/markerminer], for example).",Non-OADS,/arxiv_data1/oa_pdf/6e/be/apps.1400115.PMC4406834.pdf
"Accessibility and high-performance computing —   MarkerMiner is open- source and is made   freely accessible to the research community for use in a lo cal  computing environment as well as via the iPlant Collaborative Atmosphere cloud-computing infrastructure ( http://www.iplantcollaborative.org/ci/atmosphere ; Goff et al., 2011 [also available at  https://bitbucket.org/srikarchamala/mark erminer ]).",OADS,/arxiv_data1/oa_pdf/6e/be/apps.1400115.PMC4406834.pdf
A user manual for the web application and instructions to access an example data set are provided at  https://bitbucket.org/srikarchamala/markerminer .,OADS,/arxiv_data1/oa_pdf/6e/be/apps.1400115.PMC4406834.pdf
"Gray [ Tuskan et al., 2004 ; International   Populus   Genome Consortium: http://www.ornl.gov/sci/ipgc/ssr_resource.htm],    1  Manuscript received 22 December 2014; revision accepted 16 February  2015.",Non-OADS,/arxiv_data1/oa_pdf/ac/61/apps.1400120.PMC4406835.pdf
Website  http://www.environment.nsw.gov.au/determinations/acacamelvilleiFD.htm  [ac-cessed 13 December 2013].,Non-OADS,/arxiv_data1/oa_pdf/55/27/apps.1400121.PMC4406836.pdf
Website  http://ssr.nwisrl.ars.usda.gov/  [accessed 16 April 2012].,Non-OADS,/arxiv_data1/oa_pdf/6c/be/apps.1400123.PMC4406837.pdf
Website  http://plants.usda.gov/core/proﬁ le?symbol=FOGA  [accessed 27 February 2014].,OADS,/arxiv_data1/oa_pdf/6c/be/apps.1400123.PMC4406837.pdf
"We detected microsatellites using MISA Perl script (MIcroSAtellite identiﬁ  ca- tion tool,  http://pgrc.ipk-gatersleben.de/misa/ ) from all unigenes obtained in the study.",OADS,/arxiv_data1/oa_pdf/13/78/apps.1500001.PMC4406838.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/b9/6b/10.1177_2047981615572273.PMC4406922.pdf
"creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permiss ion provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).",Non-OADS,/arxiv_data1/oa_pdf/05/c7/10.1177_2047981615570417.PMC4406923.pdf
"1Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.1 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:1-7Dendritic Cell-Based Cancer Immunotherapy against Multiple  Myeloma: From Bench to Clinic My-Dung Hoang1, Sung-Hoon Jung1,2, Hyun-Ju Lee1, Youn-Kyung Lee3, Thanh-Nhan  Nguyen-Pham1, Nu-Ri Choi1, Manh-Cuong Vo1, Seung-Shin Lee2, Jae-Sook Ahn2, Deok-Hwan  Yang2, Yeo-Kyeoung Kim2, Hyeoung-Joon Kim2 and Je-Jung Lee1,2,3,* 1Research Center for Cancer Immunotherapy and 2Department of Hematology-Oncology, Chonnam National University Hwasun Hospital,  3Vaxcell-Bio Therapeutics, Hwasun, Korea Although the introduction of stem cell tr ansplantation and novel agents has improved  survival, multiple myeloma (MM) is still di fficult to cure.",Non-OADS,/arxiv_data1/oa_pdf/fa/17/cmj-51-1.PMC4406989.pdf
"Key Words:   Multiple myeloma; De ndritic cells; Immunotherapy This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 19 March, 2015 revised 19 March, 2015 accepted 23 March, 2015 Corresponding Author: Je-Jung Lee Department of Hematology-  Oncology, Chonnam National  University Hwasun Hospital, 322 Seoyang-ro, Hwasun 519-763, Korea TEL:  ＋82-61-379-7638 FAX: ＋82-61-379-7628 E-mail: drjejung@chonnam.ac.kr DENDRITIC CELL-BASED CANCER  IMMUNOTHERAPY 　Advances in our understanding of cancer immunology  have expedited tumor control in the battle against cancer through cancer immunotherapy.",Non-OADS,/arxiv_data1/oa_pdf/fa/17/cmj-51-1.PMC4406989.pdf
"19Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.19 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:19-25Nine-Month Follow-up Results of Treatment for Nasolacrimal Duct  Obstruction by Probing with Adjunctive Mitomycin C in Adults: A Prospective Randomized Placebo-Controlled Trial Nader Dehghani1, Mohamad Reza Fouladivanda2, Mohamed Amin Ghobadifar3,*,  Gelayol Safshekan-Esfahani2 and Armin Akbarzadeh4 1Department of Ophthalmology, 2Department of Student Research Committee, 3Zoonoses Research Center, Jahrom University of Medical  Sciences, Jahrom, 4Department of Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran The current study aimed to determine the effi cacy of probing with adjunctive mitomycin  C (MMC) as a treatment for nasolacrimal duct  obstruction (NLDO) in adults and to  study the association of probing succe ss with demographic and obstruction  characteristics.",Non-OADS,/arxiv_data1/oa_pdf/af/f6/cmj-51-19.PMC4406990.pdf
"Key Words:  Adult; Lacrimal duct obstruction; Mitomycin This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 12 February, 2015 revised 14 March, 2015 accepted 16 March, 2015 Corresponding Author: Mohamed Amin GhobadifarZoonoses Research Center, Medicine School, Jahrom University of Medical  Sciences, 193, Motahari Avenue,  Jahrom, IranTEL: +98-936-620-8078 FAX: +98-711-636-13-86 E-mail: amin_m505@yahoo.com INTRODUCTION 　Nasolacrimal duct obstruct ion (NLDO) is a common dis- order in adults that can lead to intermittent or constant tearing (epiphora), watery eye with blurred vision, and chronic or acute dacryocystitis.",Non-OADS,/arxiv_data1/oa_pdf/af/f6/cmj-51-19.PMC4406990.pdf
"26Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.26 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:26-32Long-Term Outcome of Treatment with Topical Corticosteroids for  Severe Dry Eye Associated with Sjögren’s Syndrome Hyun Ho Jung1, Yong Sok Ji1, Mi Sun Sung1, Kyung Keun Kim2 and Kyung Chul Yoon1,* 1Department of Ophthalmology, Chonnam National University Medical School and Hospital, Gwangju,  2Medical Research Center of Gene  Regulation and Center for Creative Biomedical Scientists, Chonnam National University Medical School, Gwangju, Korea This retrospective study was performed to analyze the long-term outcome of topical  corticosteroid treatment for severe dry eye associated with Sjögren’s syndrome (SS).",Non-OADS,/arxiv_data1/oa_pdf/f8/74/cmj-51-26.PMC4406991.pdf
"Key Words:  Dry eye syndromes; Sjögren’s  syndrome; Fluorometholone;  Loteprednol  etabonate This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 20 December, 2014 revised 10 January, 2015 accepted 13 January, 2015 Corresponding Author: Kyung Chul YoonDepartment of Ophthalmology,  Chonnam National University Medical  School and Hospital, 8 Hak-dong, Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6741 FAX: +82-62-227-1642E-mail: kcyoon@jnu.ac.kr INTRODUCTION 　Dry eye is one of the most common problems encountered  by ophthalmologists.",Non-OADS,/arxiv_data1/oa_pdf/f8/74/cmj-51-26.PMC4406991.pdf
"33Original Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.33 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:33-38Growth Hormone Responses to Provocative Tests in Children  with Short Stature Noorisaem Rhee, Ka Young Oh, Eun Mi Yang and Chan Jong Kim * Department of Pediatrics, Chonnam National Univers ity Medical School and Hospital, Gwangju, Korea  Growth hormone deficiency (GHD) is defi ned as a serum peak GH concentration ＜10  ng/mL with provocation as tested by a combin ation of at least two separate tests.",Non-OADS,/arxiv_data1/oa_pdf/ae/f2/cmj-51-33.PMC4406992.pdf
"Key Words:  Growth hormone; Dwarfism; Child This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 6 March, 2015 revised 31 March, 2015 accepted 3 April, 2015 Corresponding Author: Chan Jong Kim Department of Pediatrics, Chonnam  National University Medical School and Hospital, 42 Jebong-ro,  Dong-gu, Gwangju 501-757, Korea TEL: +82-62-220-6645FAX: +82-62-222-6103 E-mail: cjkim@jnu.ac.kr INTRODUCTION The diagnosis of growth hormone deficiency (GHD) in  children with short stature is based on clinical features.",Non-OADS,/arxiv_data1/oa_pdf/ae/f2/cmj-51-33.PMC4406992.pdf
"39Case Report www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.39 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:39-42IgG4-Related Systemic Disease Can Be Easily Mistaken as a  Uroepithelial Tumor Song Yi Han1, Seung Ik Lee1, Yeon Hee Lee1, Ae Jin Kim1, Hye Jin Lim1, Han Ro1,2,  Jae Hyun Chang1,2, Hyun Hee Lee1,2, Wookyung Chung1,2 and Ji Yong Jung1,2 1Division of Nephrology, 2Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University School of Medicine,  Incheon, Korea  Immunoglobulin G4-related disease (IgG4- RD) is a newly recogn ized systemic syn- drome characterized by elevated serum IgG4 concentrations and tumefaction or tissue  infiltration by IgG4-positive plasma cells.",Non-OADS,/arxiv_data1/oa_pdf/af/ba/cmj-51-39.PMC4406993.pdf
"Key Words:  Immunoglobulin G, Sclerosis; Kidney This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 24 October, 2014 revised 10 December, 2014 accepted 29 December, 2014 Corresponding Author: Ji Yong Jung Division of Nephrology, Department of  Internal Medicine, Gachon University Gil Medical Center, Gachon University  School of Medicine, 1198  Guwol-dong, Namdong-gu, Incheon 405-760, Korea  TEL:  ＋82-32-460-3654 FAX: ＋82-32-460-3431 E-mail: jyjung@gachon.ac.kr INTRODUCTION 　Immunoglobulin G4-related disease (IgG4-RD) is a fibro-in- flammatory systemic disease characterized by elevation of se-rum IgG4, dense fibrotic infiltration of IgG4-positive plasma cells, and obliterative phlebitis.",Non-OADS,/arxiv_data1/oa_pdf/af/ba/cmj-51-39.PMC4406993.pdf
"43Case Report www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.43 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:43-46Totally Occluded Grafted Right Internal Mammary Artery to  Anomalously Originated Right Coronary Artery Hyukjin Park, Young Joon Hong *, Seunghun Lee, Tae Ryom Oh, Jungho Choi, Minah Kim,  Keun Ho Park, Doo Sun Sim, Youngkeun Ahn, Myung Ho Jeong, Jeong Gwan Cho and  Jong Chun Park Division of Cardiology of Chonnam National University Hospita l, Cardiovascular Convergence Research Center Nominated by Korea  Ministry of Health and Welfare, Gwangju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/7b/b5/cmj-51-43.PMC4406994.pdf
"Key Words:  Coronary artery bypass; Coronary  disease; Coronary vessel anomalies This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 28 June, 2014 revised 18 July, 2014 accepted 9 August, 2014 Corresponding Author: Young Joon HongDivision of Cardiology of Chonnam  National University Hospital, Cardiovascular Convergence  Research Center Nominated by Korea  Ministry of Health and Welfare, 42 Jebong-ro, Dong-gu, Gwangju  501-757, Korea TEL: +82-62-220-5778FAX: +82-62-223-3105 E-mail: hyj200@hanmail.net INTRODUCTION An anomalous aortic origin of a coronary artery is a rare  congenital anomaly with an  incidence of about 0.17%.1  Such anomalies are reported as an important cause of sud-den death in specific populati ons such as athletes or mili- tary recruits.",Non-OADS,/arxiv_data1/oa_pdf/7b/b5/cmj-51-43.PMC4406994.pdf
"http://dx.doi.org/10.4068/cmj.2015.51.1.47 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:47-49Successful Delivery Following Staphylococcus aureus  Bacteremia  after In Vitro Fertilization and Embryo Transfer Hyung Ho Kim1, Na Ra Yun1,*, Dong-Min Kim1 and Soo Ah Kim2 Departments of 1Internal Medicine, 2Obstetrics and Gynecology, Chosun University School of Medicine, Gwangju, Korea A 30-year-old, 16-week primipara woman visi ted with complaints of lower back pain  over the past 3 weeks.",Non-OADS,/arxiv_data1/oa_pdf/f2/1b/cmj-51-47.PMC4406995.pdf
"Key Words:   Staphylococcus aureus; Fertilization  in vitro; Spondylitis; Pregnancy  This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 22 August, 2014 revised 8 October, 2014 accepted 10 October, 2014 Corresponding Author: Na Ra Yun Department of Internal Medicine, Chosun University School of Medicine,  588, Seosuk-dong, Dong-gu,  Gwangju 501-717, KoreaTEL: +82-62-220-3093 FAX: +82-62-234-9653 E-mail: shine@chosun.ac.kr  INTRODUCTION 　Staphylococcus aureus  bacteremia is potentially fatal.",Non-OADS,/arxiv_data1/oa_pdf/f2/1b/cmj-51-47.PMC4406995.pdf
"8Review Article www.cmj.ac.k r http://dx.doi.org/10.4068/cmj.2015.51.1.8 ⒸChonnam Medical Journal, 2015 Chonnam Med J 2015;51:8-18Comorbidity of Depression with Physical Disorders: Research and  Clinical Implications Hee-Ju Kang1, Seon-Young Kim2, Kyung-Yeol Bae1, Sung-Wan Kim1, Il-Seon Shin1,  Jin-Sang Yoon1 and Jae-Min Kim1,* 1Department of Psychiatry, Chonnam National University Medical School, Gwangju, 2Mental Health Clinic, Chonnam National University  Hwasun Hospital, Hwasun, Korea Depression is prevalent in patients with phys ical disorders, particularly in those with  severe disorders such as cancer, stroke, and acute coronary syndrome.",Non-OADS,/arxiv_data1/oa_pdf/8e/05/cmj-51-8.PMC4406996.pdf
"Key Words:  Depression; Risk factors; Prognosis This is an Open Access article dist ributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org /licenses/by-nc/3.0) which permit s unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.Article History: received 17 March, 2015 revised 19 March, 2015 accepted 20 March, 2015 Corresponding Author: Jae-Min Kim Department of Psychiatry, Chonnam  National University Medical School, 160, Baekseo-ro, Dong-gu, Gwangju  501-746, Korea TEL: +82-62-220-6143FAX: +82-62-225-2351 E-mail: jmkim@chonnam.ac.kr INTRODUCTION Depression refers to a state of low mood, loss of positive  affect (markedly diminished interest and enjoyment in ac-tivities that were previously  considered pleasurable), and  a variety of emotional, cognitive, and behavioral symptoms including anhedonia, disrupted sleep and eating, worth-lessness, and recurrent thought of death.",Non-OADS,/arxiv_data1/oa_pdf/8e/05/cmj-51-8.PMC4406996.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/36/TOOPHTJ-9-33.PMC4406997.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial Licen se (http://creativecommons.org/ licenses/ - by-nc/3.0/) which permits unrestricted, non -commercial use, d istribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/51/41/TOMICROJ-9-1.PMC4406998.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/b3/TOOPHTJ-9-28.PMC4407001.pdf
"Multiple sequence analysis was performed across ten  plants by usin g ClustalW (http://www.ebi.ac.uk/Tools/   msa/clustalw2/) software using default parameters, which  depicts the conserved regions of proteins.",OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
Accession  numbers of all ten plants were retrieved from NCBI  (http://www.ncbi.nlm.nih.gov/) as summarized in Table 1.,OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
[33] http://www.ncbi.nlm.nih.gov/protein .,OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
"[36] http://spdbv.vital -it.ch/   [37] http://nihserver.mbi.ucla.edu/SAVES/   [38] http://scripts.iucr.org/cgi - bin/paper?gl0276   [39] Colovos, C.; Yeates, T.O.",Non-OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
[43] http://accelrys.com .,Non-OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
[44] http://www.pymol.org .,Non-OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
[46] http://pubchem.ncbi.nlm.nih.gov/   [47] http://openba bel.org .,Non-OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non -Commercial License (http://creativecommons.org/licenses/   by-nc/3.0/) which permits unrestricted, non -commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/58/43/TOBIOCJ-9-15.PMC4407003.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/19/TOOPHTJ-9-41.PMC4407004.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/16/TOOPHTJ-9-36.PMC4407005.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/4.0/J-N Schulz et al.",Non-OADS,/arxiv_data1/oa_pdf/94/91/jid201524a.PMC4407012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Regulatory T cells require CD28 for homeostasis DF r a n c k a e r t et al 423 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/62/a4/icb2014108a.PMC4407013.pdf
The Supplementary Information that accompanies this paper is available on the Immunology and Cell Biology website (http://www.nature.com/icb).,Non-OADS,/arxiv_data1/oa_pdf/fb/1e/icb2014102a.PMC4407014.pdf
IBC Life Sciences 2011 (http://www.biotest.de/ shared/data/pdf/biotherapeutics/ibc_2011.pdf).,OADS,/arxiv_data1/oa_pdf/fb/1e/icb2014102a.PMC4407014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/BT-061-induced unique signaling pathway BH e l l i n g et al 405 Immunology and Cell Biology",Non-OADS,/arxiv_data1/oa_pdf/fb/1e/icb2014102a.PMC4407014.pdf
"To view a copy  of this  license, visit http://creativecommons.org/licenses/  by-nc-sa/4.0/ 702 Pediatric ReSeARCh       Volume 77  |  N umber 5  |  May  2015",Non-OADS,/arxiv_data1/oa_pdf/1e/8b/pr201525a.PMC4407015.pdf
Available from: http://www.unicef.org/gambia/SOWC_Report_ 2013.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/16/8a/jphr-2015-1-318.PMC4407034.pdf
Available from: http://hpod.org/pdf/Disability- poverty-and-development.pdf 19.,Non-OADS,/arxiv_data1/oa_pdf/16/8a/jphr-2015-1-318.PMC4407034.pdf
Available from: http://www.un.org/disabilities/default.asp?id=161 21.,Non-OADS,/arxiv_data1/oa_pdf/16/8a/jphr-2015-1-318.PMC4407034.pdf
Available from: http://ucp.org/ 23.,Non-OADS,/arxiv_data1/oa_pdf/16/8a/jphr-2015-1-318.PMC4407034.pdf
Available from: http://www.pewinternet.org/2013/03/13/teens-and- technology-2013/ 23.,Non-OADS,/arxiv_data1/oa_pdf/93/6c/jphr-2015-1-376.PMC4407036.pdf
Available from: http://www.cdc.gov/ healthliteracy/pdf/Simply_Put.pdf 26.,Non-OADS,/arxiv_data1/oa_pdf/93/6c/jphr-2015-1-376.PMC4407036.pdf
Avaiòable frm: http://www.pewinternet.org/files/old- media/Files/Reports/2012/PIP_ParentsTeensAndPrivacy.pdf 36.,Non-OADS,/arxiv_data1/oa_pdf/93/6c/jphr-2015-1-376.PMC4407036.pdf
Available from: http://www.cdc.gov/ healthcommunication/ToolsTemplates/SocialMediaToolkit_BM.pdf 37.,Non-OADS,/arxiv_data1/oa_pdf/93/6c/jphr-2015-1-376.PMC4407036.pdf
Available from: http://www.rvz.net/uploads/docs/Achtergrondstudie _-_Governance_tools_and_framework1.pdf 2.,OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: https://www.kri- book.com/read-doc/slide-1-4436 3.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.unbrussels.org/component/content/article/41- reports/177-statement-by-zsuzsanna-jakab-world-health-organiza- tion-regional-director-for-europe-at-the-eu-open-health-forum- brussels-29-30-june-2010.html.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.who.int/ whr/2002/en/whr02_en.pdf 9.,OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.publichealth.ie/files/file/DECLARATION_ADOPTED_SI GNATURES.pdf 11.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://ec.europa.eu/health/ph_projects/2005/action1/docs/2005_1_1 8_frep_a4_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.ktl.fi/attachments/ english/organization/annual_report_2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.globalhealtheurope.org/index.php?option=com_con- tent&view=article&id=276&catid=39&Itemid=92.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Implementing health in all policies: Adelaide 2010. http://www.who.int/sdhconference/resources/implementinghia- padel-sahealth-100622.pdf.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://ec.europa.eu/health/archive/ph_information/documents/health_in_all_policies.pdf 17.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.lessismoremedi- cine.com/.,Non-OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.who.int/sdhconference/declaration/en/.,OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://sgc.ca.gov/docs /workgroups/HiAP_Final_Report_12.3.10.pdf.,OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
Available from: http://www.euro.who.int/__data/ assets/pdf_file/0004/109759/EHFA5-E.pdf.,OADS,/arxiv_data1/oa_pdf/69/5a/jphr-2015-1-393.PMC4407037.pdf
"The ITR, like other Twin Registers worldwide, is a valuable tool for epidemiological studies essential to the development of health prevention plans (http://www.iss.it/gemelli/index.php?",Non-OADS,/arxiv_data1/oa_pdf/5c/26/jphr-2015-1-401.PMC4407038.pdf
Available from: http://www.who.int/healthinfo/global_burden_disease/GlobalHealt hRisks_report_full.pdf.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/jphr-2015-1-406.PMC4407039.pdf
Available from: https://sites.google.com /site/theipaq/questionnaire_links 18.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/jphr-2015-1-406.PMC4407039.pdf
Available frm: http://www.who.int/healthinfo/paper31.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/68/7c/jphr-2015-1-406.PMC4407039.pdf
Available frm: http://www.euro.who.int/__data/assets/pdf_file/0011/87545/E89490 .pdf 26.,OADS,/arxiv_data1/oa_pdf/68/7c/jphr-2015-1-406.PMC4407039.pdf
Available from: http://www.who.int/topics/ millennium_d evelopment_goals/hunger/en/index.html 4.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.who.int/topics/millennium_develop- ment_goals/child_mortality/en/ 5.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.unicef.org/publications/files/Tracking_Progress_on_Ch ild_and_Maternal_Nutrition_EN_110309.pdf 6.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.unicef.org/sowc/archive/ENG- LISH/The%20State%20of%20the%20World%27s%20Children%201998.pdf 8.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.who.int/pmnch/media/publications/oanfullreport.pdf 16.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.idrc.ca/EN/Programs/Social_and_Economic_Policy/Gov ernance_for_Equity_in_Health_Systems/Pages/nehsi.aspx 18.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.crossriverstate.gov.ng/index.php?option=com _content&view=article&id=113:land-and-people&catid=95:facts- about-cross-river-state&Itemid=753 20.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: https://wwwn.cdc.gov/epiinfo/html/ ei6_down- loads.htm 26.,OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.who.int/childgrowth/software/en/ 28.,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
"Available from: http://www.thou- sanddays.org/about/                               [Journal of Public Health Research 2015; 4:408]                                               [page 63]                                                                                                                                  Article Correspondence: Candyce Hamel, CIET-PRAM, Department of Family Medicine, McGill University, Chemin de la Côte-des-Neige, 3rd floor, Montreal, Quebec 5858, H3S 1Z1 Canada.",Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
Available from: http://www.schoolsandhealth.org/ Shared%20Documents/The%20Impact%20of%20Maternal%20Educ ation%20on%20Child%20Nutrition%20Evidence%20from%20Mala wi%20Tanzania%20and%20Zimbabwe.pdf                                 Article,Non-OADS,/arxiv_data1/oa_pdf/6f/f9/jphr-2015-1-408.PMC4407040.pdf
[page 6]                                                   [Journal of Public Health Research 2015; 4:414]                             Available from: http://www.cdc.gov/hiv/statistics/surveillance/inci- dence/index.html.,Non-OADS,/arxiv_data1/oa_pdf/b8/3c/jphr-2015-1-414.PMC4407041.pdf
Available from: http://www.fbi.gov/about-us/cjis/ucr/hate-crime/2011/narra- tives/incidents-and-offenses.,OADS,/arxiv_data1/oa_pdf/b8/3c/jphr-2015-1-414.PMC4407041.pdf
Available from: http://www.acha-ncha.org/grvanalysis.html.,Non-OADS,/arxiv_data1/oa_pdf/b8/3c/jphr-2015-1-414.PMC4407041.pdf
Available from:  http://www.epilepsyfoundation.org/aboutepilepsy/ whatisepilepsy/statistics.cfm.,Non-OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Available from: http://www.cdc.gov/chronicdisease/resources/publications/aag/epil epsy.htm.,OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Available from: http://www.oshpd.ca.gov/ HID/Products/EmerDeptData/.,OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Available from: http://www.dof.ca.gov/research/ demographic/.,OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Available from: http://www.census.gov/geo/reference/zctas.html.,OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Available from: http://www.kaspersky.com/downloads/internet-security 33.,Non-OADS,/arxiv_data1/oa_pdf/86/0f/jphr-2015-1-441.PMC4407042.pdf
Times of India: 2013. availble from: http://timesofindia.indiatimes.com/life-style/health-fitness/health/Diabetes-epidemic-on-the-rise-in- India/articleshow/25758884.cms 2.,Non-OADS,/arxiv_data1/oa_pdf/81/62/jphr-2015-1-448.PMC4407043.pdf
Available from: https://www.nice.org.uk/guidance/cg63/resources.,Non-OADS,/arxiv_data1/oa_pdf/81/62/jphr-2015-1-448.PMC4407043.pdf
Available from: http://www.rchiips.org/pdf/ rch3/state/Karnataka.pdf 21.,Non-OADS,/arxiv_data1/oa_pdf/81/62/jphr-2015-1-448.PMC4407043.pdf
Available from: http://www.worlddiabetesfoundation.org/sites/default/files/GDM%2 0Review.pdf 32.,OADS,/arxiv_data1/oa_pdf/81/62/jphr-2015-1-448.PMC4407043.pdf
Available from: https://www.ispad.org/ sites/default/files/resources/files/idf-ispad_diabetes_in_ childhood_and_adolescence_guidelines_2011_0.pdf 22.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available from: http://www.diabetes.org.uk/Guide-to-diabetes/Schools /School-staff/ 23.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available from: http://www.idf.org/education/k ids/dia- betes-in-school-information-pack 26.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available form: http://www.world- diabetesfoundation.org/sites/default/files/School%20Health%20Revie w.pdf59.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available from: http://www.un.org/en/ga/ncdmeeting2011/ 60.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available from: http://daccess-dds-ny.un.org/doc/UNDOC/ GEN/N06/507/87/PDF/N0650787.pdf  61.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
Available from: http://www.lancaster.ac.uk/shm/research/nssr/research/dissemina- tion/publications.php 65.,Non-OADS,/arxiv_data1/oa_pdf/6f/40/jphr-2015-1-467.PMC4407044.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
Issued January 2013. http://bsac.org.uk/wp-content/ uploads/2014/01/BSAC-ICED-infection-for-consultation.pdf (1 February 2014).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
Issued May 2013. http://bsac.org.uk/wp-content/uplo ads/2012/02/Version-12-Apr-2013_ﬁnal.pdf (22 November 2013).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
URL http://www.R-project.org/ (2013).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
http://CRAN.R-project.org/package=psych Version = 1.3.10 (2013).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
http://CRAN.R-project.org/package=epiR (2011).17.,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
R package version 2.15.1.0. http://cran.r-project.org/package=epicalc (2012).,Non-OADS,/arxiv_data1/oa_pdf/33/1e/jeu295.PMC4407104.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/2f/awv050.PMC4407190.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/7b/awv051.PMC4407191.pdf
Editor: Fazoil Ataullakhanov./C2112015 The Authors 0006-3495/15/04/2007/12 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.03.018 Biophysical Journal Volume 108 April 2015 2007–2018 2007,Non-OADS,/arxiv_data1/oa_pdf/7b/49/main.PMC4407247.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/main.PMC4407275.pdf
http://dx.doi.org/10.1016/j.pmedr.2015.03.0122211-3355/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/main.PMC4407275.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/main.PMC4407275.pdf
Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: http://ees.elsevier.com/pmedr,Non-OADS,/arxiv_data1/oa_pdf/b8/d5/main.PMC4407275.pdf
"Accession Numbers 4XM54XLG Gaur et al., 2015, Cell Reports 10, 1467–1476 March 10, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.celrep.2015.02.019",OADS,/arxiv_data1/oa_pdf/c5/13/main.PMC4407285.pdf
"Wyatt,2Weronika Komorowska,1Roman H. Szczepanowski,3Daniele de Sanctis,4 Karolina M. Gorecka,1Stephen C. West,2and Marcin Nowotny1,* 1Laboratory of Protein Structure, International Institute of Molecular and Cell Biology, 4 Ksie ˛cia Trojdena Street, 02-109 Warsaw, Poland 2London Research Institute, Cancer Research UK, Clare Hall Laboratories, Blanche Lane, South Mimms, Herts EN6 3LD, UK 3Biophysics Core Facility, International Institute of Molecular and Cell Biology, 4 Ksie ˛cia Trojdena Street, 02-109 Warsaw, Poland 4European Synchrotron Radiation Facility (ESRF), 71 Avenue des Martyrs, CS 40220, 38043 Grenoble Ce ´dex 9, France *Correspondence: mnowotny@iimcb.gov.pl http://dx.doi.org/10.1016/j.celrep.2015.02.019 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/c5/13/main.PMC4407285.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Results, Supplemental Experimental Procedures, ﬁve ﬁgures, and one table and can be found withthis article online at http://dx.doi.org/10.1016/j.celrep.2015.02.019 .",OADS,/arxiv_data1/oa_pdf/c5/13/main.PMC4407285.pdf
"The Samples As evident in Table 2 , the interventions  reviewed for this report were provided to Child disaster mental health interventions, part I Techniques, outcomes, and methodological considerations Betty Pfefferbaum1,2,*, Jennifer L Sweeton3, Elana Newman4, Vandana Varma1,2, Pascal Nitiéma1,2, Jon A Shaw5, Allan K Chrisman6  and Mary A Noffsinger7 1Department of Psychiatry and Behavioral Sciences; College of Medicine; University of Oklahoma Health Sciences Center; Oklahoma City, OK USA; 2Terrorism  and Disaster Center; University of Oklahoma Health Sciences Center; Oklahoma City, OK USA; 3Veterans Affairs Medical Center; Oklahoma City, OK USA;  4Tulsa Institute of Trauma, Abuse and Neglect; Department of Psychology; University of Tulsa; Tulsa, OK USA; 5Division of Child and Adolescent Psychiatry;  University of Miami School of Medicine; Miami, FL USA; 6Duke Child and Family Study Center; Department of Psychiatry and Behavioral Sciences; Duke  University Medical Center; Durham, NC USA; 7Courtroom Sciences, Inc.; Irving, TX USA Keywords : children, disaster,  intervention, outcomes, posttraumatic stress, posttraumatic stress disorder, research, terrorism, therapy, treatment *Correspondence to: Betty Pfefferbaum;   Email: betty-pfefferbaum@ouhsc.edu Submitted: 08/12/13Revised: 11/20/13Accepted: 12/15/13http://dx.doi.org/10.4161/dish.27534",Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Consult Clin Psychol  2010; 78:765-80;  PMID:21114340 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Psychiatry  2002 ; 65:207- 39; PMID:12405079 ; http://dx.doi.org/10.1521/ psyc.65.3.207.20173 3.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Prof Psychol Res Pr 2004 ; 35:466- 76; http://dx.doi.org/10.1037/0735-7028.35.5.466 5.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Trauma Stress 2011 ; 24:155-65;  PMID:21425191 ; http://dx.doi.org/10.1002/ jts.20622 6.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Clin Child  Adolesc Psychol  2008 ; 37:156-83; PMID:18444057 ;  http://dx.doi.org/10.1080/15374410701818293 7.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Am J Prev Med 2008 ; 35:287- 313; PMID:18692745 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Pediatrics  2013 ; 131:526-39;  PMID:23400617 ; http://dx.doi.org/10.1542/ peds.2012-3846 10.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Child  Dev Perspect  2009 ; 3:4-10; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Adolesc Health  2012 ; 51:453-61; PMID:23084166 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Trauma Stress  2007 ; 20:541-51; PMID:17721962 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Child Psychol Psychiatry 2009 ;  50:962-71; PMID:19207621 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Trauma Stress 2011 ; 24:309- 16; PMID:21618288 ; http://dx.doi.org/10.1002/ jts.20638 17.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
"J Am Acad  Child Adolesc Psychiatry  2011 ; 50:340-8, e1-2 ;  PMID:21421174 ; http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Child Psychol Psychiatry 2011 ;  52:853-60; PMID :21155776 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Am Acad Child Adolesc Psychiatry  2010 ; 49:1034 -42; PMID:20855048 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Child Adolesc Trauma 2010 ; 3:330-43;  http://dx.doi.org/10.1080/19361521.2010.523063 22.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
"J Trauma Stress 2010 ; 23:699- 707; PMID:21171130 ; http://dx.doi.org/10.1002/ jts.20594 23. de Roos C, Greenwald  R, den Hollander-Gijsman   M, Noorthoorn  E, van Buuren S, de Jongh A.",OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Eur J Psychotraumatol 2011 ; 2:1-11;  PMID :22893815 ; http://dx.doi.org/10.3402/ejpt.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Harv Rev Psychiatry  2004 ; 12:187-98; PMID :15371061 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Psychother  Psychosom  2009 ; 78:364-71; PMID:19738402 ;  http://dx.doi.org/10.1159/000235976 26.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
BMC Psychiatry  2009 ; 9:22; PMID:19439099 ;  http://dx.doi.org/10.1186/1471-244X-9-22 27.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Clin Psychol 2002 ; 58:99-112; PMID:11748599 ;  http://dx.doi.org/10.1002/jclp.1131 28.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Arch Pediatr Adolesc Med  2002 ; 156:211-6; PMID:11876663 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Am Acad  Child Psychiatry  1986 ; 25:357-63; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Clin Child Psychol Psychiatry 2006 ;  11:543-53; PMID:17163223 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Am J Psychiatry 2005 ;  162:2302 -8; PMID:16330594 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Harv  Rev Psychiatry  2004 ; 12:199-212; PMID:15371062 ;  http://dx.doi.org/10.1080/10673220490509534 37.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Am  J Clin Hypn 2009 ; 52:23-34; PMID:19678557 ;  http://dx.doi.org/10.1080/00029157.2009.10401689 41.,OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Brief  Treat Crisis Interv  2009 ; 8:313-26; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Disaster  Prev Manag  1999 ; 8:169-76; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Risk Anal  2003 ; 23:1009 -20; PMID :12969415 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Traumatology  2011 ; 17:41-9;  http://dx.doi.org/10.1177/1534765610395624 47.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Clin Child Adolesc Psychol  2008 ; 37:495-507; PMID:18645741 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Behav Res Ther  2012 ; 50:169-79; PMID:22317753 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Int J Play Ther 2002 ; 11:43-63;  http://dx.doi.org/10.1037/h0088856 50.,OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Adolesc Health 2008 ; 42:466- 72; PMID:18407041 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Int Rev Psychiatry  2006 ; 18:515-22; PMID:17162691 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J  Appl Develop  2009 ; 30:218-26; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
J Child Psychol Psychiatry 2005 ;  46:1161-8; PMID:16238663 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Psychother Psychosom  1992 ;  57:200-5; PMID:1410197 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Br J Clin Psychol  1991 ; 30:131-8; PMID:2059745 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Child Youth Care Forum 2013 ; 42:351-69;  http://dx.doi.org/10.1007/s10566-013-9206-1 62.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Child Abuse Negl  2007 ; 31:125-41; PMID:17306369 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
Annu  Rev Psychol  1997 ; 48:449-80; PMID:9046566 ;  http://dx.doi.org/10.1146/annurev.psych.48.1.449,Non-OADS,/arxiv_data1/oa_pdf/b4/d7/kdsh-02-01-10927534.PMC4407368.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/c0/rjv048.PMC4407410.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/ca/rjv052.PMC4407419.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e50607 | Page 1 of 11Video Article CometChip: A High-throughput 96-Well Platform for Measuring DNA Damage in Microarrayed Human Cells Jing Ge*1, Somsak Prasongtanakij*2, David K. Wood3, David M. Weingeist1, Jessica Fessler1, Panida Navasummrit2, Mathuros Ruchirawat2, Bevin P. Engelward1 1Department of Biological Engineering, Massachusetts Institute of Technology 2Environmental Toxicology, Chulabhorn Graduate Institute 3Department of Biomedical Engineering, University of Minnesota *These authors contributed equally Correspondence to: Jing Ge at jing_ge@mit.edu URL: http://www.jove.com/video/50607 DOI: doi:10.3791/50607 Keywords: Bioengineering, Issue 92, comet assay, electrophoresis, microarray, DNA damage, DNA repair Date Published: 10/18/2014 Citation: Ge, J., Prasongtanakij, S., Wood, D.K., Weingeist, D.M., Fessler, J., Navasummrit, P., Ruchirawat, M., Engelward, B.P.",Non-OADS,/arxiv_data1/oa_pdf/82/31/jove-92-50607.PMC4407627.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50607/ Introduction The single cell gel electrophoresis (SCGE) assay (a.k.a.,Non-OADS,/arxiv_data1/oa_pdf/82/31/jove-92-50607.PMC4407627.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/e4/ce/srep09929.PMC4407725.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 215–222Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  215RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S4778 4Itolizumab – a humanized anti-CD6   monoclonal antibody with a better side   effects profile for the treatment of psoriasis Roshni Menon Brinda G David Department of Dermatology,  venereology and Leprosy, Sri  venkateshwaraa Medical College  Hospital and Research Centre,  Ariyur, Pondicherry, India   Correspondence: Roshni Menon  Department of Dermatology,  venereology and Leprosy, Sri  venkateshwaraa Medical College  Hospital and Research Centre D II/17,  JIPMeR Campus, Dhanvanthri Nagar,  Pondicherry, India  605006   Tel +91 944 329 8140  email roshnijagdish@gmail.co mAbstract:  Management of psoriasis is a challenge to the treating physician.",Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
Available from: http://www.biocon.,Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
"Available  from: http://pi.amgen.com/united_states/enbrel/derm/enbrel_pi.pd f.  Accessed April 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/f3/b0/ccid-8-215.PMC4407739.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f4/d2/copd-10-791.PMC4407740.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 791–801International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  791RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S7860 7effectiveness of pulmonary rehabilitation in COPD  with mild symptoms: a systematic review with  meta-analyses Mette Rugbjerg1 Ulrik winning Iepsen1 Karsten Juhl Jørgensen2 Peter Lange1,3,4 1The Centre of Inflammation  and Metabolism and The Centre  for Physical Activity Research,   Department of Infectious  Diseases,   Rigshospitalet, University of   Copenhagen, Copenhagen, Denmark;   2The Nordic Cochrane Centre,   Rigshospitalet, Copenhagen, Denmark;   3Department of Respiratory Medicine,   University Hospital Hvidovre,   Copenhagen, Denmark; 4Department  of Public Health, Section of Social  Medicine, University of Copenhagen,   Copenhagen, DenmarkPurpose:  Most guidelines recommend pulmonary rehabilitation (PR) for patients with chronic  obstructive pulmonary disease (COPD) and modified Medical Research Council dyspnea scale  (mMRC) levels 2, but the effectiveness of PR in patients with less advanced disease is not well  established.",Non-OADS,/arxiv_data1/oa_pdf/f4/d2/copd-10-791.PMC4407740.pdf
rugbjerg.02@regionh.d k Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Rugbjerg et al Running head recto: Effectiveness of pulmonary rehabilitation in COPD with mild symptoms DOI: http://dx.doi.org/10.2147/COPD.S78607,Non-OADS,/arxiv_data1/oa_pdf/f4/d2/copd-10-791.PMC4407740.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/f4/d2/copd-10-791.PMC4407740.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f4/d2/copd-10-791.PMC4407740.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/34/opth-9-721.PMC4407742.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Ophthalmology 2015:9 721–724Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  721Case repO rtopen access to scientific and medical research Open access Full text article http: //dx.doi.org/10.2147/OPTH.S8115 8Infected ptosis surgery – a rare complication from  a multidrug-resistant organism Chan Jan-Bond1,2 abdul-rahman Norazah1 palani sree-Kumar1 embong Zunaina2 Qamarruddin Fazilawati1 1Department of Ophthalmology,   Hospital selayang, Lebuhraya  selayang-Kepong, Batu Caves,   selangor, Malaysia; 2Department  of Ophthalmology, school of Medical  sciences, Universiti sains Malaysia,   Kubang Kerian, Kelantan, MalaysiaAbstract:  A 7-year-old boy had a case of congenital ptosis of the right eye and has undergone  frontalis sling surgery using Gore-tex material.",Non-OADS,/arxiv_data1/oa_pdf/79/34/opth-9-721.PMC4407742.pdf
"Chloramphenicol  ointment was given to the patient till review.Correspondence: Chan Jan-Bond Department of Ophthalmology, school  of Medical sciences, Universiti sains  Malaysia, 16150 Kubang Kerian, Kelantan,  Malaysia tel +60 12 206 8126 Fax +60 9 765 3370 email janbond@hotmail.co mJournal name: Clinical Ophthalmology Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Jan-Bond et al Running head recto: Infected ptosis surgery DOI: http://dx.doi.org/10.2147/OPTH.S81158",Non-OADS,/arxiv_data1/oa_pdf/79/34/opth-9-721.PMC4407742.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/79/34/opth-9-721.PMC4407742.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/34/opth-9-721.PMC4407742.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 741–749Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  741OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7548 6Diagnostic and therapeutic path of breast cancer:  effectiveness, appropriateness, and costs – results  from the DOCMa study Maria rosaria giovagnoli1 Adriana Bonifacino2 Cosimo neglia3 Marco Benvenuto3,4 Francesco Vincenzo  sambati3 lorenzo giolli5 Alessandra giovagnoli6 Prisco Piscitelli7,8 1Department of Clinical and  Molecular Medicine, 2Department  of Medical- surgical sciences and  Translational Medicine, sapienza  University of rome, sant’Andrea  University hospital, rome, 3euro  Mediterranean scientific Biomedical  Institute (IsBeM), Brindisi,   4Department of economics, scuola  superiore sant’Anna, Pisa, 5eCampus  University, novedrate, 6Department  of statistical sciences, University  of Bologna, Bologna, 7Coleman ltd,   8IOs, southern Italy hospital Institute,   naples, ItalyObjective:  An increase in breast cancer incidence has been documented in Italy and in other  countries, and some women decide by themselves to undergo diagnostic examinations outside  the official screening campaigns.",Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
"Keywords:  breast cancer, early diagnosis, prevention, screening, cost analysis, breast unit Introduction After cardiovascular diseases, cancer is the first cause of death among women in Italy,  with breast cancer being the main tumor.1–3 Official data from the Italian Ministry of  Health have estimated the total breast cancer incidence at about 40,000 new cases  per year, with an overall prevalence of 416,000 cases (women living with cancer).1,2  The incidence per age-group was estimated to exceed 100 new cases every 100,000  women 40 years of age, rising up to 200 new cases and over 300 cases in women  aged 50 and 60 years, respectively.1,4 The number of deaths due to breast cancer  in the Italian female population is about 18% of the overall mortality due to cancer.1,5,6  In 2009, a total of 12,195 deaths among Italian women were attributed to breast cancer Correspondence: Prisco Piscitelli IOs Medicina Futura group, Centro  Direzionale, Isola e3, Palazzo Avalon,  naples 80143, Italy Tel +39 081 787 9520 Fax +39 081 787 9481 email prisco.piscitelli@tiscali.i t Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Giovagnoli et al Running head recto: Diagnostic and therapeutic path of breast cancer  DOI: http://dx.doi.org/10.2147/CIA.S75486",Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
"Available from:  http://www.eusoma.org/Engx/Guidelines/Guideline.aspx?cont =breas t.  Accessed November 20, 2014.",Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
Available  from: http://www.asplazio.it/asp_online/att_territoriale/sias_new/ nomenclatore .php?menu =s7.,Non-OADS,/arxiv_data1/oa_pdf/53/a3/cia-10-741.PMC4407743.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ac/11/tcrm-11-633.PMC4407744.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 633Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ac/11/tcrm-11-633.PMC4407744.pdf
"Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.Dove pres s 633CoRRigenduMopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8551 9Travel advice for the immunocompromised traveler: prophylaxis,  vaccination, and other preventive measures [Corrigendum] Patel RR, Liang SY, Koolwal P, Kuhlmann FM.",Non-OADS,/arxiv_data1/oa_pdf/ac/11/tcrm-11-633.PMC4407744.pdf
"On page 224, Meningococcal vaccine heading, second sen - tence “Vaccination is recommended with the quadrivalent  polysaccharide (Menactra™)” should have read “Vaccination  with the quadrivalent meningococcal conjugate vaccine  (MCV4) is recommended”.Journal name: Therapeutics and Clinical Risk Management Article Designation: Corrigendum Y ear: 2015 Volume: 11 Running head verso: Patel et al Running head recto: Corrigendum DOI: http://dx.doi.org/10.2147/TCRM.S85519",Non-OADS,/arxiv_data1/oa_pdf/ac/11/tcrm-11-633.PMC4407744.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinicoEconomics and Outcomes Research 2015:7 213–225ClinicoEconomics and Outcomes Research Dove press submit your manuscript | www.dovepress.co m Dove press  213ORiginal REsEaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CEOR.S7811 5incorporating ulipristal acetate in the care of  symptomatic uterine fibroids: a Canadian cost- utility analysis of pharmacotherapy management Bernice Tsoi1,2 gord Blackhouse1,2 simon Ferrazzi3 Clare J Reade4 innie Chen5,6 Ron goeree1,2,7 1Department of Clinical Epidemiology  and Biostatistics, McMaster University,   hamilton, On , Canada;  2Programs for  assessment of T echnology in health  (PaTh) Research institute, st Joseph’s  healthcare hamilton, hamilton, On ,   Canada;  3independent Consultant,   Oakville, On , Canada;  4Division of  gynecologic Oncology, University  of T oronto, T oronto, On , Canada;   5Department of Obstetrics and  gynaecology, University of Ottawa,   6Ottawa hospital Research institute,   Ottawa, On , Canada;  7Centre for  Evaluation of Medicines (CEM),   st Joseph’s healthcare hamilton,   hamilton, On , Canada Correspondence: Bernice Tsoi   Programs for assessment of Technology  in health (PaTh) Research institute,   25 Main street West, suite  2000,  hamilton, On, Canada l8P  1h1  Tel +1 905 523 7284  Fax +1 905 522 0568  Email tsoib@mcmaster.c aObjective:  To present a Canadian economic evaluation on the cost-utility of ulipristal acetate  (5 mg orally daily) compared to leuprolide acetate (3.75 mg intramuscular monthly) in the   treatment of moderate-to-severe symptoms of uterine fibroids in women eligible for surgery.",Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
"ClinicoEconomics and Outcomes Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinicoeconomics-and-outcomes-research-journa lClinicoEconomics & Outcomes Research is an international, peer- reviewed open-access journal focusing on Health Technology Assess - ment, Pharmacoeconomics and Outcomes Research in the areas of  diagnosis, medical devices, and clinical, surgical and pharmacological  intervention.",Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
"Available  from: http://www.nice.org.uk/guidance/cg44/resources/guidance- heavy-menstrual-bleeding-pd f. Accessed April  23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
Available from: http://www.actavis.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
Available from: http://www.pmprb-cepmb.,Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
"Avail - able from: http://www.health.gov.on.ca/en/public/programs/drugs/pro - grams/odb/opdp_dispensing_fees.asp x. Accessed February  8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
"Available from: http://www.health.gov.on.ca/en/pro/ programs/drugs/odbf_eformulary.asp x. Accessed February  8, 2015.",Non-OADS,/arxiv_data1/oa_pdf/89/4a/ceor-7-213.PMC4407745.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/73/b7/ott-8-877.PMC4407746.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 877–883OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  877Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7103 4synergistic inhibition of colon carcinoma   cell growth by hedgehog-gli1 inhibitor   arsenic trioxide and phosphoinositide   3-kinase inhibitor l Y294002 Xinyi cai1,* Kun Yu1,* lijuan Zhang2 Yunfeng li1 Qiang li1 Zhibin Yang1 Tao shen1 lincan Duan3 Wei Xiong1 Weiya Wang1 1colorectal cancer center,   2Department of Pathology,   3Department of Thoracic surgery,    The Third affiliated hospital of  Kunming Medical University,    Kunming, People’s republic of china *These authors contributed equally   to this work correspondence: Weiya Wang   colorectal cancer center, The Third  Affiliated Hospital of Kunming Medical  University,  519 Kunzhou road, Kunming   650118, People’s republic of china   Tel +86 871 131 7061 3056  Fax +86 871 6818 1942  email daliduanlincan@163.co mAbstract:  The Hedgehog (Hh) signaling pathway not only plays important roles in embryogenesis   and adult tissue homeostasis, but also in tumorigenesis.",Non-OADS,/arxiv_data1/oa_pdf/73/b7/ott-8-877.PMC4407746.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/73/b7/ott-8-877.PMC4407746.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/73/b7/ott-8-877.PMC4407746.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/51/c5/clep-7-281.PMC4407747.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 281–293Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  281REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CLEP .S4433 6Cushing’s syndrome: epidemiology   and developments in disease management Susmeeta T Sharma1 Lynnette K Nieman1 Richard A Feelders2 1Program in Reproductive and Adult  Endocrinology, Eunice Kennedy  Shriver National institute of Child  Health and Human Development,   National institutes of Health,   Bethesda, MD, USA;  2Division of  Endocrinology, Department of  internal Medicine, Erasmus Medical  Center, Rotterdam, the Netherlands Correspondence: Richard A Feelders   Division of Endocrinology, Department  of internal Medicine, Erasmus Medical  Center,  230 Gravendijkwal,   Rotterdam  3015 CE, the Netherlands   Fax +31 10 703 3639  Email r.feelders@erasmusmc.n lAbstract:  Cushing’ s syndrome is a rare disorder resulting from prolonged exposure to excess glu - cocorticoids.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/clep-7-281.PMC4407747.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/clep-7-281.PMC4407747.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/docu - ment_library/Press_release/2013/07/WC500146613.pd f. Accessed  November  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/clep-7-281.PMC4407747.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm362415.ht m. Accessed November  13, 2014.",Non-OADS,/arxiv_data1/oa_pdf/51/c5/clep-7-281.PMC4407747.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/cd/d6/ndt-11-1091.PMC4407757.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1091–1096Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1091OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8288 4comorbid personality disorders among patients  with depression Nahathai Wongpakaran Tinakon Wongpakaran Vudhichai Boonyanaruthee Manee Pinyopornpanish suthi intaprasert Department of Psychiatry, Faculty  of Medicine, chiang Mai University,   chiang Mai, ThailandPurpose:  To investigate the personality disorders (PDs) diagnosed in patients with depressive  disorders.",Non-OADS,/arxiv_data1/oa_pdf/cd/d6/ndt-11-1091.PMC4407757.pdf
"In terms of PDs and types of depressive disorder,  Sanderson et al reported a prevalence of PDs among those with major depressive correspondence: Nahathai Wongpakaran Department of Psychiatry, Faculty of  Medicine, chiang Mai University, 110  intawaroros road, Tambon sriphum,  amphoe Muang, chiang Mai, 50200,  Thailand Tel +66 53 945 422 Fax +66 53 945 426 email nahathai.wongpakaran@cmu.ac.t h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Wongpakaran et al Running head recto: Personality disorders in depression DOI: http://dx.doi.org/10.2147/NDT.S82884",Non-OADS,/arxiv_data1/oa_pdf/cd/d6/ndt-11-1091.PMC4407757.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/cd/d6/ndt-11-1091.PMC4407757.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/cd/d6/ndt-11-1091.PMC4407757.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 871–876OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  871Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8048 8enzalutamide for patients with metastatic  castration-resistant prostate cancer Correspondence: wijdan H Ramadan Department of Pharmacy Practice,  School of Pharmacy, Lebanese American  University, PO Box 36-F 53, Byblos,  Lebanon Tel +961 9 547 249 ext 2267 Fax +961 9 547 256 ext 2897 email wramadan@lau.edu.l b wijdan H Ramadan1 wissam K Kabbara1 Hiba S Al Basiouni Al Masri2 1Department of Pharmacy Practice,   School of Pharmacy, Lebanese  American University, Byblos, Lebanon;   2School of Pharmacy, Beirut Arab  University, Beirut, LebanonObjective:  To review and evaluate current literature on the US Food and Drug Administration  (FDA)-approved drug enzalutamide (XTANDI®) in metastatic castration-resistant prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
"In addition,  DNA mutations to the AR gene affect the LBD, causing altered response of the AR  to hormones other than testosterone, such as estrogen or hydrocortisone, as well as  responding to AR antagonists such as bicalutamide.5Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Ramadan et al Running head recto: Enzalutamide for metastatic castration-resistant prostate cancer DOI: http://dx.doi.org/10.2147/OTT.S80488",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
"Atlanta, Ga:  American Cancer Society, 2015. http://www.cancer.gov/cancertopics/ types/commoncancer s. Accessed March 15, 2015.",Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
Available   from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/   203415lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
Available  from: http://clinicaltrials.gov/ct2/show/NCT01288911?term=MDV3 100&rank=13.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
Available from: http://pharmastrategyblog.com/2011/04/abiraterone- now-approved-as-zytiga-by-the-fda-in-castrate-resistant-prostate- cancer.html/.,Non-OADS,/arxiv_data1/oa_pdf/ae/6c/ott-8-871.PMC4407758.pdf
2012 .http://www.who.int/in ﬂuenza/vaccines/virus/ recommendations/201202_recommendation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/6c/f4/jiu647.PMC4407759.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/e7/jiu651.PMC4407760.pdf
"This is an Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivslicence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of thework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1b/82/jiu811.PMC4407763.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/8d/opth-9-691.PMC4407764.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 691–695Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  691Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7948 2surgical effects of nasal transposition of inferior  rectus muscle –  135 cases of acquired superior  oblique palsy Mana Okamoto akiko Kimura akiko Masuda Osamu Mimura Department of Ophthalmology,   hyogo College of Medicine hospital,   nishinomiya, JapanAbstract:  Nasal transposition of the inferior rectus (IR) muscle, which is transposed nasally  with the insertion parallel to the spiral of Tillaux, could correct excyclotropia.",Non-OADS,/arxiv_data1/oa_pdf/f3/8d/opth-9-691.PMC4407764.pdf
"Furthermore, vertical transposition  of the horizontal rectus muscles has also been reported to correct cyclodeviation.12  These techniques utilized the fact that the superior rectus (SR) and medial rectus (MR) Correspondence: Mana Okamoto Department of Ophthalmology, hyogo  College of Medicine hospital, 1-1  Mukogawa-cho, nishinomiya city, hyogo,  Japan 663-8501 Tel +81 798 45 6462 Fax +81 798 45 6464 email manamana429@gmail.co mJournal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Okamoto et al Running head recto: Surgical effects of IR nasal transposition – 135 cases of SO palsy DOI: http://dx.doi.org/10.2147/OPTH.S79482",Non-OADS,/arxiv_data1/oa_pdf/f3/8d/opth-9-691.PMC4407764.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/f3/8d/opth-9-691.PMC4407764.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/8d/opth-9-691.PMC4407764.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 803–811International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  803OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7984 2Anti-inflammatory effects of salmeterol/fluticasone  propionate 50/250 mcg combination therapy  in Japanese patients with chronic obstructive  pulmonary disease Kazuhisa Asai1 Akihiro Kobayashi2 Yukio Makihara3 Malcolm Johnson4 1Department of Respiratory Medicine,   Graduate School of Medicine,   Osaka City University, Osaka, Japan;   2Biomedical Data Sciences, 3Medical  Affairs Respiratory Department,   GlaxoSmithKline, T okyo, Japan;   4Respiratory Global Franchise,   GlaxoSmithKline, Uxbridge, UKPurpose:  Using sputum neutrophils as the primary measure, and other inflammation biomarkers,  this study evaluated the anti-inflammatory effects of the combination salmeterol 50 mcg and  fluticasone propionate 250 mcg (SFC 250) in Japanese patients with chronic obstructive  pulmonary disease (COPD).",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
"Keywords:  biomarkers, IL-8, neutrophils, serum, sputum Introduction Chronic obstructive pulmonary disease (COPD) is currently ranked as the tenth highest  cause of death in Japan, and its prevalence is increasing.1 COPD is underrecognized in  Japan, and data suggest its prevalence is also underestimated.2–5 COPD is considered a  multicomponent disease, involving both pulmonary and systemic inflammation.1,6,7 In Japan, and globally, the current goals of COPD management include the  improvement of symptoms and quality of life as well as the prevention and treatment Correspondence: Yukio Makihara Medical Affairs Respiratory Department,  GlaxoSmithKline, 6-15 Sendagaya  4-chome, Shibuya-ku, Tokyo, 151-8566  Japan Tel +81 357 865 336 email yukio.2.makihara@gsk.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Asai et al Running head recto: Salmeterol/fluticasone propionate in Japanese COPD patients DOI: http://dx.doi.org/10.2147/COPD.S79842",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
"Available from: http://www.goldcopd.com/uploads/users/ files/GOLD_Report_2014_Oct30.pd f. Accessed December 15, 2014.",OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/d3/copd-10-803.PMC4407765.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/05/imcrj-8-093.PMC4407820.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 93–96International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  93Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S8303 6acute orbital apex syndrome and rhino-orbito- cerebral mucormycosis Ursula M anders1 elise J taylor1 Joseph R Martel1–3 James B Martel1–3 1Research Center, Martel eye Medical  Group, Rancho Cordova, 2Graduate  Medical education, California  Northstate University College of  Medicine, elk Grove, 3Department  of ophthalmology, Dignity Health,  Carmichael, Ca, Usa Correspondence: James B Martel   Graduate Medical education,   California Northstate University   College of Medicine,  9700 West taron   Drive, elk Grove, Ca  95757, Usa   tel +1 916 686 7300  Fax +1 916 686 7310  email james.martel@cnsu.ed uPurpose:  To demonstrate the successful clinical identification and management of rhino-orbital  mucormycosis, a fungal infection with a high mortality rate.",Non-OADS,/arxiv_data1/oa_pdf/6e/05/imcrj-8-093.PMC4407820.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/6e/05/imcrj-8-093.PMC4407820.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/05/imcrj-8-093.PMC4407820.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ijn-10-3031.PMC4407821.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3031–3042International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3031OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7898 3Pharmacokinetics of quercetin-loaded  nanodroplets with ultrasound activation  and their use for bioimaging li-Wen chang1 Mei-ling hou1 shuo-hui hung2 lie-chwen lin3 T ung-hu Tsai1,4–6 1Institute of Traditional Medicine,   school of Medicine, National Yang- Ming University, 2Department  of surgery, 3National research  Institute of chinese Medicine,   Ministry of health and Welfare,   Taipei, 4Department of education  and research, Taipei city hospital,   5school of Pharmacy, college of  Pharmacy, Kaohsiung Medical  University, Kaohsiung, 6graduate  Institute of acupuncture science,   china Medical University, Taichung,   TaiwanAbstract:  Bubble formulations have both diagnostic and therapeutic applications.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ijn-10-3031.PMC4407821.pdf
"Compared with other imaging techniques, ultrasound systems are cost- effective, portable, easy to use, and safe for both clinical staff and patients over repeated  use due to lack of ionizing radiation.12 Bubble formulations represent a new class of encapsulation systems with both  diagnostic and therapeutic applications.11 They can transport drugs or genes to a specific  location, at which point ultrasound is applied, causing the formulations to burst and  leading to site-specific delivery of bioactive materials.13 In addition to targeted drug correspondence: Tung-hu Tsai Institute of Traditional Medicine, school  of Medicine, National Yang-Ming  University, 155, section 2, li-Nong  street, Taipei 112, Taiwan Tel +886 2 2826 7115 Fax +886 2 2822 5044 email thtsai@ym.edu.t w Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chang et al Running head recto: Pharmacokinetics of quercetin-loaded nanodroplets DOI: http://dx.doi.org/10.2147/IJN.S78983",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ijn-10-3031.PMC4407821.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ijn-10-3031.PMC4407821.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e3/c6/ijn-10-3031.PMC4407821.pdf
"Author contributions All authors have agreed on the ﬁnal version and meet atleast one of the following criteria [recommended by the IC- MJE (http://www.icmje.org/ethical_1author.html)]: substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; drafting the article or revising it critically for importantintellectual content.",Non-OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Retrieved from http://www.ahrq.gov/data/hcup on 29 May 2009.,OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Retrieved fromhttp://www.handbook.cochrane.org on 02 June 2012. International Monetary Fund (2014) World Economic Outlook Database April .,OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Retrieved from http://www.imf.org/external/pubs/ft/weo/2014/01/weodata/index.aspx on 18 August 2014.,Non-OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Retrieved from http://joannabriggs.org/assets/docs/approach/JBI-Levels-of- evidence_2014.pdf on 15 August 2014.,OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Retrievedfrom http://www.nice.org.uk/media/D45/1E/GuideToMethods TechnologyAppraisal2013.pdf (accessed 12 March 2013).,Non-OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
Fast and easy online submission: online submission at http://mc.manuscriptcentral.com/jan.,Non-OADS,/arxiv_data1/oa_pdf/25/b8/jan0071-0975.PMC4407837.pdf
"The phylogenetic tree for the VP1 region was generated using the neighbor-joining method, as implemented in MEGA software (http://www.megasoftware.net/).",OADS,/arxiv_data1/oa_pdf/1c/f0/rmv0025-0102.PMC4407910.pdf
http://www.picornaviri- dae.com/enterovirus/ev-d/ev-d.htm [10 Oc- tober 2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/f0/rmv0025-0102.PMC4407910.pdf
http://www.cdc.gov/non-polio-enterovi-rus/outbreaks/EV-D68-outbreaks.html [10October 2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/f0/rmv0025-0102.PMC4407910.pdf
http://www.neurology.org/ content/82/10_Supplement/P3.335 [10 Oc-tober 2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/f0/rmv0025-0102.PMC4407910.pdf
http://www.cidrap.umn.edu/news-per-spective/2014/09/cdc-notes-more-ev-d68-sees-link-earlier-polio-illness [10 October2014].,Non-OADS,/arxiv_data1/oa_pdf/1c/f0/rmv0025-0102.PMC4407910.pdf
Version 2013.2. http://www.iucnredlist.org.,Non-OADS,/arxiv_data1/oa_pdf/ea/8b/jpe0052-0422.PMC4407913.pdf
Version 2013.2. http://www.iucnredlist.,Non-OADS,/arxiv_data1/oa_pdf/ea/8b/jpe0052-0422.PMC4407913.pdf
The Genomatix Matin- spector program (http://www.genomatix.de) was usedto perform the scan.,OADS,/arxiv_data1/oa_pdf/cf/10/liv0035-1152.PMC4407926.pdf
iThe cellular location of identiﬁed proteins as predicted by TargetP (http://www.cbs.dtu.dk/services/TargetP) and/or PSORT (http://psort.hgc.,OADS,/arxiv_data1/oa_pdf/86/ed/pce0038-0655.PMC4407928.pdf
Protein classiﬁcation and hierarchical cluster analysis The functional information for the identiﬁed proteins was extracted from Blast searches against the NCBI(http://www.ncbi.nlm.nih.gov/protein) and UniProt (http://www.uniprot.org) databases.,OADS,/arxiv_data1/oa_pdf/86/ed/pce0038-0655.PMC4407928.pdf
The sub-cellular location information of each protein wasobtained using the Target P (http://www.cbs.dtu.dk/services/TargetP/) or PSORT (http://psort.hgc.jp/) software predic-tion programs.,OADS,/arxiv_data1/oa_pdf/86/ed/pce0038-0655.PMC4407928.pdf
A self-organizing tree algorithm ofhierarchical clustering of protein relative abundance proﬁleswas performed on the log-transformed fold change values ofprotein spots using Cluster software (version 3.0; http://rana.lbl.gov/EisenSoftware).,OADS,/arxiv_data1/oa_pdf/86/ed/pce0038-0655.PMC4407928.pdf
MS/MS data were interpreted usingMASCOT (http://www.matrixscience.com) program search-ing the EST database of Halogeton glomeratus .,OADS,/arxiv_data1/oa_pdf/86/ed/pce0038-0655.PMC4407928.pdf
"Signi ﬁcance testing was calculated using the StatCalc chi-squared test function of EpiInfoTMsoftware for data collection, analysis, and reporting made available by the US Centers forDisease Control and Prevention (http://www.cdc.gov/ epiinfo, accessed 1 September 2013).",OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
"The National Acad-emies Press: Washington, DC; 2009: http://www.nap.edu/catalog.php?record_id=12648.",Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
"Rockville, MD: Agency for Healthcare Research and Quality; 2012: http://www.effective healthcare.ahrq.",Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Availableat: https://www.ncdr.com/webncdr/icd/.,OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Available at: http://seer.cancer.gov/about/.,Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
"(Tuesday, October 11, 2011) ed; 2011. http://www.gpo.gov/fdsys/pkg/FR-2011-10-11/html/2011-25907.htm.",Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Available at: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
"Search results at: http://circ.ahajournals.org/search?submit=yes&pubdate_year=1997&volume=& ﬁrstpage=&doi=&author1=&aut- hor2=&title=registr*&andorexacttitle=and&titleabstract=registr*&andorexactti-tleabs=and&fulltext=registr*&andorexactfulltext=and&exclude ﬂag=exclude_n- one&fmonth=&fyear=&tmonth=&tyear=&format=condensed&hits=10&sortsp-ec=relevance&submit=yes&submit=Submit AND Searching journal content for 2012 in year, registr* (all words) in title, registr* (all words) in title or abstract, and registr* (all words) in full text.",Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Search results at: http://circ.ahajournals.org/search?submit=yes&pubdate_year=2012&volume=& ﬁrstpage=&doi=&author1=&aut- hor2=&title=registr*&andorexacttitle=and&titleabstract=registr*&andorexactti- tleabs=and&fulltext=registr*&andorexactfulltext=and&exclude ﬂag=exclude_n- one&fmonth=&fyear=&tmonth=&tyear=&format=condensed&hits=10&sortsp-ec=relevance&submit=yes&submit=Submit.,Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Available at: http://www.encepp.eu/.,Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
"Patient-CenteredOutcomes Research Institute (PCORI): Washington, DC, 2012: http://pcori.org/assets/MethodologyReport-Comment.pdf [24 January 2013] 26.",Non-OADS,/arxiv_data1/oa_pdf/2f/71/pds0024-0389.PMC4407929.pdf
Medscape http://reference.medscape.,Non-OADS,/arxiv_data1/oa_pdf/ad/a9/jcph0055-0490.PMC4407950.pdf
"Available at:http://www.effectivehealthcare.ahrq.gov/ehc/products/169/834/urinary-incontinence-treatment-report-130909.pdf Accessed Dec 3, 2013.",Non-OADS,/arxiv_data1/oa_pdf/ea/8c/nau0034-0244.PMC4407951.pdf
Available from: http://www.pewinternet.org/Reports/2013/Health- online.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ea/8c/nau0034-0244.PMC4407951.pdf
Available from: http://www.scb.s e/Pages/SSD/SSD_Tr eeView.aspx?id ¼340478& ExpandNode ¼AM%2fAM0110.,OADS,/arxiv_data1/oa_pdf/ea/8c/nau0034-0244.PMC4407951.pdf
"Available from: http://www.socialstyrelsen.se/publikationer2010/2010-10-15/Documents/ halsoekonomiskt-vetenskapligt-underlag.pdf Accessed Nov 27, 2013.250 Sj€ostr€om et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/8c/nau0034-0244.PMC4407951.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2014  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseOctober 2014 |  92  | e52142 | Page 1 of 6Video Article Use of Stopped-Flow Fluorescence and Labeled Nucleotides to Analyze the ATP Turnover Cycle of Kinesins Jennifer T. Patel1, Hannah R. Belsham1, Alexandra J. Rathbone1, Claire T. Friel1 1School of Life Sciences, University of Nottingham Correspondence to: Claire T. Friel at claire.friel@nottingham.ac.uk URL: http://www.jove.com/video/52142 DOI: doi:10.3791/52142 Keywords: Chemistry, Issue 92, Kinesin, ATP turnover, mantATP, mantADP, stopped-flow fluorescence, microtubules, enzyme kinetics, nucleotide Date Published: 10/17/2014 Citation: Patel, J.T., Belsham, H.R., Rathbone, A.J., Friel, C.T.",Non-OADS,/arxiv_data1/oa_pdf/82/20/jove-92-52142.PMC4408023.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/52142/ Introduction The kinesins are a superfamily of proteins characterized by a highly conserved motor domain1.,Non-OADS,/arxiv_data1/oa_pdf/82/20/jove-92-52142.PMC4408023.pdf
"Briefly,  counterions were removed, whereas specific chemotypes such as aromatic and nitro groups  were normalized using the ChemAxon Standardizer (v.5.3, ChemAxon, Budapest, Hungary,  http://www.chemaxon.com ).",Non-OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
"In this study, we have employed the Sequential Agglomerative  Hierarchical Non-overlapping (SAHN) method implemented in the ISIDA/Cluster program  (http://infochim.u-strasbg.fr ) (Varnek et al., 2007 ).",OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
DERMWIN— The Dermal Permeability Coefficient Program (DERMWIN) is a module  available in the EPI Suite package developed by the EPA’s Office of Pollution Prevention  Toxics and Syracuse Research Corporation and available at http://www.epa.gov/oppt/ exposure/pubs/episuitedl.htm .,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
The compiled datasets and  all the models developed in this study have been made publicly available at the Chembench  Web Portal ( http://chembench.mml.unc.edu ).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
URL http://ntp.niehs.nih.gov/iccvam/docs/immunotox_docs/LLNA-LD/TMER.pdf  (accessed 2.20.12).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
URL http://www.oecd.org/ chemicalsafety/risk-assessment/37849783.pdf  (accessed 4.11.13).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
URL  http://search.oecd.org/officialdocuments/displaydocumentpdf/?cote=env/jm/mono(2012)10/ part1&doclanguage=en  (accessed 4.11.12).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
URL http://www.oxea-chemicals.com/download/wercs/ MTA5MDAjZW4jcHMjYXVzIzEzNjg2MTA1NzIwMDAjb3hlYSMxI0Q=/10900-en-ps-us.pdf  (accessed 11.18.14).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
URL http://www.epa.gov/oswer/riskassessment/ragse/index.htm  (accessed 5.13.13).,OADS,/arxiv_data1/oa_pdf/f1/49/nihms662049.PMC4408226.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distributio n, and reproduction in any medium, provided the original work is properly cited.1 Citation: Libyan J Med 2015, 10: 27760 - http://dx.doi.org/10.3402/ljm.v10.27760 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/59/6d/LJM-10-27760.PMC4408317.pdf
"2011; 6: 5934, doi: http://dx.doi.org/ 10.3402/ljm.v6i0.5934Helmi Ben Saad 2 (page number not for citation purpose)Citation: Libyan Journal of Medicine 2015, 10: 27760 - http://dx.doi.org/10.3402/ljm.v10.27760",Non-OADS,/arxiv_data1/oa_pdf/59/6d/LJM-10-27760.PMC4408317.pdf
"Our most important criterion was that the participant must have been a regular and exclusive smoker of shisha or cigarettes for many years,leaving the kind of tobacco for future research.Sincerely, Abdessalem Koubaa Clinical Laboratory of Physiology Physiology and Functional Testing Department, 98/UR08-67 Medical School of Sousse, University of Sousse Sousse, Tunisia Moez Triki Clinical Laboratory of Physiology Physiology and Functional Testing Department, 98/UR08-67 Medical School of Sousse, University of Sousse Sousse, Tunisia Email: trikimoez27@yahoo.fr Hajer Trabelsi Clinical Laboratory of Physiology Physiology and Functional Testing Department, 98/UR08-67 Medical School of Sousse, University of Sousse Sousse, Tunisia Ahmad Hakim Clinical Laboratory of Physiology Physiology and Functional Testing Department, 98/UR08-67 Medical School of Sousse University of Sousse Sousse, TunisiaLetter to the editor Citation: Libyan Journal of Medicine 2015, 10: 27760 - http://dx.doi.org/10.3402/ljm.v10.27760 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/59/6d/LJM-10-27760.PMC4408317.pdf
"Raw methylation percentages of all genes weredepicted in ‘‘Online Resource Table 7.’’ Correlation between mRNA expression and promoter methylation by TCGA To correlate methylation of the investigated tumor sup- pressor genes to mRNA expression, we used The Cancer Genome Atlas ( https://tcga-data.nci.nih.gov/tcga/ ).",OADS,/arxiv_data1/oa_pdf/6f/f7/10549_2015_Article_3362.PMC4408366.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/6f/f7/10549_2015_Article_3362.PMC4408366.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/41/5a/10549_2015_Article_3363.PMC4408370.pdf
google.com/) and PubMed database (http://www.ncbi.nlm.nih.gov/pubmed/) were used.,OADS,/arxiv_data1/oa_pdf/96/93/CEJU-68-00474.PMC4408390.pdf
"27th Annual Congress  of European Association  of Urology,  Paris (France), 24 –28 February 2012.  http://dx.doi.org/10.1016/S1569–9056  (12)60806–9.",Non-OADS,/arxiv_data1/oa_pdf/83/34/CEJU-68-00496.PMC4408394.pdf
Available  from: http://www.cancerjournal.net/ preprintarticle.asp?id=146125 9.,Non-OADS,/arxiv_data1/oa_pdf/4f/39/CEJU-68-00498.PMC4408395.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/23/4c/msv005.PMC4408405.pdf
Supplementary Material Supplementary table S1–S3 and methods S1 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/23/4c/msv005.PMC4408405.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/7b/44/msv008.PMC4408406.pdf
"A relatively large number of sequenced genomic fragments from diverse plants is available for the further in-depth miningof LTR retrotransposons ( http://www.phytozome.net/ ,l a s taccessed May 25, 2014).",OADS,/arxiv_data1/oa_pdf/7b/44/msv008.PMC4408406.pdf
"Therefore, we used an additional round of struc- tural domain prediction, and the representative LTR retro- transposons were scanned using HHpred, a server thatperforms homology detection and structure prediction(http://toolkit.tuebingen.mpg.de/hhpred/ , last accessed August 10, 2014; S€oding et al.",OADS,/arxiv_data1/oa_pdf/7b/44/msv008.PMC4408406.pdf
"2005 ) and using COILS, which predicts CCs ( http://toolkit.tuebingen.mpg.de/pcoils ,l a s t accessed August 10, 2014; Lupas et al.",OADS,/arxiv_data1/oa_pdf/7b/44/msv008.PMC4408406.pdf
Supplementary Material Supplementary table S1 and ﬁgures S1–S5 a r ea v a i l a b l ea t Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/7b/44/msv008.PMC4408406.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/ef/msv011.PMC4408407.pdf
Supplementary Material Supplementary tables S1–S6 and ﬁgures S1–S8 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/4b/ef/msv011.PMC4408407.pdf
Data Accessibility The genotype data matrix from the SX transect is available from http://hdl.handle.net/2027.42/83674 Acknowledgments The SX genotype data were collected with support from NSF DEB 0746560 to P.K.T.,OADS,/arxiv_data1/oa_pdf/4b/ef/msv011.PMC4408407.pdf
Available from: http://CRAN.R-project.org/ package=nlme .,Non-OADS,/arxiv_data1/oa_pdf/4b/ef/msv011.PMC4408407.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"S1 and table S1 ,Supplementary Material online, database available for download at http://msbi.ipb-halle.de/down- load/phyloBlastDB_Drost_Gabel_Grosse_Quint.fa.tbz ,l a s t accessed August 2, 2015).",OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"Materials and Methods Scripts for complete reproducti on of all data presented in this manuscript including database generation, constructionof phylostratigraphic and sequence divergence maps, compu-tation of TAI and TDI patterns, essential gene analysis,and statistical tests are available via the GitHub re-pository ( https://github.com/HajkD /Active-maintenance-of- phylotranscriptomic-hourglasses , last accessed August 2, 2015).",Non-OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"Detailed instructions for applications of the same anal-yses to any expression data set and any species with sufﬁcientgenome information can be found in the R packages myTAI(Drost 2014 ) and orthologr ( https://github.com/HajkD/ orthologr , last accessed August 2, 2015).",OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"Third, we generate a target database from these sequences ( http://msbi.ipb-halle.de/ download/phyloBlastDB_Drost_Gabel_Grosse_Quint.fa.tbz , last accessed August 2, 2015) and BLAST each amino acidsequence of A. thaliana (TAIR10; 35,386), Da.",OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"It can be applied to any chosen species pair with available coding se-quence genomes and can be computed using the orthologrpackage ( https://github.com/HajkD/orthologr , last accessed August 2, 2015).",OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
Supplementary Material Supplementary ﬁgures S1–S10 and tables S1–S5 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
Available from: http://CRAN.R-project.org/package=myTAI .,Non-OADS,/arxiv_data1/oa_pdf/05/0c/msv012.PMC4408408.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/57/msv017.PMC4408412.pdf
Available from: http://www.phrap.org .,Non-OADS,/arxiv_data1/oa_pdf/09/57/msv017.PMC4408412.pdf
Available from: http://tree.bio.ed.ac.uk/software/seal .,OADS,/arxiv_data1/oa_pdf/09/57/msv017.PMC4408412.pdf
Available from: http://www.repeatmasker.org .,Non-OADS,/arxiv_data1/oa_pdf/09/57/msv017.PMC4408412.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use , distribution, and reproduction in any medium, provided the original work is prop erly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/4c/msv024.PMC4408414.pdf
"Structural homology models were generated using the S W I S S - M O D E Lo n l i n es e r v i c e( http://swissmodel.expasy.org/ , last accessed February 18, 2015; Arnold et al.",OADS,/arxiv_data1/oa_pdf/8b/4c/msv024.PMC4408414.pdf
Supplementary Material Supplementary ﬁgures S1–S3 and text S1 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/8b/4c/msv024.PMC4408414.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommerci al 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use, distribution, and reproductio n in any medium, provided the original work is properly cited.1 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking lunch 12:15-13:15 Poster viewing sessions I, II, III, IV, V, VI, VII Posters attended by authors 12:45-13:15 Poster walk by chairpersons, sessions I, II, III, IV, V, VI, VII Posters attended by authors 14:00-15:00Thursday April 23, 2015 2 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"However,each Rab has very different effects on SC intracellular compartments.Importantly, overexpression of dominant negative Rabs does notproduce these specific defects, suggesting that their effects are notScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 3",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The interpretationof the effects of Rab knockdown on EV secretion, therefore, requirescareful analysis of trafficking in compartments in addition to endolysosomes.Thursday April 23, 2015 4 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Finally, molecular analysis of MSC exosomal contentrevealed an enrichment of a panel of microRNA, which we arecurrently investigating for dysregulation of interferon signaling.Summary/conclusion : Taken in aggregate, these data suggest that HSPC activation occurs via MSC exosome trafficking of microRNA and involves the upregulation of type I interferon-signaling pathways.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 5",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : During an oral presentation we will provide the rationale and structure of the biorepository and patient safetystandards and then demonstrate file-encoding, acquisition, bulk fileacquisition on a ‘‘real-time basis’’ as a model for synergies within theISEV community.Thursday April 23, 2015 6 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"We have shown that the VRD not only stains microvesicles but also lipoproteins identified as ApoE positiveScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 7",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ conclusion : Identification of these EV sub-populations provides an inventory of the complex composition of extra-cellular vesiclesfound in human ejaculate, their morphologies and prevalence.Thursday April 23, 2015 8 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Importantly, we showed that extracellular miRNA reper-toires from these two epididymal regions are distinct and differfrom the miRNA signature identified in epididymal epithelial cells,Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 9",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ Conclusion : Our results demonstrate the development of a minimally invasive tumour ‘‘biopsy’’ that eliminates the need to find and accessa tumour.Thursday April 23, 2015 10 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Cell cycle analysis revealed that normoxic and hypoxic RKO and LoVo cells in serum-free medium arrested in G1 phase.Summary/conclusion : Bovine exosomes (in FBS) and exosomes from cells arrested in the G1 phase of the cell cycle may impinge onScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 11",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"On the contrary, in vivo metastatic mouse model demonstrated that EVs from SD-MSCsThursday April 23, 2015 12 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : Our findings provide novel insights on how endocytic receptor trafficking regulatesScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 13",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"When human neuroglioma cells that express mutated forms of presenilin 1 that cause familial Alzheimer’s diseaseThursday April 23, 2015 14 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Further in vitro and in vivo analysis of the therapeutic potential of EVs from ECs is ongoing in orderto better understand the effect of source cell phenotype-specific differences on the potential of EVs to stimulate vascularization.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 15",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Arthritis Res TherThursday April 23, 2015 16 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Exosomal markers, CD81 and Alix wereenriched in EV preparations while gp96 (endoplasmic reticulumScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 17",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Funded by NIH EB003824 (JPN), NIH TR000931 (BSC, FHH),TR000891 (KJ, MH) and TR000903 (JAS, JFQ).Thursday April 23, 2015 18 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 16:00-16:30 Poster sessions I, II, III, IV, V, VI, VII continued Posters not attended by authors 16:00-16:30Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 19",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"In addition,this algorithm is capable of identifying artifacts like rotational dif-fusion making the NTA particle size analysis more robust.Thursday April 23, 2015 20 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Direct isolation methods have the potentialnot only to shorten the workflow, but also to reduce any artifacts or contamination that can result from the enrichment procedure.Ballroom E Biotechnology: sponsored session B Chairs: Sai Kiang Lim and Steven M. Jay 16:30-17:00Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 21",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ conclusion : With precise configuration and close attention to theThursday April 23, 2015 22 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The antibodies represent the first group of immunological reagents that have been specifically developed for EV characterization based on primaryimmunization with highly purified EV preparations.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 23",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Our work aims at the development of a novelimmunotherapeutic approach for CLL based on the transfer ofCD40L together with immunodominant Epstein-Barr-Virus (EBV) andCytomegalovirus (CMV) proteins to malignant CLL cells by means ofThursday April 23, 2015 24 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The MSC-EVs’ immunomodulatory properties were studied inScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 25",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Even though, all MSC-EV fractions which we had used in in vivo studies were selectedaccording to their capabilities to exert immunosuppressive functionsin vitro, it will be important to also study the therapeutic impact ofMSC-EV fractions lacking in vitro immunosuppressive functions.Currently, we are improving the platform to produce MSC-EVs for the clinical setting and search for surrogates to discriminate therapeutic effective and non-effective MSC-EV samples.Thursday April 23, 2015 26 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : Both MMC and CTMC released distinct EV populations after stimulation as indicated by changes in buoyantScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 27",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"EVs contained less mRNA than their cells of origin butThursday April 23, 2015 28 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These findings suggest that the normal RPE milieu mayskew monocyte differentiation towards a regulatory phenotype andthe inflammatory milieu of the RPE reverses this regulatory phenotypein particular through exosomes.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 29",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Presenters: Joel Rozowsky (intro/overview), Roger Alexander (use case), Sai Lakshmi Subramanian (exRNA Atlas), Rob Kitchen (RNA-Seq pipelines/WikiPathways/Cytoscape).Thursday April 23, 2015 30 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These experiments were performed on whole mount prepara- tions of the choroid plexus (CP) and lateral wall from WT and Alix- KO brains; ex vivo cultures of tracheal epithelial cells; cultured CP cells.Results :Alix-KO mice were viable and had a normal lifespan, but wereScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 31",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"With the information, we suggest that thepresence of these proteins found in the OMVs from RC85 /C27is essential for the bacterial growth and survival in an environment with antibiotics.Thursday April 23, 2015 32 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-II-4 Experimental conditions of exosomes derived from adipose-derived mesenchymal stem cells effectively protect glutamate-induced PC-12 cell injury Xiaofei Ji1,Jing Liu1, Yu Sun1, Chao Li1, Rutao Liu2, Jingjing Zhang1, Yan Ren1and Wenjuan Wei1Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 33",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"However, there have been some recent debates regardingthe low yields, purity and biophysical properties of these purified EVs.We have recently demonstrated in a systematic comparison studythat an alternative strategy /C1size-exclusion liquid chromatography (LC), is more efficient than UC in deriving higher yields of pure EVsThursday April 23, 2015 34 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Downregulation of either of these markers sufficed for astriking downregulation of circulating immune complexes (CIC)Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 35",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Research onThursday April 23, 2015 36 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Thus, MSC-derivedEVs may represent an alternative to MSC transplantation for therapeuticScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 37",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These data have significant implications for potentialproduction of MSC-derived EVs for therapeutic applications.Thursday April 23, 2015 38 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Samples of 4 ml and under are realistic in vitroworking volumes and are within the advertized ranges of all kits,Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 39",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-III-10 Detection of cancer-derived extracellular vesicles from body fluid by aqueous two-phase system Jiyoon Kim1, Hyunwoo Shin Shin2and Jaesung Park2Thursday April 23, 2015 40 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Main disadvantage has been reported in exosome pellet solubilization, very hard for some reagent tested.Remarkable, a chemical reagent showed high efficiency in isolatingScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 41",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : Here we demonstrate parameters important for efficient capture kinetics ofThursday April 23, 2015 42 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-III-21 Optimization of extracellular vesicle isolation directly from melanoma metastases Rossella Crescitelli1, Taral R. Lunavat1, Johanna Ho ¨o¨g1, Valerio Belgrano2, Su Chul Jang3, Cecilia La ¨sser1, Yong Song Gho3, Roger Olofsson Bagge2 and Jan Lo ¨ tvall1Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 43",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"miRNA and messengerThursday April 23, 2015 44 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Sponsored posterScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 45",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : A microchip-basedThursday April 23, 2015 46 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-IV-11 Detection of epithelial antigens on tumour vesicles by flow cytometry: selection of antibodies Anita N. Bo ¨ ing, Anita E. Grootemaat, Auguste Sturk and Rienk NieuwlandScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 47",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-IV-14 A new fluorescent probe for identifying extracellular vesicles Joshua Welsh1, Nicola Englyst1, Judith Holloway1, James Wilkinson2and David Smith3 1Department of Medicine, University of Southampton, Southampton, United Kingdom;2Department of Engineering, University of Southampton, Southampton, United Kingdom;3Anaesthetics, University Hospitals Southampton, Southampton, United Kingdom Please see Oral with poster A P-IV-15 A novel method to validate fluorescence nanoparticle tracking analysis for phenotyping extracellular vesicles Rebecca Dragovic1, Gavin Collett1, Patrick Hole2, Christopher Redman1, Ian Sargent1and Dionne Tannetta1 1Nuffield Department of Obstetrics & Gynaecology, University of Oxford, Oxford, United Kingdom;2Malvern Instruments, Amesbury, United Kingdom Please see Oral with poster A P-IV-16 Differential detergent sensitivity of extracellular vesicle subpopulations Xabier Osteikoetxea1, Barbara So ´dar1, Andrea Ne ´meth1, Krisztina Pa ´lo´czi1, Katalin Szabo ´-Taylor1, Krisztina Vukman1,A´gnes Kittel2,E´va Pa ´llinger1and Edit I. Buzas1 1Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary;2Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest, Hungary Please see Oral with poster A P-IV-17 Simplified protocol for flow cytometry analysis of fluorescently labelled microvesicles and exosomes using dedicated flow cytometer Vendula Pospichalova1, Jan Svoboda2, Zankruti Dave1, Anna Kotrbova1, Dobromila Klemova3, Ladislav Ilkovics3, Ales Hampl3, Igor Crha4, Eva Jandakova4, Lubos Minar4, Vit Weinberger4and Vitezslav Bryja1 1Institute of Experimental Biology, Masaryk University, Brno, Czech Republic; 2Bio-port Europe, Svinare, Czech Republic;3Faculty of Medicine, Masaryk University, Brno, Czech Republic;4Department of Obstetrics and Gynecology, Faculty Hospital Brno, Brno, Czech Republic Introduction : Flow cytometry is a powerful method, which is widely used for high-throughput quantitative and qualitative analysis of cells.However, its straightforward applicability for extracellular vesicles andThursday April 23, 2015 48 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-IV-21 Violet SSC: an alternative to FSC PMT or fluorescence in the detection of extracellular vesiclesJohn Tigges, Virginia Camacho and Vasilis Toxavidis Flow Cytometry, Beth Israel Deaconess, Boston, MA, USAScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 49",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Sponsored poster P-IV-24 Use of ApogeeMix beads to assess the performance of flow cytometers for small particle analysis Oliver Kenyon Apogee Flow Systems Ltd, Hemel Hempstead, United Kingdom Introduction : The complex relationship between particle size and the amount of light scattered at different collection angles makes itdifficult to infer particle size from a flow cytometer’s light scatter data.A population may be described as scattering an amount of light equalThursday April 23, 2015 50 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Sponsored posterScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 51",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-V-4 Hybrid exosomes by fusion with functional liposomes for drug delivery systemYoko Sato 1, Kaori Umezaki1, Shin-ichi Sawada1,2, Sada-atsu Mukai1,2, Naozumi Harada1,3, Hiroshi Shiku1,3and Kazunari Akiyoshi1,2 1Department of Research Project, JST ERATO, Tokyo, Japan; 2Bio-macromolecular Science, Kyoto University, Kyoto, Japan;3Mie University, Mie, JapanThursday April 23, 2015 52 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : Exosome-like nanoparticles canScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 53",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"SPECT/CT images of99mTc-HMPAO-ENV injected mice exhibited high uptake in liver and no uptake in brain, whereas 99mTc-HMPAO only injected mice showed high brain uptake untilThursday April 23, 2015 54 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-V-14 Novel tools for labeling and manipulation of extracellular vesicle cargo to engineer intercellular delivery shuttles Archana Gupta, Jasmine Sethi, Maureen Peterson, Nicole Otoc and Travis Antes System Biosciences, Mountain View, CA, USAScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 55",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Sponsored posterThursday April 23, 2015 56 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The proteomic and genomic analysis of vesicular cargoidentified immune signatures both unique to each and shared amongScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 57",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results :P-glycoprotein (P -gp) encoded by multidrug resistance protein 1 (MDR1) gene plays an important role in drug-resistance.Thursday April 23, 2015 58 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"It is currently unclearwhich stimulus (exosomes or TGF-beta) gives a myofibroblastphenotype that best reflects the perturbed, cancer-educated stromalScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 59",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Extracellular vesicles (EVs) released from tumour cells bear oncogenicThursday April 23, 2015 60 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"No differences betweenPSMA levels were detected between the platelet-rich plasma of non- PCA and drug-naı ¨ve metastatic patients but PSMA /C27and 1A5 /C27 microvesicles were significantly enriched in platelet poor plasmaScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 61",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The most relevant biomarkers could be then used to exposure profiling in blood samples.Thursday April 23, 2015 62 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The EVs carried various RNA speciesScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 63",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-VII-6 Hypoxia-induced lipid accumulation in prostate cancer cells controls extracellular vesicles biogenesis promoting growth and invasiveness Gagan Deep, Isabel Schlaepfer, Dhanya Nambiar, Anand Ramteke, RahulKumar, Deepanshi Dhar, Chapla Agarwal, Bryan Bergman, Michael Graner,Paul Maroni, Rana Singh and Rajesh Agarwal University of Colorado Denver, Aurora, USAThursday April 23, 2015 64 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-VII-10 Exosome fractions of conditioned media from normal and pre-eclamptic placental villi are selectively anti-angiogenic andreversed by low molecular weight heparin Kalpana Pillai1, Dora Baczyk1and John Kingdom1 1Lunenfeld Tanunbaum Research Institute, Toronto, Canada Please see Oral with poster B P-VII-11 Cancer-associated urinary extracellular vesicles as novel bladdercancer biomarker Yusuke Yoshioka1, Yuki Konishi2, Hideo Sasaki3, Nobuyoshi Kosaka2, Hideki Ohta4, Hiroyuki Okamoto4, Hikaru Sonoda4and Takahiro Ochiya2 1Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan;2Division of Molecular and Cellular Medicine, National Cancer Center Research Institute, Tokyo, Japan;3Department of Urology, St. Marianna University School of Medicine, Kawasaki, Japan;4Diagnostic Division, Shionogi & Co., LTD, Osaka, Japan Introduction : Small membranous extracellular vesicles (EVs) are naturally secreted by almost all cell types including cancer cellsScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 65",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/Conclusion : ExoScreen propose a novel liquid biopsy technique to detect bladder cancer-specific urinary EVs.Thursday April 23, 2015 66 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"ABSTRACTSScientiﬁc Program ISEV 2015 meeting Friday April 24, 2015 Oral Presentations Registration 08:00-09:00 Setting up posters (Poster sessions VIII, IX, X, XI, XII, XIII) 08:00-09:00 Ballroom D Meet the experts I: Diversity of EVs Chair: Clotilde The ´ry Speakers: Jan Lo ¨tvall and Stephen J. Gould 08:00-08:45 Ballroom E Meet the experts II: Stem cells and EVs as therapeutics Chair: Steven M. Jay Speakers: Bernd Giebel and Sai Kiang Lim 08:00-08:45 Ballroom F-H Meet the experts III: EVs in cardiovascular disease Chair: Chantal Boulanger Speakers: Eduardo Marban and Dominique de Kleijn 08:00-08:45 Sponsor Exhibition 10:00-18:00 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 67",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 10:15-10:45 Poster viewing sessions VIII, IX, X, XI, XII, XIII Posters not attended by authors 10:15-10:45Friday April 24, 2015 68 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Despite the clinical potential ofScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 69",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These findings should prompt furtherinvestigations of the role of these sRNAs in the extracellular space.Friday April 24, 2015 70 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Following confirmation of florescence-conjugated exo- some incorporation by human endothelial cells (ECs) and human iPSC-derived cardiac myocytes, cells were treated with eitherScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 71",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"On-going studies are exploring the impact of apoE on the cellular release of miR-146a into exosomes, and HDL that can be communicated to leukocytes and vascular cells to suppressinflammation and atherosclerosis.Friday April 24, 2015 72 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : Collectively, these observa- tions demonstrate that exosomes derived from HIV-1 infected celland HIV-1 cells treated with HIV-1 protease inhibitor Ritonavir can cause neuronal dysfunction and degeneration.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 73",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking lunch 12:00-13:00 Poster viewing sessions VIII, IX, X, XI, XII, XIII Posters not attended by authors 12:30-13:00 Poster walk by chairperson, Session VIII, IX, X, XI, XII, XIII Posters not attended by authors 13:00-14:00Friday April 24, 2015 74 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"O-4A-3 Exosome-mediated transfer of alphaV integrins promotes cell-cell communication in prostate cancerAmrita Singh 1, Carmine Fedele1, Rachel DeRita1, Alexander N. Duffy1, Adam M. Hawkins2, Wm K. Kelly2, Renato V. Iozzo3and Lucia R. Languino1 1Cancer Biology, Thomas Jefferson University, Philadelphia, PA, USA;2Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA;3Pathology, Thomas Jefferson University, Philadelphia, PA, USAScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 75",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : We interpret these findings that the contribution of Tspan8 andCD151 to tumour progression mostly relies on exosomal activities ofthese 2 tetraspanins.Friday April 24, 2015 76 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Thepotential inducer of MSC re-education might be the miRNA contentof exosomes.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 77",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Vesiclesunder TEM displayed a highly variable size distribution, which wasFriday April 24, 2015 78 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Mir-9 mediated migration of microglia invol-ved downregulated expression of the key target protein, monocyteScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 79",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"EV-loaded anti-miRs could be developed as a potential therapeutic strategy for HAND.Friday April 24, 2015 80 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"In order to determine whetherEV subsets are relevant in performing regulatory effects, we must be able to isolate EV subsets from the bulk population of EVs andScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 81",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Interestingly, lipids are emerging as important constituents of this machinery.Friday April 24, 2015 82 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 15:30-16:00 Poster sessions VIII, IX, X, XI, XII, XIII Posters not attended by authors 15:30-16:00Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 83",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"To exclude somevariables, such as drugs, that may influence exosome secretion onour chosen experimental cell lines, we examined the effect of theFriday April 24, 2015 84 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Methods : EVs were purified by differential centrifugation and density gradientScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 85",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"$These authors have contributed equally to the work.Friday April 24, 2015 86 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"This work is supported by the Canadian Institute of Health Research (CIHR) and the Canadian National Transplantation Research Program (CNTRP)Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 87",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ Conclusion : In conclusion, our results suggest that the inhibitory activity of human T regulatory cells can, at least in part, utilize theregulatory function of vesicle-associated microRNAs.Friday April 24, 2015 88 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"VSMC phenotypic conversion is associated with cytoskeletal re-arrangements so in the present study we testedhow components of the cytoskeleton impact on exosome secretion.Methods : Exosomes were quantified by a CD63-bead capture assay.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 89",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Poster viewing (not attended by authors) 17:15-18.00 ISEV networking event - Dinner Cruise 19:30-22:30 Buses to the dinner location leave from the Marriott Conference Center entrance at 18:00Friday April 24, 2015 90 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Methods : Endothelial cells were treated withScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 91",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Methods : EVsFriday April 24, 2015 92 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Canine valve interstitial cells (VICs) from diseased heart valves have a greater prevalence of cells with a myofibroblastic phenotype, growth retardation and lowerScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 93",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-VIII-15 Muscle-released exosomes act as paracrine signal during the development of lipid-induced insulin-resistance Sophie Rome1, Hala Aswad1, Alexis Forterre1, Oscar Wiklander2, Guillaume Vial1, Emmanuelle Berger-Danty1, Audrey Jalabert1, Antonin Lamazie `re3, Emmanuelle Meugnier1, Sandra Pesenti1, Samir El-Andaloussi2,4, Hubert Vidal1, Jennifer Rieusset1and Etienne Lefai1 1CarMeN Laboratory (INSERM 1060, INRA 1362, INSA), Faculte ´de Me ´decine Lyon-Sud, University of Lyon, Oullins, France;2Department of Laboratory Medicine, Clinal Research Center, Karolinska Institut, Stockholm, Sweden;Friday April 24, 2015 94 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-VIII-18 Future potential of human cell-derived extracellular vesicles in cardiovascular research Baharak Hosseinkhani1, Katrijn Vanschoenbeek1, Tom Struy1, Nynke Van den Akker2, Daniel Molin2, Marcel Ameloot1and Luc Michiels1 1BIOMED, Hasselt University, Diepenbeek, Belgium;2Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands Introduction : Healthcare systems are facing increasing costs for the diagnosis and treatment of patients with cardiovascular disease.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 95",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"This work was supported by the EU through the VaRiA- Vascular Risk Assessment (IVA-VLANED-3.65) project.Friday April 24, 2015 96 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ conclusion : Some exosomal proteins identified from cell lines will be confirmed in a large-scale of clinical samples to increase the potentialof early diagnostic biomarker for colon cancer.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 97",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : Our analyses identified a limited number of candidate subset-specific proteins,and we found clusters of proteins associated with specific cell typesFriday April 24, 2015 98 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-IX-10 Comparative biophysical and lipidomic analysis of mammalian and nematode exosomes Fabio Simbari1, Jana J. McCaskill1, Gillian Coakley1, Marissa Lear1, Rick Maizels1, Josefina Casas2and Amy Buck1 1Institute of Infection and Immunology Research, University of Edinburgh, Edinburgh, United Kingdom;2The Institute of Advanced Chemistry of Catalonia, Barcelona, SpainScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 99",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Current availableFriday April 24, 2015 100 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Annotation revealed breast cancer derivedexosomes were enriched in plasma membrane proteins with knownScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 101",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Well characterized cellmarkers were detected on the originating cells as well as on thesecreted exosomes, for example CD42a on platelet exosomes andFriday April 24, 2015 102 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The composition of exosomes in biological fluids can bededuced from this specific protein set under different physiological and pathological conditions, for example to monitor disease pro- gression or to evaluate immune responses after therapy.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 103",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Furthermore, whenFriday April 24, 2015 104 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"BMEVs treatment of mice showed a delayed onset of arthritis in both the IL-1Ra /C28//C28and CIA model and diminishedScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 105",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-X-15 Characterization of murine cytotoxic T-cell-derived exosomes in the prevention of tumour growth Naohiro Seo1,2, Yoshitaka Shirakura1, Daisuke Muraoka1, Yoshiro Tahara2,3, Shin-ichi Sawada2,3, Kazunari Akiyoshi2,3and Hiroshi Shiku1,2Friday April 24, 2015 106 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-X-19 Platelet microparticles reprogram macrophage gene expression and function Benoit Laffont, Aure ´lie Corduan, Matthieu Rousseau, Anne-Claire Duchez, E´ric Boilard and Patrick Provost CHUQ Research Center /C1University Laval, Quebec, Canada Please see Symposium Session 5BScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 107",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These results suggest that detection of circulating MPs may be valuable for the prognostic of radiotherapy complications.Eventually, this study could contribute to propose a new anti-MPstherapeutic approach for the treatment of radiation-induced pelvicdisease.Friday April 24, 2015 108 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Top-performing linear combinations of 3,Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 109",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"infusedFriday April 24, 2015 110 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XI-12 Exosomal RNA isolated from kidney transplantation preservation fluid provides a biomarker source for organ quality Bas W. M. van Balkom1, Raechel J. Toorop2, Arjan D. van Zuilen1, Olivier G. de Jong1, Alexander V. Vlassov3and Marianne C. Verhaar1 1Nephrology and Hypertension, UMC Utrecht, Utrecht, The Netherlands; 2Vascular Surgery, UMC Utrecht, Utrecht, The Netherlands;3ThermoFisher, Austin, TX, USAScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 111",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The level and distribution of a biomarker in plasma EVs with respect to whole plasma, could enhance the rigour, robustness and specificity of the biomarker.Friday April 24, 2015 112 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Of those miRNAs, an average of 15 were observed to beScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 113",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : Exosomes secreted by UBC cells exhibit a specific miRNA signature depending on the invasiveFriday April 24, 2015 114 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Tomer Cooks1, Ioannis Pateras2, Keval Patel3, Nitzan Rosenfeld3, Vassilis Gorgoulis2and Curtis C. Harris1 1Lab of Human Carcinogenesis, NCI, Bethesda, MA, USA;2Molecular Carcinogenesis Group, Department of Histology and Embryology, School of Medicine, University of Athens, Athens, Greece Please see Oral with poster B P-XII-12 Identification of specific exosome-associated markers as early detectors of malignant transformation from neurofibromato MPNST Natasa Zarovni1, Pietro Ferruzzi1, Paolo Guazzi2, Davide Zocco1, Costanza Fondelli1, Steven Carroll3, Jodie Longo3and Antonio Chiesi1Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 115",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XII-18 Role of extracellular vesicles derived from mesenchymal stem/stromal cells in breast cancer progression and metastasisKrishna C. Vallabhaneni 1, Fei Xing2, Yoni Hassler1, Kounosuke Watabe2 and Radhika Pochampally1,3Friday April 24, 2015 116 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : This study shows the link between thrombotic events and EVs-PCA and suggests the role of EVs derivedfrom leukaemic blast and other cells in procoagulant state in AL.Moreover, EVs-PCA could have a predicting value for VTE and DIC inpatients with AL and could inform haematologists for the thrombosis prophylaxis.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 117",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"They are produced by a variety of cells intoPoster session XIII - Late breaker, Advances in isolation and characterization of EVs and EV subpopulations Chairs: Bernd Giebel and Anna Banizs .Friday April 24, 2015 118 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XIII-8 Examination of extracellular RNAs in cerebrospinal fluid Kendall Van Keuren-Jensen1, Rebecca Reiman1, Jay Phillips2, Molly Malone2, Johnny Akers3, Ryan Kim3, Matthew Huentelman1, Robert Spetzler4, P. David Adelson5, Jorge Arango5, Yashar Kalani4, Joseph Quinn6, Julie Saugstad2, Bob Carter3and Fred Hochberg3Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 119",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XIII-12 Exosome release and bioactivity is associated with the invasiveness of ovarian cancer cell linesMiharu Kobayashi 1, Jorge Tapia2, Richard Kline3, Murray Mitchell1, Gregory Rice1and Carlos Salomon1Friday April 24, 2015 120 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"This combined purification and isolation protocol may aid inobtaining specific circulating EVs from plasma patient samples, forfurther downstream characterization.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 121",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The characterization of SCN-derivedexosomes is essential in furthering our understanding of the bio-logical role of exosomes in circadian clock.Friday April 24, 2015 122 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"(a) direct labelling using Qdot conjugated CD9 (1 g) versus (b) indirectlabelling using biotinylated CD9 ant ibody or isotype (1g) and secondaryScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 123",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/conclusion : In conclusion, our positive miRNA sensor system allows for the detection of changes in a singlemiRNA both in cellular in vitro and in vivo models, constituting a formidable tool for the study of extracellular miRNAs functionalityand miRNA expression changes in mammalian development anddisease.Friday April 24, 2015 124 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"ABSTRACTSScientific Program ISEV 2015 meeting Saturday April 25, 2015 Oral Presentations Registration 08:00-09:00 Setting up posters (Poster sessions XIV, XV, XVI, XVII, XVIII, XIX, XX) 08:00-09:00 Ballroom D Meet the experts IV: EVs in biotechnology and therapeutics Chair: Raymond Schiffelers Speakers: Janusz Rak and Samir El-Andaloussi 08:00-08:45 Ballroom E Meet the experts V: Bacterial and parasite EVs Chair: Pamela Wearsch Speakers: Yong Song Gho and Antonio Marcilla 08:00-08:45 Ballroom F-H Meet the experts VI: EVs in inﬂammation and immunity Chair: Esther Nolte-’t Hoen Speakers: Edit Buza ´s and Stefano Pluchino 08:00-08:45 Sponsor Exhibition 10:00-18:00 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 125",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"EVs are generally 100 /C1200 nm in diameter and can be shed from the cell surface (ectosomes) and secreted frominternal compartments (exosomes) of many different cell types.Saturday April 25, 2015 126 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Further studies are underway to determine whether RBC-derived MV activate endothe- lial cell pro-inflammatory gene expression and whether the inflam-matory status of the endothelium prior to contact with RBC-derivedMV alters their responses.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 127",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Global normal and PE placental glycosylation levels were investigated byimmunohistochemistry (IHC) using a panel of FITC conjugated lectins.Those lectins showing altered PE placenta staining were then used toSaturday April 25, 2015 128 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Focal transferof endothelial- CLN-5/C27EVs to leukocytes might aid the latter in TEM across the BBB by forging transient interactions with TJs on BMEC.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 129",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Furthermore, the interaction ofSaturday April 25, 2015 130 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 10:00-10:30 Poster viewing sessions XIV, XV, XVI, XVII, XVIII, XIX, XX Posters not attended by authors 10:00-10:30Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 131",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Tumour-derived EVs in the blood contain a variety of potentially useful biomarkers which could facilitate the delivery of personalized medicine approaches.Saturday April 25, 2015 132 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"EVs proteins were subjectedto proteomic analysis by GeLC-MS/MS and identified against theScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 133",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Acknowledgements : Work supported by the ‘‘Fondation Ernst et Lucie Schmidheiny’’.Saturday April 25, 2015 134 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Regardless the type of strain used for in vivo infection, inchronic infected mice, Colombiana and Y strains vesicles exhibited aScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 135",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : We find that average vesicle production rates can vary by multiple orders of magnitude among cultured marine bacteria growing at their maximal growth rate.Saturday April 25, 2015 136 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These data provide a first step toward improving our understanding of the distribution andbiological roles of vesicles in the marine environment.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 137",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The ELV-2 mRNA correlated better with the cellular mRNA (Pearson 0.95;ELV-2 vs. cells), than the ELV-1 mRNA (Pearson 0.78; ELV-1 vs. cells).Saturday April 25, 2015 138 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"While several reports have analyzed theScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 139",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking lunch 12:00-13:00 Poster viewing sessions XIV, XV, XVI, XVII, XVIII, XIX, XX Posters attended by authors 12:30-13:00Poster walk by chairperson, XIV, XV, XVI, XVII, XVIII, XIX, XX Posters attended by authors 13:00-14:00Saturday April 25, 2015 140 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"For EVsScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 141",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"MicroRNA analysis was purified with MicroRNA Easy kit (Qiagen) and was performed withSaturday April 25, 2015 142 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"These results suggest that SA-EVs play a major role of tumour suppression in tumourmicroenvironments.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 143",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"O-8B-4 Exosome-associated AAV as a novel platform for gene therapy of hearing loss Bence Gyo ¨ rgy1,2, Cyrille Sage1, Deborah Scheffer1, Artur A. Indzhykulian1, Dakai Mu2, Xandra O. Breakefield2, Casey A. Maguire2and David P. Corey1Saturday April 25, 2015 144 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"We will continue to optimize the protocol and test the gene delivery functions in vivo.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 145",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Moreover, the blocking of C5 complement factor inhibitedATG-induced MV release and consequently thrombin generation.Saturday April 25, 2015 146 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The physiologic effects of these secreted humanplexosomes on target cells such as the endothelium were alsoScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 147",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 15:30-16:00 Poster viewing sessions XIV, XV, XVI, XVII, XVIII, XIX, XX Posters not attended by authors 15:30-16:00 ISEV General Assembly 16:00-17:00 J Extracell Vesicles: Editorial Board meeting 17:00-18:00 Kick-off meeting, EV-flow cytometry working group (ISEV-ISAC-ISTH), hosted by Marca Wauben and Jennifer Jones 18:00-19:30 Evening poster viewing 19:00-21:00 A cash bar will be available for drinks and snacksSaturday April 25, 2015 148 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"More- over, most of the differentiated cells co-expressed insulin and PDX-1,Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 149",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Exosome concentrationSaturday April 25, 2015 150 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Methods : PMVs in CPP and liquid stored PLTs (LSP, paired control) were characterized by flow cytometry (FC), nanoparticle tracking analysis (NTA), laser scanning confocal micro-scopy (LSCM), field emission scanning electron microscopy (FESEM),Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 151",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"We correlated the new MPSaturday April 25, 2015 152 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XIV-15 Isolation, characterization and procoagulant role of platelet-derived extracellular vesicles Rene ´Weiss1, Carla Tripisciano1, Tanja Eichhorn1, Andreas Spittler2, Michael Fischer1,3and Viktoria Weber1,3 1Christian Doppler Laboratory for Innovative Therapy Approaches in Sepsis, Danube University Krems, Krems, Austria;2Core Facility Flow Cytometry, Medical University Vienna, Vienna, Austria;3Center for Biomedical Technology, Danube University Krems, Krems, Austria Please see Oral with poster CScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 153",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"EVs may be used as anefficient drug delivery system to tumour cells, which is influenced bythe EV surface receptors.Saturday April 25, 2015 154 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XV-8 Haemocompatibility of estetrol and estradiol cyclodextrins complexes Julie Laloy1,2, Claudio Palazzo3, Lutfiye Alpan1,2, Jean-Michel Foidart4, Ge´raldine Piel3and Jean-Michel Dogne ´1,2 1Department of Pharmacy, University of Namur, Namur, Belgium; 2Namur Nanosafety Centre, Namur, Belgium;3Laboratoire de Technologie Pharmaceutique et Biopharmacie, University of Lie `ge, Lie `ge, Belgium; 4University of Lie `ge, Lie `ge, BelgiumScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 155",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"In our work, we focused on PPAR g, CEBP aand CEBPd, as these transcription factors are seen as the master regulatorsSaturday April 25, 2015 156 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Morphol-Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 157",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Signalling between different cell types and theeffects of vesicles coming from outside sources can be systematically investigated in our setup.Saturday April 25, 2015 158 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XVI-6 Lipid content of extracellular vesicles isolated from bovine ovarian follicles according to oocyte competence Juliano Da Silveira1, Gabriella M. Andrade1, Thais Y. Nakamura1, Marcelo C. Ce ´sar1, Marcelo F. G. Nogueira2, Helio A. Martins-Junior3, Roseneide C. Simas4, Felipe Perecin1and Fla ´vio V. Meirelles1Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 159",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XVI-10 Aggregation of extracellular vesicles induced by high-speed sedimentation and re-suspension: a combined cryo-electronmicroscopy and flow cytometry study Alain R. Brisson, Sisareuth Tan, Ce ´line Gounou and Nicolas Arraud CNRS-UMR CBMN, University of Bordeaux, Pessac, FranceSaturday April 25, 2015 160 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"2014;3:23262, doi: http://dx.doi.org/10.3402/jev.v3.23262 2.",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Similar reductions were observed when select miRNAs (miR-21, miR-24, miR-103 and miR-125)Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 161",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XVI-18 Postprandial increase in blood plasma concentration of tissue factor-bearing extracellular vesicles Morten Mørk1, Morten H. Nielsen1, Malene M. Jørgensen2, Rikke Bæk2, Morten K. Nielsen1, Shona Pedersen1and Søren R. Kristensen1 1Department of Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark;2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark Introduction : Tissue factor (TF)-bearing extracellular vesicles (EVs) have been suggested to play an important role in both normalSaturday April 25, 2015 162 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Methods : Two human ovarian cancer cell lines, A2780 and OVCAR5,Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 163",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"This will allow identification of a signature patternof uEVs that can serve as the basis for a clinical screen for kidneydiseases.Saturday April 25, 2015 164 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XVII-5 Exosomal proteins as diagnostic biomarkers in advanced lung adenocarcinoma Kristine Raaby Jakobsen1, Birgitte S. Paulsen2, Rikke Bæk3, Kim Varming3, Boe Sandahl Soerensen4and Malene Møller Jørgensen3Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 165",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"In this study we have evaluated the role ofcirculating exosomes in a prospectively recruited cohort of advancedgastric cancer (AGC) patients and their potential role as biomarkersin response to first-line therapy, including a subgroup of patientsSaturday April 25, 2015 166 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XVII-12 Potential use of stromal cell-derived exosomal mRNAs as markers of aggressive prostate cancer Jason Webber, Lisa Spary, Zsuzsanna Tabi and Aled Clayton Institute of Cancer & Genetics, Cardiff University, Cardiff, United KingdomScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 167",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"This invasion is mostSaturday April 25, 2015 168 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"2013;2:20920, doi: http://dx.doi.org/10.3402/ jev.v2i0.20920 P-XVII-18 mRNA-sequencing of tumour-educated platelets allows for multiclass liquid biopsy-based diagnosis of cancerMyron Best 1,2, Nik Sol3, Irsan Kooi4, Jonas Nilsson5,6, Bart Westerman2, Bauke Ylstra1, Josephine Dorsman4, Egbert Smit7, Henk Verheul8, Jaap Reijneveld3, Bakhos Tannous9, Pieter Wesseling1,10, Thomas Wu ¨rdinger2,5,9 1Pathology, VU University Medical Center, Amsterdam, The Netherlands; 2Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands; 3Neurology, VU University Medical Center, Amsterdam, The Netherlands; 4Clinical Genetics, VU University Medical Center, Amsterdam, The Netherlands; 5ThromboDx B.V., Amsterdam, The Netherlands;6Radiation Sciences Oncology, Umea ˚ University, Umea ˚, Sweden,7Pulmonary Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands;8Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands,9Neurology, Harvard Medical School, Boston, MA, USA;10Pathology, Radboud University Medical Center, Nijmegen, The Netherlands Introduction : Cancer diagnosis and subsequent treatment is fre- quently hampered by limited access to adequate tissue of the primarytumour or of metastatic lesions.",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Subsequently, totalRNA was isolated, subjected to SMARTer mRNA amplification andScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 169",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"However, they support our earlier findings in gliomas that plateletsmay carry the needle from the haystack that will give us a windowinto the cancer biology of individual patients.Saturday April 25, 2015 170 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Ct values for each targets miRNAs were consistent among same typeScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 171",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Finally, we examined miRNA variants (isomiRs) and observed frequent isomiRs in all common miRNAs.Summary/conclusion : This study unravelled a wide variety of RNA species embedded in circulating exosomes and moreover identifiedSaturday April 25, 2015 172 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Hierarchical clustering showed enrichment of specific miRNA in exosomes, including hsa-miR-214-3p, hsa-miR-199a-3p and hsa-miR-155-5p, all being associated with melanoma progression.Comparison of exosomal microRNAs with microRNAs in clinicalmelanoma samples indicate that multiple miRNAs in exosomesalso are expressed in melanoma tissues, but not in benign naevi.Summary/conclusion : This study shows the presence of distinct small RNAs in subsets of EVs released by melanoma cells, with significantScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 173",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Altogether, this work will help to shed light on themolecular mechanism behind miRNA trafficking and on its implicationon the therapeutic effect of transplanted NPCs.Saturday April 25, 2015 174 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XIX-4 Non-typeable Haemophilus influenzae induces the release of pro-inflammatory extracellular vesicles by macrophages Charlotte Volgers, Birke Benedikter, Paul Savelkoul, Frank Stassen Medical Microbiology, Maastricht University, Maastricht, The Netherlands Introduction : Control over infections is mainly conferred by immune cells including dendritic cells and macrophages and involves a soundScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 175",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Results : Through microarray of H. polygyrus exosome-treated small intestinal epithelial cells, we see significant gene changes, including those involved in theSaturday April 25, 2015 176 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Summary/ conclusion : The results indicate that the exosomes released fromScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 177",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"However, their potential to become reliableresearch or diagnostic tools is currently limited due to the difficulty ofdistinguishing apoptotic and plasma membrane EVs, exosomes, andSaturday April 25, 2015 178 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"In future, the function of this exosomes will be studied.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 179",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"P-XX-4 Source cell microenvironment impacts extracellular vesicle cargo composition Divya Patel, Tek Lamichhane and Steven Jay Bioengineering, University of Maryland, College Park, MD, USA Please see Oral with poster B P-XX-5 Acoustic microfluidic system for microvesicle purification Kyungheon Lee1, Huilin Shao2, Ralph Weissleder1,3and Hakho Lee1 1Center for Systems Biology, Massachusetts General Hospital, Boston, MA, USA; 2Institute of Molecular and Cell Biology, Singapore;3Systems Biology, Harvard Medical School, Boston, MA, USA Please see Oral with poster A P-XX-6 Microfluidics exosome lysis and detection of microRNA for cancer study and diagnosis Katherine Richards and Reginald Hill Molecular Biology, University of Notre Dame, South Bend, IN, USASaturday April 25, 2015 180 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The therapeutic cur-exoScnano-units (20 mg) were used for mice treatment through intranasal route for 7 days.Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 181",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"$These authors have contributed equally to the work.Saturday April 25, 2015 182 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"ABSTRACTSScientiﬁc Program ISEV 2015 meeting Sunday April 26, 2015 Registration 08:00-09:00 Ballroom D Meet the experts VII: EVs in the tumor microenvironment Chair: Aled Clayton Speakers: David Lyden and Mattias Belting 08:00-08:45 Ballroom E Meet the experts VIII: EVs as diagnostics and prognostics Chair: Fred Hochberg Speakers: Lorraine O’Driscoll and Clark Chen 08:00-08:45 Ballroom F-H Meet the experts IX: Possibilities and limitations of single EV-based analysis Chair: Jennifer Jones Speakers: Marca Wauben and Alain Brisson 08:00-08:45 Sponsor Exhibition 10:00-TBA Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 183",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"While standard flow cytometry due to the configurationSunday April 26, 2015 184 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"To elucidate their functions, vesicles areScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 185",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Thus, to understand the functionaloutcomes of EVs research, it is of utter importance to know whatdifferent types of EV the used isolate contain.Sunday April 26, 2015 186 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"O-9B-4 Immunosuppressive exosomes persist in plasma of acute myeloid leukaemia patients in complete remission and may contribute to relapse Michael Boyiadzis, Chang Sook Hong and Theresa Whiteside University of Pittsburgh Cancer Institute, Pittsburgh, PA, USAScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 187",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The understanding of how exoand MV can induce different immune responses may help to developoptimal vesicle-based tools in immunotherapy.Sunday April 26, 2015 188 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"O-9C-6 A novel mechanism for loading specific target proteins into exosomes Ulrich Sterzenbach, Ulrich Putz, Seong-Seng Tan and Jason HowittScientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 189",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"The Rosa mT/mG murinemodel allows for the investigation of CM-derived EVs in health and disease.Sunday April 26, 2015 190 Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783",OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"Networking coffee 10:15-10:45 Ballroom D-E Plenary Session Chairs: Marca Wauben and Andrew Hill 10:45-11:45 Gary Ruvkun, Ph.D. Department of Genetics, Massachusetts General Hospital, Boston, MA, USA The tiny RNA pathways of C. elegans Ballroom D-E Plenary closing ceremony, prizes & announcement of ISEV 2016 11:45-12:30 Networking/farewell lunch 12:30-13:30Departure 13:30Scientific Program ISEV 2015 meeting Citation: Journal of Extracellular Vesicles 2015, 4: 27783 - http://dx.doi.org/10.3402/jev.v4.27783 191",Non-OADS,/arxiv_data1/oa_pdf/f3/91/JEV-4-27783.PMC4408443.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Validation of an aggregate exposure model Delmaar et al 323 © 2015 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2015), 317 –323",Non-OADS,/arxiv_data1/oa_pdf/94/44/jes201468a.PMC4408489.pdf
Concise International Chemical Assessment Document 17: Butyl benzyl phthalate http://www.inchem.org/documents/cicads/cicads/cicad17.htm#PartNumber:4.,Non-OADS,/arxiv_data1/oa_pdf/35/0a/jes201465a.PMC4408490.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Temporal variability of bisphenol A and phthalates Fisher et al 239 © 2015 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2015), 231 –239",Non-OADS,/arxiv_data1/oa_pdf/35/0a/jes201465a.PMC4408490.pdf
NHANES is a cross-sectional survey designed to monitorthe health and nutritional status of the civilian non-institutionalizedUS population (http://www.cdc.gov/nchs/nhanes.htm).,OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"There exist a few large- scale surveys that include biomonitoring data for multiple phthalates, such as NHANES (http://www.cdc.gov/nchs/nhanes.htm), DEMOCOPHES in the European Union (http://www.",Non-OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"eu-hbm.info/democophes), and Canadian health measures survey in Canada (http://www.hc-sc.gc.ca /ewh-semt/contaminants/human- humaine/chms-ecms-eng.php).The NHANES data set, which includes data for multiple phthalates for given individuals, provides useful insights to coexposure patterns.",OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"Human Health Evaluation Manual (Part A), 1989; available at http://www.epa.gov/oswer/riskas-sessment/ragsa/pdf/rags_a.pdf.",OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"Risk Assessment Guidance for Superfund (RAGS): Volume III — Part A, Process for Conducting Probabilistic Risk Assessment 2001, available at http://www.epa.gov/oswer/riskassessment/rags3adt/pdf/rags3adt_complete.pdf.",OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"WHO OECD ILSI/HESI International Workshop on Risk Assess- ment of Combined Exposures to Multiple Chemicals Workshop Report, 2011;available at http://search.oecd.org/ofﬁcialdocuments/displaydocumentpdf/?cote=env/jm/mono(2011)10&doclanguage=en.",OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"WHO: Geneva, Switzerland, 2009; available at http://www.oecd.org/ofﬁcialdocuments/displaydocumentpdf/?cote=env/jm/mono%282011%2910&doclanguage=en.",Non-OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and DiseaseRegistry: Atlanta, GA, USA 2001, available at http://www.atsdr.cdc.gov/toxproﬁles/tp135.pdf.",OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"Chapter R.14: Occupational Exposure Estimation, Ver2, 2012; available athttp://echa.europa.eu/documents/10162/13632/information_requirements_r14_en.pdf.",Non-OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Exposure Science and Environmental Epidemiology website (http:// www.nature.com/jes)Phthalate coexposure patterns in NHANES Qian et al 255 &2015 Nature America, Inc. Journal of Exposure Science and Environmental Epidemiology (2015), 249 – 255",Non-OADS,/arxiv_data1/oa_pdf/87/6a/jes201424a.PMC4408491.pdf
"S132 Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAMeningioma of the superior leaflet of the velum interpositum:  A case report Pierre‑Olivier Champagne, Michel W .",Non-OADS,/arxiv_data1/oa_pdf/0b/87/SNI-6-132.PMC4408616.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/4/132/155703 Copyright: © 2015 Champagne P .,Non-OADS,/arxiv_data1/oa_pdf/0b/87/SNI-6-132.PMC4408616.pdf
"S127 Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAIntradural extramedullary capillary hemangioma of the cauda  equina: Case report and literature review Jonathan J. Liu, Darrin J. Lee, Lee‑Way Jin1, Kee D. Kim Departments of Neurological Surgery, University of California‑Davis, 4860 Y .",Non-OADS,/arxiv_data1/oa_pdf/9c/d9/SNI-6-127.PMC4408617.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/4/127/155701 Copyright: © 2015 Liu JJ.,Non-OADS,/arxiv_data1/oa_pdf/9c/d9/SNI-6-127.PMC4408617.pdf
"S124 Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USARetrograde cysto‑myelogram: Case Report Jayson A. Neil, Dimitri Laurent, Kaushik Das, Hasit Mehta1 Departments of Neurological Surgery, and 1Radiology, New York Medical College, Valhalla, New York, USA E-mail: Jayson A. Neil - Jayson.neil@gmail.com; Dimitri Laurent - dimitri_laurent@nymc.edu; Kaushik Das - DasK@wcmc.com;   *Hasit Mehta - mehtah@wcmc.com   *Corresponding author Received: 15 January 15  Accepted: 30 January 15  Published: 22 April 15 Abstract Background:  In the scenario of blunt trauma with suspected bladder injury,  conventional retrograde cystography is the gold standard for accurate diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/45/11/SNI-6-124.PMC4408618.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/4/124/155698 Copyright: © 2015 Neil JA.,Non-OADS,/arxiv_data1/oa_pdf/45/11/SNI-6-124.PMC4408618.pdf
"S117 Surgical Neurology International OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Unique Case Observations, a supplement to  Surgical Neurology International Editor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAHigh risk of cerebrospinal fluid leakage in surgery of a rare  primary intraosseous cavernous hemangioma of the clivus  showing meningeal infiltration: A case report and review of the  literature Lucas Serrano#, Eleftherios Archavlis#, Elke Januschek, Peter T .",Non-OADS,/arxiv_data1/oa_pdf/36/dd/SNI-6-117.PMC4408619.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/4/117/155695 Copyright: © 2015 Serrano L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/36/dd/SNI-6-117.PMC4408619.pdf
Available from: http://www.alere.com/in/en/brands/inratio.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/IJA-59-264.PMC4408666.pdf
Access this article online Quick response code Website:   www.ijaweb.org DOI:  10.4103/0019‑5049.155015 Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8e/42/IJA-59-264.PMC4408666.pdf
Available  from: http://www.bihhealth.cloudapp.net/doctor/home/ vacancy_status.asp [Last cited on 2015 Feb 20].,Non-OADS,/arxiv_data1/oa_pdf/9f/cd/JFMPC-4-159.PMC4408692.pdf
Available from:  http://www.mciindia.org/AboutMCI/CouncilMembers.,Non-OADS,/arxiv_data1/oa_pdf/9f/cd/JFMPC-4-159.PMC4408692.pdf
Available from: https://www.mycii.in/ KmResourceApplication/42087.UHCPaperfinal8July2014.,Non-OADS,/arxiv_data1/oa_pdf/9f/cd/JFMPC-4-159.PMC4408692.pdf
Available from: http://www.cisncancer.org/ research/how_cancer_is_studied/epidemiological/study_ types.html.,Non-OADS,/arxiv_data1/oa_pdf/10/bd/JFMPC-4-162.PMC4408693.pdf
Available from: http://www.gmc‑uk.org/10a_Review_of_ Tomorrow_s_Doctors.pdf_25397631.pdf.,Non-OADS,/arxiv_data1/oa_pdf/24/08/JFMPC-4-168.PMC4408694.pdf
Available from: http://www.ama.,Non-OADS,/arxiv_data1/oa_pdf/24/08/JFMPC-4-168.PMC4408694.pdf
Available from: http://www.medicalboard.gov.au/ Codes‑Guidelines‑Policies.aspx.,Non-OADS,/arxiv_data1/oa_pdf/24/08/JFMPC-4-168.PMC4408694.pdf
Available  from http://www.timesofindia.indiatimes.com/india/44 ‑ advised‑unnecessary‑surgery‑2nd‑opinion‑givers/ articleshow/45746903.cms [Last cited on 2015 Mar 01].,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/JFMPC-4-174.PMC4408695.pdf
Available from: http://www.worldbank.org/en/news/ feature/2014/07/30/is‑that ‑surgery‑really‑necessary [Last  cited on 2015 Mar 01].11.,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/JFMPC-4-174.PMC4408695.pdf
Available from: http://www.businesstoday.intoday.,Non-OADS,/arxiv_data1/oa_pdf/cd/a1/JFMPC-4-174.PMC4408695.pdf
Available from: http://www.globalfamilydoctor.com/groups/Young  DoctorsMovements.aspx.,Non-OADS,/arxiv_data1/oa_pdf/77/f8/JFMPC-4-177.PMC4408696.pdf
Available from: http://www.aafp.org/news/ opinion/20140625gsted‑woncafm360.html.,Non-OADS,/arxiv_data1/oa_pdf/77/f8/JFMPC-4-177.PMC4408696.pdf
Available from: http://www.acpinternist.org/ archives/2008/04/two.htm.,Non-OADS,/arxiv_data1/oa_pdf/77/f8/JFMPC-4-177.PMC4408696.pdf
Available from: http://www.vdgm.woncaeurope.org/ about.,Non-OADS,/arxiv_data1/oa_pdf/77/f8/JFMPC-4-177.PMC4408696.pdf
Available from: http://www.academia.edu/645013/Young_ People_and_Social_Capital_An_Exploration.,Non-OADS,/arxiv_data1/oa_pdf/77/f8/JFMPC-4-177.PMC4408696.pdf
Available from: http://www.wateraid.org/~/media/Files/ Global/MHM%20files/Module1_HR.pdf.,OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available from: http://www.sswm.info/content/ menstrual‑hygiene‑management.,Non-OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
"Available  from: http://www.eepa.be/wcm/component/option,  com_remository/func, startdown/id, 26/.",OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available  from: http://www.unicef.org/wash/files/10_case_study_ BANGLADESH_4web.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available from: http://www.womenshealth.answers.com/ menstruation/common‑myths‑about‑your‑period.,Non-OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available from:  http://www.soschildrensvillages.org.uk/news/blog/ social‑taboos‑damage‑the‑health‑of‑girls‑and‑women.,Non-OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available from:  http://www.wsscc.org/sites/default/files/publications/ kirk‑2006‑menstruation‑kit_paper.pdf.,Non-OADS,/arxiv_data1/oa_pdf/15/ab/JFMPC-4-184.PMC4408698.pdf
Available from: http://www.cdc.gov// obesity/childhood/contributing_factors.html  [Last accessed  on 2014 Jul 01].,Non-OADS,/arxiv_data1/oa_pdf/45/b9/JFMPC-4-187.PMC4408699.pdf
Available from: http://www.aap.org/obesity/about.,Non-OADS,/arxiv_data1/oa_pdf/45/b9/JFMPC-4-187.PMC4408699.pdf
Available from: http://biomedj.org/preprintarticle.,Non-OADS,/arxiv_data1/oa_pdf/45/b9/JFMPC-4-187.PMC4408699.pdf
Available from: http://www.aihw.gov.au/ high‑blood‑pressure 2.,Non-OADS,/arxiv_data1/oa_pdf/8b/1b/JFMPC-4-193.PMC4408700.pdf
Available from: http://www2.deloitte.com/ content/dam/Deloitte/in/Documents/life ‑sciences ‑health‑ care/in‑lshc‑medical ‑technology‑in‑India‑noexp.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Patkar A.10 reasons why Indian doctors say NO to medical  software.Available from: http://www.wellsphere.com/general  ‑medicine ‑article /10‑ reasons ‑why ‑indian‑ doctors‑ say‑  no‑to‑medical‑software /831498.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from:  http://www.csi‑india.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from:  http://www.moneycontrol.com/news/business/ book‑your‑doctors‑appointment‑onlinepracto_912754.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from: http://www.nuemd.com/ white‑papers/managing‑ehr‑pm‑vendor‑integration.,OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from: http://www.desktopindia.com/overview.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from: http://www.blog.drmalpani.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from: http://www.versaform.com/news/4/139/ How‑to‑Evaluate‑Medical‑Practice‑Management‑Software.,Non-OADS,/arxiv_data1/oa_pdf/ca/ee/JFMPC-4-208.PMC4408703.pdf
Available from:  http://www.Apps.Who.Int/Medicinedocs/Documents/S17035e/S17035e.Pdf.,Non-OADS,/arxiv_data1/oa_pdf/7e/b7/JFMPC-4-217.PMC4408704.pdf
Available  from: http://www.plateaustategov.org/visit/jos.html.,Non-OADS,/arxiv_data1/oa_pdf/7e/b7/JFMPC-4-217.PMC4408704.pdf
Available from: http://www.books.google.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available from: http://teachersites.schoolworld.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available from: http://www.nhrc.nic.in/Documents/ Publications/KYR%20Elderly%20English%20Final.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available  from: http://www.mospi.nic.in/mospi_new/upload/elderly_ in_india.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available from: http://www.rnjournal.com/journal ‑of‑ nursing/malnutrition‑in‑the‑elderly‑an‑unrecognized‑ health‑issue.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available from: http://www.mna ‑elderly.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available  from: http://www.gjmedph.org/uploads/O1‑Vo3No1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
2012; Available from: http://www.ncbi.nlm.nih.gov/books/ NBK109208/.,Non-OADS,/arxiv_data1/oa_pdf/0c/87/JFMPC-4-221.PMC4408705.pdf
Available from: http://www.nrhm.gov.,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://www.nrhm.gov.in/ communitisation/village‑health‑nutrition‑day.html  [Last cited on 2014 Dec 25].,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://www.angul.nic.in/ Mamata Diwas.pdf [Last cited on 2014 Dec 25].,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://angul.nic.in/pdivas.pdf [Last cited on 2015 Mar 07].,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://www.nrhmorissa.gov.,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://www.panchayat.,Non-OADS,/arxiv_data1/oa_pdf/34/90/JFMPC-4-244.PMC4408709.pdf
Available from: http://mohfw.nic.in/WriteReadData/ l892s/6960144509Annual%20Report%20to%20the%20 People%20on%20Health.pdf [Last retrieved on 2014 Dec 10].,Non-OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
Available from: http://censusindia.gov.in/ vital_statistics/SRS_Bulletins/SRS_Bulletin‑September_2013.,OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
Available from: http://www.unicef.org/india/National_ Fact_Sheet_CES_2009.pdf [Last retrieved on 2014 Dec 10].,Non-OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
Available from:  http://www.nrhm.gov.in/images/pdf/nrhm‑in‑state/state  program/pip/Uttarakhand/uttarakhand‑pip‑12‑13.zip [Last  accessed on 2014 Sep 30].,Non-OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
Clinical Epidemiology and Global Health  08/2014; Available from: http://www.dx doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
"Clinical Epidemiology and  Global Health (2015), Available from: http://www.dx doi.",Non-OADS,/arxiv_data1/oa_pdf/48/4d/JFMPC-4-251.PMC4408710.pdf
Available  from: https://censusindia.gov.in/2011‑prov‑results/ Statement1_RU_State.xls [Last accessed on 2012 May 20].,OADS,/arxiv_data1/oa_pdf/3f/9a/JFMPC-4-261.PMC4408712.pdf
Available from: http://www.searo.who.int/linkfiles/ regional_tobacco_surveillance_system_gats_india.pdf  [Last accessed on 2012 June 7].,OADS,/arxiv_data1/oa_pdf/3f/9a/JFMPC-4-261.PMC4408712.pdf
Available from: http://www.who‑umc.,Non-OADS,/arxiv_data1/oa_pdf/bc/08/JFMPC-4-269.PMC4408714.pdf
Available from:  https://www.mohfw.nic.in.,Non-OADS,/arxiv_data1/oa_pdf/30/1d/JFMPC-4-287.PMC4408720.pdf
Available from: http://www.nccd.cdc.,Non-OADS,/arxiv_data1/oa_pdf/30/1d/JFMPC-4-287.PMC4408720.pdf
"The “Staphylococcal Regulatory RNA Database ”(SRD, http://srd.genouest.org/) compiled all published data in a single interface including genetic locations, sequences and other features.",OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049346.114.© 2015 Sassi et al.,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
"Here, we report a Staphylococcus Regulatory RNA Database (SRD, http://srd.genouest.org/) which compiles, after an in-depth scrubbing all the sRNA se- quences identified so far, with a primary focus on the humanpathogen S. aureus as a reference.",OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
"Ninenty-seven srnwere predicted to be be- tween 50 and 100 nt and the others were longer than 100 nt.Overall, only 159 srn were detected as transcripts or as RNA antisense under our experimental conditions (Supplemental Data S5 and http://srd.genouest.org/browsevalidated).",OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
Read mapping and visualization The genome sequences and annotation files were obtained fromNCBI (ftp://ftp.ncbi.nlm.nih.gov/genomes/Bacteria/).,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
A “heatmap ”clusterization was constructed using a matrix based on presence and absence of srngenes using the R package (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
Database design The web server has been designed in PHP with the “Symfony ” framework (http://symfony.com).,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
This distribution is displayed using the D3js library(http://d3js.org/).,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
2002) and are acces- sible through GEO Series accession number GSE64026 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE64026).,OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
"We are most grateful to the “plate-forme Génomique Santé ”Biogenouest Genomics, Biosit core facility for its technical support and to the CNRS-UPMC ABiMS bioinformaticsplatform (http://abims.sb-roscoff.fr) for providing computationalresources and support.",Non-OADS,/arxiv_data1/oa_pdf/41/1b/1005.PMC4408781.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048470.114.© 2015 Innocenti et al.,OADS,/arxiv_data1/oa_pdf/d8/a2/1018.PMC4408782.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d8/a2/1018.PMC4408782.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD 1018 RNA 21:1018 –1030; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/d8/a2/1018.PMC4408782.pdf
"Annotation and gene on- tology information show that most of the differentially ex- pressed genes in Supplemental Table SD are involved in thecentral metabolism associated with the consumption of sug- ars and amino acids as sources of carbon and nitrogen, main- ly centered on glycolysis, pyruvate metabolism, and citratecycle (TCA) (http://www.genome.jp/kegg/pathway.html and Fig.",OADS,/arxiv_data1/oa_pdf/d8/a2/1018.PMC4408782.pdf
Visualization of results All coverage information and tag signals resulting from our experi-ments and analysis can be visualized in a user-friendly and interactivemanner online at the address http://ebio.u-psud.fr/eBIO_BDD.php(select the entry called “The ppRNome browser ”).,OADS,/arxiv_data1/oa_pdf/d8/a2/1018.PMC4408782.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047845.114.© 2015 Rodgers et al.,OADS,/arxiv_data1/oa_pdf/36/3b/1031.PMC4408783.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/36/3b/1031.PMC4408783.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.METHOD RNA 21:1031 –1041; Published by Cold Spring Harbor Laboratory Press for the RNA Society 1031",Non-OADS,/arxiv_data1/oa_pdf/36/3b/1031.PMC4408783.pdf
The software miRBoost is available on our web server http://EvryRNA.ibisc.univ-evry.fr.,OADS,/arxiv_data1/oa_pdf/72/ac/775.PMC4408786.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.043612.113.,OADS,/arxiv_data1/oa_pdf/72/ac/775.PMC4408786.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 21:775 –785; Published by Cold Spring Harbor Laboratory Press for the RNA Society 775",Non-OADS,/arxiv_data1/oa_pdf/72/ac/775.PMC4408786.pdf
The software miRBoost is available on our web server http://EvryRNA.ibisc.univ-evry.fr.,OADS,/arxiv_data1/oa_pdf/72/ac/775.PMC4408786.pdf
"Negative data set for cross-validation From selected genomes, we randomly choose the exonic regionsfrom protein-coding genes at NCBI (http://www.ncbi.nlm.nih.gov/genome).",Non-OADS,/arxiv_data1/oa_pdf/72/ac/775.PMC4408786.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048801.114.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
"This article, published in RNA , is available under a Creative Commons License (Attribution-NonCommercial 4.0 Internation-al), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS 786 RNA 21:786 –800; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
To determine whether these EERs were associated with unannotated coding genes we assessed their coding potential using Coding PotentialCalculator application (http://cpc.cbi.pku.edu.cn/).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Folding free energies were calculated using UNAFold (Markham and Zuker 2008) (http://mfold.rna.albany.edu/?q=DINAMelt/software).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
The logo was created using Seq2Logo (http://weblogo.threeplusone.com/create.cgi).Whipple et al.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Data tracks were visu-alized using the Integrated Genome Browser (http://bioviz.org/igb/).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Structure prediction was calculated using the Vienna RNAfold webserver (http://rna.tbi.univie.ac.at/) and visualized using VARNA (http ://varna.lri.fr/).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Expression data were obtained from the modEncode database (http://www.modencode.org/).Whipple et al.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
"Sequence alignment using novoalign and GNUMAP Paired-end sequencing reads were aligned to C. elegans genome WS220/ce10 using novoalign (V2.07.13, http://www.novocraft.com/products/novoalign/) with option “-r All ”to retain repeats.",OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
"Alignments were filtered using the SamTranscriptomeParser application of the USEQ package (http://useq.sourceforge.net) using the following options: “-a 120 ”to re- move reads with excessive mismatches ( ∼4/100 bp read), “-n 1 ”to keep only unique reads or “-n 1000000 ”to keep both unique and repeat reads, “-r”to reverse the strand of paired reads, and “-p”to merge paired reads.",Non-OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
The same paired-end data as above were also aligned to WS220/ ce10 using an RNA editing-aware version of GNUMAP-bs (http://dna.cs.byu.edu/gnumap/) with the following GNUMAP argu-ments: “–lib_type unstrand –read_type rna –per_dist 150 –nt_conv a2i–top_k_hash 10 –map_quality sensitive ”.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Annotation of EERs and individual editing sites A BED file of EERs was intersected with BED files for genome anno-tations (described below) using the Bedtools (http://bedtools.readthedocs.org/) application annotateBed (Quinlan and Hall2010).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Variant calling to identify RNA editing sites was performed using Samtools essentially as described (http://samtools.sourceforge.net/mpileup.shtml).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Variant annotation was performed using Annovar (http://www.openbioinformatics.org/annovar/) against the WS220/ce10 genomebuild.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
We defined RNA editing sites as A-to-G variants on the for-ward strand or T>C variants on the reverse strand supported bynonreference bases from reads aligned to their respective strands.SNPs in dbSNP build 138 (https://www.ncbi.nlm.nih.gov/SNP/)were filtered from editing sites after liftover from ce6 to ce10(http://genome.ucsc.edu/cgi-bin/hgLiftOver).,Non-OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
Transposon anno- tations were obtained from Wormbase (http://www.wormbase.org/).,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
DATA DEPOSITION RNA sequencing data were deposited in the NCBI Gene ExpressionOmnibus database (http://www.ncbi.nlm.nih.gov/geo/) under ac-cession number GSE61564.,OADS,/arxiv_data1/oa_pdf/cf/73/786.PMC4408787.pdf
We offer a public web service (http://splicemap.bioinf.uni-leipzig.de) that allows to retrieve sets of orthologous splice sites and to produce overview maps of evolutionarily conservedsplice sites for visualization and further analysis.,OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
An electronic supplement containing the ncRNA data sets used in this study isavailable at http://www.bioinf.uni-leipzig.de/publications/supplements/12-001.,OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.046342.114.© 2015 Nitsche et al.,OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 21:801 –812; Published by Cold Spring Harbor Laboratory Press for the RNA Society 801",Non-OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
Agraphical representation of all splice sites in an interval of the geno-mic sequence of any of the included taxa can be generated using ourweb server (http://splicemap.bioinf.uni-leipzig.de); see Figure 1 foran example.,OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
The service can be accessed at http://splicemap.bioinf.uni-leipzig.de.,OADS,/arxiv_data1/oa_pdf/73/6a/801.PMC4408788.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048769.114.© 2015 Busch and Hertel This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/c8/d4/813.PMC4408789.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.BIOINFORMATICS RNA 21:813 –823; Published by Cold Spring Harbor Laboratory Press for the RNA Society 813",Non-OADS,/arxiv_data1/oa_pdf/c8/d4/813.PMC4408789.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049197.114.© 2015 Unciuleac and Shuman This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/d6/e5/824.PMC4408790.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.REPORT 824 RNA 21:824 –832; Published by Cold Spring Harbor Laboratory Press for the RNA Society",Non-OADS,/arxiv_data1/oa_pdf/d6/e5/824.PMC4408790.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048116.114.© 2015 Ivashuta et al.,OADS,/arxiv_data1/oa_pdf/e2/90/840.PMC4408792.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e2/90/840.PMC4408792.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e2/90/840.PMC4408792.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047381.114.© 2015 Aseev et al.,OADS,/arxiv_data1/oa_pdf/9d/64/851.PMC4408793.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/9d/64/851.PMC4408793.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049379.114.© 2015 Lebo et al.,OADS,/arxiv_data1/oa_pdf/86/0d/862.PMC4408794.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/86/0d/862.PMC4408794.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047506.114.© 2015 Garmann et al.,OADS,/arxiv_data1/oa_pdf/e8/fe/877.PMC4408795.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/e8/fe/877.PMC4408795.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/e8/fe/877.PMC4408795.pdf
2004) within ImageJ (http://imagej.nih.gov/ij/) as previously described (Gopal et al.,OADS,/arxiv_data1/oa_pdf/e8/fe/877.PMC4408795.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048637.114.© 2015 Toma et al.,OADS,/arxiv_data1/oa_pdf/72/a3/887.PMC4408796.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/72/a3/887.PMC4408796.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/72/a3/887.PMC4408796.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.045211.114.© 2015 Kelly and Bedwell This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http:// rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/37/54/898.PMC4408797.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/37/54/898.PMC4408797.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048421.114.© 2015 Burke et al.,OADS,/arxiv_data1/oa_pdf/df/5e/923.PMC4408799.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/df/5e/923.PMC4408799.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.049080.114.© 2015 Wolf and Grayhack This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/b8/c0/935.PMC4408800.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommer-cial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/b8/c0/935.PMC4408800.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.048215.114.© 2015 García-López et al.,OADS,/arxiv_data1/oa_pdf/3c/df/946.PMC4408801.pdf
"After 12 months, it is availableunder a Creative Commons License (Attribution-NonCommercial 4.0 Inter-national), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/3c/df/946.PMC4408801.pdf
DATA DEPOSITION Public data base accessions are provided for all raw data sets and alldata obtained as result of analysis here mentioned have been depos-ited in the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE59255.,OADS,/arxiv_data1/oa_pdf/3c/df/946.PMC4408801.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047357.114.© 2015 Giambas ¸u et al.,Non-OADS,/arxiv_data1/oa_pdf/4f/57/963.PMC4408802.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/4f/57/963.PMC4408802.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/4f/57/963.PMC4408802.pdf
Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.047985.114.© 2015 Collins et al.,OADS,/arxiv_data1/oa_pdf/27/5e/997.PMC4408805.pdf
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml).,Non-OADS,/arxiv_data1/oa_pdf/27/5e/997.PMC4408805.pdf
"After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.",Non-OADS,/arxiv_data1/oa_pdf/27/5e/997.PMC4408805.pdf
"2012) (http://fungidb.org/fungidb/) by selecting genes annotated as having one exon (i.e.,no introns), and analyzed as described above for Neurospora .",Non-OADS,/arxiv_data1/oa_pdf/27/5e/997.PMC4408805.pdf
"To minimize this problem, preventing damage to the  authors and the journal itself, it was adopted, as in a large  number of competitors, the online publication “Ahead of  Print”, providing the study on our site (http://www.rbccv.org.",Non-OADS,/arxiv_data1/oa_pdf/bc/32/rbccv-29-04-000I.PMC4408806.pdf
Disponível em: http://arxiv.org/ pdf/1410.2217.pdf,Non-OADS,/arxiv_data1/oa_pdf/bc/32/rbccv-29-04-000I.PMC4408806.pdf
Disponível em: http://www.politics.co.uk/opinion-formers/ royal-college-of-physicians/article/royal-college-of-physicians- sir-michael-rawlins-attacks-trad 38.,Non-OADS,/arxiv_data1/oa_pdf/d3/46/rbccv-29-04-0494.PMC4408810.pdf
Disponível  em: http://www.datasus.org.br 4.,Non-OADS,/arxiv_data1/oa_pdf/95/eb/rbccv-29-04-0513.PMC4408812.pdf
Available at: http://spo.escardio.org/eslides/view.,Non-OADS,/arxiv_data1/oa_pdf/ea/53/rbccv-29-04-0622.PMC4408826.pdf
Watch the videos acessing the link below: http://www.rbccv.org.br/article/2306/Tratamento-cirurgico-do-aneurisma-gigante-de-ventriculo-esquerdo---Relato-de-caso,Non-OADS,/arxiv_data1/oa_pdf/24/5f/rbccv-29-04-0663.PMC4408833.pdf
"JournalofGeophysicalResearch: Atmospheres 10.1002/2014JD022430 aretakenfromEDGAR(EmissionDatabaseforGlobalAtmosphericResearch,http://www.pbl.nl/edgar/ emission_data/edgar_32ft2000).",OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
"SO2emissionsfromoutgassingvolcanoes(i.e.,volcanoesemittingintothelowerandmiddletroposphere overlongertimeperiods)areincludedasclimatologicalsources.VolcanicSO2fromexplosiveeruptions isinjectedintothestratosphereusingtheSO2massesderivedfromOMI(OzoneMonitoringInstrument) orTOMS(TotalOzoneMappingSpectrometer)satellitedatafromtheNASASO2database(http://so2.gsfc.",OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
", 2015] or theSmithsonian database (http://www.volcano.si.edu) from which also thenames of smallervolcanoesareadopted.IfnoMIPASSO 2isavailable,SAGEII(StratosphericAerosolandGasesExperiment) (update of Thomason and Peter [2006]; Thomason et al.",OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
Most volcano names are from the Smithsonian database (http://www.volcano.si.edu).,OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
",2001]withhigher concentrationsinthemiddlestratosphereduring theeasterlyphaseinbothsimulationsandobservations, duetoenhancedupwardtransport.TheoverlaidcontoursinFigure1showtheaveragezonalwindintheinnertropicsassimulated(top)andasobserved(bottom)overSingapore(http://www.geo.fu-berlin.de/en/met/ag/strat/produkte/qbo).Asstatedearlier,untilabout2006thesimulatedQBOisinphasewiththeobservations,whilelaterthephaseisoﬀduetoastallofthesimulatedeastphaseoreasterlyshearin2007(inthepresentsimulation).ThedistributionofsimulatedCOSwithlatitudeagreeswithobservations,alsoshownin Brühl et al.",OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
For theMIPAS data we refer to http://www.imk-asf.kit.edu/english/308.php.,Non-OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
The sulfur injections from the volcanoes were estimated utilizing the NASA SO 2 database at GSFC (http://so2.gsfc.nasa.,OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
"gov) and the Smithsonian volcano database (http://www.volcano.si.edu).The group of C. Bingen at BIRA,Belgium, provided the processed OSIRIS data for comparison.",OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
[Available at http://www.sparc-climate.org/publications/sparc-reports.],Non-OADS,/arxiv_data1/oa_pdf/5d/04/jgrd0120-2103.PMC4408860.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jbm-6-125.PMC4408911.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Blood Medicine 2015:6 125–129Journal of Blood Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  125Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JBM.S8097 7Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jbm-6-125.PMC4408911.pdf
"Or use: http://youtu.be/lj8s7zIaW_ IOccurrence of anti-D alloantibodies among  pregnant women in Kasese District, Western  Uganda Y ona Mbalibulha1 enoch Muwanguzi1 godfrey r Mugyenyi2 Bernard natukunda1 1Department of Medical laboratory  sciences,  2Department of Obstetrics  and gynecology, Faculty of Medicine,   Mbarara University of science and  T echnology, Mbarara, Uganda correspondence: Yona Mbalibulha   Department of Medical laboratory  sciences, Faculty of Medicine, Mbarara  University of science and Technology,   PO Box  1410, Mbarara, Uganda   Tel +256 752 454 242  email yonamilly@yahoo.co.u kObjectives:  This study was undertaken to determine the distribution of ABO/RhD (rhesus D  antigen) blood phenotypes, prevalence of anti-D alloantibodies, and the risk factors for alloim - munization among pregnant women in Kasese District, Western Uganda.",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jbm-6-125.PMC4408911.pdf
"Journal of Blood Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/Journal-of-blood-medicine-journa lThe Journal of Blood Medicine is an international, peer-reviewed, open  access, online journal publishing laboratory, experimental and clinical aspects  of all topics pertaining to blood based medicine including but not limited to:  Transfusion Medicine; Blood collection, Donor issues, Transmittable diseases,  and Blood banking logistics; Immunohematology; Artificial and alternative blood based therapeutics; Hematology; Biotechnology/nanotechnology of  blood related medicine; Legal aspects of blood medicine; Historical perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jbm-6-125.PMC4408911.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/9f/jbm-6-125.PMC4408911.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b0/0a/nihms652461.PMC4408922.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 725–732Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  725Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7874 7a 3-day regimen with azithromycin 1.5%  eyedrops for the treatment of purulent bacterial  conjunctivitis in children: efficacy on clinical signs  and impact on the burden of illness Dominique Bremond- gignac1,2 riadh Messaoud3 sihem lazreg4 Claude speeg-schatz5 Didier renault6 Frédéric Chiambaretta7,8 On behalf of the  azithromycin Pediatric  study group 1Ophthalmology Department,   Centre st Victor, University hospital  of amiens, Picardie Jules Verne  University, amiens, France; 2Cnrs  Fr3636, Paris V University, France;   3Ophthalmology Department, Tahar  sfar University hospital, Mahdia,   T unisia; 4Dar el Beida, Blida, algeria;   5Ophthalmology Department,   University hospital of strasbourg,   strasbourg, France; 6laboratoires  ThÉa, Clermont-Ferrand, France;   7Ophthalmology Department,   University hospital of Clermont- Ferrand, gabriel Montpied hospital,   Clermont-Ferrand, France; 8ea  7281 r2D2, auvergne University,   Clermont-Ferrand, FrancePurpose:  To compare the efficacy of azithromycin 1.5% versus tobramycin 0.3% eyedrops  on clinical ocular signs and symptoms of bacterial conjunctivitis in children and to assess the  parents’ satisfaction regarding the dosing regimen.",Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
"Follicular reaction of palpebral conjunctiva, eyelid erythema,  and swelling are also common clinical signs.4,5 In preschool- and school-age chil - dren, Haemophilus influenzae  and Streptococcus pneumoniae  are the most common  pathogens, and thus quite different from the bacteriological profile in adults in whom  Staphylococcus epidermidis , coagulase-negative staphylococcus,  and S. aureus  patho - gens are predominantly found.5–8 Although bacterial conjunctivitis generally resolves spontaneously in a few days,  there is broad agreement that topical antibiotics are worthwhile, particularly in moderate Correspondence: Dominique Bremond- gignac service d’Ophtalmologie, Centre saint  Victor, ChU d’amiens, 354 Bd de  Beauville, 80054 amiens, France Tel +33 3 22 82 41 08 Fax +33 3 22 82 40 61 email bremond.dominique@chu-amiens.f r Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bremond-Gignac et al Running head recto: Azithromycin in children with bacterial conjunctivitis DOI: http://dx.doi.org/10.2147/OPTH.S78747",Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
"The study was carried out in  accordance with Good Clinical Practice, the Declaration  of Helsinki, and local regulations and registered under the  reference number NCT01155999 ( http://clinicaltrials.go v).",Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/41/a1/opth-9-725.PMC4408937.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/amep-6-331.PMC4408938.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 331–335Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  331OriginAl rEsEArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S7312 7Does how much a resident teaches impact  performance?,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/amep-6-331.PMC4408938.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/4e/ac/amep-6-331.PMC4408938.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4e/ac/amep-6-331.PMC4408938.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/26/dddt-9-1983.PMC4408939.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 1983–1987Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1983Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6911 7Canakinumab as rescue therapy in familial  Mediterranean fever refractory to conventional  treatment Mirella alpa Dario roccatello Centro di ricerche di  Immunopatologia e Documentazione  su Malattie rare (CMID), struttura  Complessa Direzione Universitaria  di Immunologia Clinica, Università di  T orino e ospedale G Bosco, T orino,   ItalyAbstract:  Familial Mediterranean fever is an autosomal recessive autoinflammatory disorder  mainly affecting Mediterranean populations, which is associated with mutations of the MEFV   gene that encodes pyrin.",Non-OADS,/arxiv_data1/oa_pdf/34/26/dddt-9-1983.PMC4408939.pdf
"Serum Amyloid A (SAA) was  normal as were creatinine, transaminases, and uric acid levels and urine analysis.Correspondence: Dario roccatello Centro di ricerche di Immunopatologia  e Documentazione su Malattie rare  (CMID), struttura Complessa Direzione  Universitaria di Immunologia Clinica,  Università di Torino e ospedale G  Bosco, piazza Donatore di sangue 3,  10154 Torino, Italy Tel +39 011 240 2056 Fax +39 011 240 2052 email dario.roccatello@unito.i tJournal name: Drug Design, Development and Therapy Article Designation: Case report Y ear: 2015 Volume: 9 Running head verso: Alpa and Roccatello Running head recto: Canakinumab as rescue therapy in FMF DOI: http://dx.doi.org/10.2147/DDDT.S69117",Non-OADS,/arxiv_data1/oa_pdf/34/26/dddt-9-1983.PMC4408939.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/34/26/dddt-9-1983.PMC4408939.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/26/dddt-9-1983.PMC4408939.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/amep-6-337.PMC4408940.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pAdvances in Medical Education and Practice 2015:6 337–338Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  337LEttEropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/AMEP .S8078 1British medical students suffer an inordinate  amount of stress compared to other university  students: fact or fiction?,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/amep-6-337.PMC4408940.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/bc/8c/amep-6-337.PMC4408940.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/8c/amep-6-337.PMC4408940.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/ijn-10-3043.PMC4408941.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3043–3053International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3043OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6672 3Journal name: International Journal of Nanomedicine Journal Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Mi and Xing Running head recto: Phenotypic reversion in 3D nanofiber scaffold DOI: http://dx.doi.org/10.2147/IJN.S66723 cD44+/cD24- breast cancer cells exhibit  phenotypic reversion in three-dimensional self- assembling peptide RADA16 nanofiber scaffold Kun Mi1 Zhihua Xing2 1Department of Biochemistry   and Molecular Biology, sichuan cancer  hospital and Institute, 2laboratory  of ethnopharmacology, Institute  for Nanobiomedical Technology  and Membrane Biology, West china  hospital, sichuan University, chengdu,   People’s republic of china correspondence: Kun Mi   Department of Biochemistry   and Molecular Biology, sichuan cancer  hospital and Institute, No 55, section 4,  south People’s road, chengdu 610041,   sichuan, People’s republic of china   Tel +86 28 8542 0256   Fax +86 28 8542 0116   email mikun@126.co m Background:  Self-assembling peptide nanofiber scaffolds have been shown to be a  permissive  biological material for tissue repair, cell proliferation, differentiation, etc.",Non-OADS,/arxiv_data1/oa_pdf/c5/c6/ijn-10-3043.PMC4408941.pdf
"International Journal of Nanomedicine 2015:10submit your manuscript | www.dovepress.co m Dove press Dove press International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/c5/c6/ijn-10-3043.PMC4408941.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.Dove pres s 3053Phenotypic reversion in 3D nanofiber scaffold  30.,Non-OADS,/arxiv_data1/oa_pdf/c5/c6/ijn-10-3043.PMC4408941.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/ndt-11-1097.PMC4408942.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1097–1101Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1097OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7619 3Factors associated with poor discharge status  in patients with status epilepticus at Khon  Kaen hospital Piyawan chiewthanakul1 Parinya Noppaklao2 Kittisak sawanyawisuth3,4 somsak Tiamkao3,5 1Department of Medicine, Khon  Kaen hospital, Khon Kaen, Thailand;   2Department of Medicine, Faculty  of Medicine, Khon Kaen University,   Khon Kaen, Thailand; 3Department  of Medicine, Faculty of Medicine,   Khon Kaen University, Khon Kaen,   Thailand; 4research center in Back,   Neck, Other Joint Pain and  human  Performance (BNOJP h), Khon Kaen  University, Khon Kaen, Thailand;   5integrated epilepsy research group,   Khon Kaen University, Khon Kaen,   ThailandBackground:  Status epilepticus (SE) is a serious neurological condition and has high a  mortality rate.",Non-OADS,/arxiv_data1/oa_pdf/f7/23/ndt-11-1097.PMC4408942.pdf
"correspondence: somsak Tiamkao Department of Medicine, Faculty  of Medicine, Khon Kaen University, 123  Mittraphap road, Khon Kaen 40002,  Thailand  Tel +66 43 363 664 Fax +66 43 348 399 email somtia@kku.ac.t h Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Chiewthanakul et al Running head recto: Poor discharge status in patients with status epilepticus DOI: http://dx.doi.org/10.2147/NDT.S76193",Non-OADS,/arxiv_data1/oa_pdf/f7/23/ndt-11-1097.PMC4408942.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f7/23/ndt-11-1097.PMC4408942.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/23/ndt-11-1097.PMC4408942.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/dddt-9-2285.PMC4408943.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2285–2300Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2285Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7827 7evaluation of the protective effects of curcuminoid  (curcumin and bisdemethoxycurcumin)-loaded  liposomes against bone turnover in a cell-based  model of osteoarthritis chih-chang Yeh1,2 Yu-han su3 Yu-Jhe lin3 Pin-Jyun chen3 chung-sheng shi1 cheng-n an chen3,* hsin-i chang3,* 1graduate institute of clinical Medical  sciences, college of Medicine, chang  gung University, Taoyuan 333, Taiwan,   republic of china; 2Orthopaedic  Department, chiayi Branch,   Taichung Veterans general hospital,   chiayi, Taiwan, republic of china;   3Department of Biochemical science  and Technology, national chiayi  University, chiayi, Taiwan, republic  of china *These authors contributed equally  to this workAbstract:  Curcumin (Cur) and bisdemethoxycurcumin (BDMC), extracted from Curcuma  longa , are poorly water-soluble polyphenol compounds that have shown anti-inflammatory  potential for the treatment of osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/3f/fa/dddt-9-2285.PMC4408943.pdf
"Active osteoblasts produce bone formation markers which are expressed correspondence: cheng-nan chen;  hsin-i chang Department of Biochemical science and  Technology, national chiayi University,  300 University road, chiayi, Taiwan,  republic of china email cnchen@mail.ncyu.edu.t w;  hchang@mail.ncyu.edu.t wJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Y eh et al Running head recto: Curcuminoid-loaded liposomes in a cell-based model of osteoarthritis DOI: http://dx.doi.org/10.2147/DDDT.S78277",Non-OADS,/arxiv_data1/oa_pdf/3f/fa/dddt-9-2285.PMC4408943.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/3f/fa/dddt-9-2285.PMC4408943.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3f/fa/dddt-9-2285.PMC4408943.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/a6/ijgm-8-155.PMC4408944.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of General Medicine 2015:8 155–161International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  155Case reportopen access to scientific and medical research open access Full text article 60310Liver abscess caused by Salmonella choleraesuis takashi Kamatani1 takemichi okada2 Hiroyoshi Iguchi2 Y oshihito takahashi3 Hiroaki Y okomori1 1Department of Internal   Medicine, 2Department of   radiology, 3Department of   surgery, Kitasato University   Medical Center, saitama, Japan Correspondence: Hiroaki Yokomori   Kitasato University Medical Center,   6-100 arai, Kitamoto-shi,   saitama 364-8501, Japan   tel +81 48 593 1212   Fax +81 48 593 1239   email yokomori@insti.kitasato-u.ac.j pAbstract:  A 65-year-old man with long-term alcohol abuse presented with intermittent fever.",Non-OADS,/arxiv_data1/oa_pdf/66/a6/ijgm-8-155.PMC4408944.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/66/a6/ijgm-8-155.PMC4408944.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/a6/ijgm-8-155.PMC4408944.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c6/89/rru-7-057.PMC4408945.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pResearch and Reports in Urology 2015:7 57–63Research and Reports in Urology Dove press submit your manuscript | www.dovepress.co m Dove press  57Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RRU.S5114 0Combination therapies for the management   of nocturia and its comorbidities Cenk Murat Yazici Omer Kurt Department of Urology, Namik  Kemal University School of Medicine,   T ekirdag, T urkey Correspondence: Cenk Murat Yazici   Department of Urology, Namik Kemal  University School of Medicine, 100.",Non-OADS,/arxiv_data1/oa_pdf/c6/89/rru-7-057.PMC4408945.pdf
"Research and Reports in Urology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/research-and-reports-in-urology-journa lResearch and Reports in Urology is an international, peer-reviewed,  open access journal publishing original research, reports, editorials,  reviews and commentaries on all aspects of adult and pediatric urology  in the clinic and laboratory including the following topics: Pathology,  pathophysiology of urological disease; Investigation and treatment of urological disease; Pharmacology of drugs used for the treatment of  urological disease.",Non-OADS,/arxiv_data1/oa_pdf/c6/89/rru-7-057.PMC4408945.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c6/89/rru-7-057.PMC4408945.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pCore Evidence 2015:10 49–62Core Evidence Clinical impact summary for vilazodone in major depression Outcome measure Evidence Implications Patient-oriented evidence   Reduction of depressive  symptomsClear Vilazodone more effective than placebo As effective  as citalopram   Improvement of anxiety Suggestive Vilazodone may have additional benefit for depressed  patients with high levels of anxiety Disease-oriented evidence   Symptom relief in terms  of MADRS reductionClear Vilazodone more effective than placebo on MADRS   Response to treatment Clear Vilazodone more effective than placebo   Remission after treatment Clear Vilazodone more effective than placebo Economic evidence   Cost-effectiveness No   evidenceSo far, there is no information regarding the relative  cost-effectiveness of vilazodone compared to other  marketed antidepressants in the US Abbreviation:  MADRS, Montgomery–Åsberg Depression Rating Scale.Dove press submit your manuscript | www.dovepress.co m Dove press  49REVIEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CE.S5407 5Vilazodone for the treatment of major   depressive disorder: an evidence-based   review of its place in therapy David J Hellerstein1,2 Joseph Flaxer1 1Department of Psychiatry,    Columbia University, 2New Y ork State  Psychiatric Institute, New Y ork,    NY, USA Correspondence: David J Hellerstein   New York State Psychiatric Institute,  Unit 51, 1051 Riverside Drive,   New York, NY 10032, USA   Tel +1 646 774 8069   Fax +1 646 774 8034   Email hellers@nyspi.columbia.ed uIntroduction:  It has clearly been demonstrated that depressive disorders constitute a major worldwide  public health problem, with massive economic and quality-of-life consequences.",Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
"submit your manuscript | www.dovepress.co m Dove press Dove press 50Hellerstein and Flaxer Scope, aims, and objectives Methods The medical literature was reviewed for appropriate articles  related to vilazodone on PubMed ( http://www.ncbi.nlm.nih.",Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
"Core Evidence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/core-evidence-journa lCore Evidence is an international, peer-reviewed open-access journal  evaluating the evidence underlying the potential place in therapy of  drugs throughout their development lifecycle from preclinical to post - launch.",Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
"Available  from: http://www.thecarlatreport.com/free_articles/four-%E2%   80%9Cnew%E2%80%9D-antidepressants-or-are-they-free-articl e.  Accessed January 29, 2015.",Non-OADS,/arxiv_data1/oa_pdf/19/68/ce-10-049.PMC4408952.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/82/ijn-10-3055.PMC4408953.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3055–3064International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3055OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8081 0characterization of nanostructured ureteral stent  with gradient degradation in a porcine model Xiaoqing Wang1 hongli shan2 Jixue Wang1 Yuchuan hou1 Jianxun Ding3 Qihui chen1 Jingjing guan1 chunxi Wang1 Xuesi chen3 1Department of Urology, the  First hospital of Jilin University,   2Department of clinical laboratory,   the First hospital of Jilin University,   3Key laboratory of Polymer  ecomaterials, changchun Institute  of applied chemistry, chinese  academy of sciences, changchun,   People’s republic of chinaAbstract:  A tubular poly( ε-caprolactone) (PCL)/poly(lactide-co-glycolide) (PLGA) ureteral  stent composed of nanofibers with micropores was fabricated by double-needle electrospinning.",Non-OADS,/arxiv_data1/oa_pdf/f9/82/ijn-10-3055.PMC4408953.pdf
"The dissolvable stent produced by Lingeman et al   showed the unsatisfactory results of poor fixation and a tendency to drop in clinical  trials, which caused hydronephrosis and left debris in the pelvis.8 Chew et al invented  several types of degradable Uriprene™ ureteral stents with undesirable results due to  uncontrollable degradation, which involved the sudden disintegration of material and  caused transient obstruction in animal trials.9–11 Fu and coworkers produced a polylactide  (PLA) ureteral stent, and the animal trials validated that it required more than 80 days correspondence: chunxi Wang Department of Urology, the First  hospital of Jilin University, 71 Xinmin  street, changchun 130021, People’s  republic of china Tel/Fax +86 431 8878 2292 email chunxi_wang@126.co m  Jianxun Ding Key laboratory of Polymer ecomaterials,  changchun Institute of applied  chemistry, chinese academy of sciences,  5625 renmin street, changchun 130022,  People’s republic of china Tel/Fax +86 431 8526 2116 email jxding@ciac.ac.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Wang et al Running head recto: Nanostructured ureteral stent with gradient degradation DOI: http://dx.doi.org/10.2147/IJN.S80810",Non-OADS,/arxiv_data1/oa_pdf/f9/82/ijn-10-3055.PMC4408953.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f9/82/ijn-10-3055.PMC4408953.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/82/ijn-10-3055.PMC4408953.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2257–2264Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2257MeTho Dologyopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S7827 6hDACiDB: a database for histone deacetylase  inhibitors Kasi Murugan1 Shanmugasamy Sangeetha2 Shanmugasamy Ranjitha2 Antony Vimala2 Saleh Al-Sohaibani1 gopal Rameshkumar2 1Department of Botany and  Microbiology, College of Science, King  Saud University, Riyadh, Saudi Arabia;   2Bioinformatics laboratory, Anna  University K. Balachander Research  Centre, MIT Campus of Anna  University Chennai, Chennai, IndiaAbstract:  An histone deacetylase (HDAC) inhibitor database (HDACiDB) was constructed  to enable rapid access to data relevant to the development of epigenetic modulators (HDAC  inhibitors [HDACi]), helping bring precision cancer medicine a step closer.",Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
The database is freely available on the http://hdacidb.bioinfo.au-kbc.org.in/hdacidb / website.,OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
"Among the regulatory epigenetic mechanisms, histone protein  modification has been well studied.4 The potentially reversible nature of epigenetic Correspondence: gopal Rameshkumar Bioinformatics laboratory, AU-KBC  Research Centre, MIT Campus of Anna  University Chennai, Chromepet, Chennai  600044, India email gramesh@au-kbc.or gJournal name: Drug Design, Development and Therapy Article Designation: Methodology Y ear: 2015 Volume: 9 Running head verso: Murugan et al Running head recto: Database for histone deacetylase inhibitors DOI: http://dx.doi.org/10.2147/DDDT.S78276",Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
"Description of the HDACiDB  database The HDACiDB ( http://hdacidb.bioinfo.au-kbc.org.in/ hdacidb /) is organized and constructed around publicly  available literature and is based on HDACi main compounds  collected from open literature, patent databases, and clini - cal trial compound databases approved by the US Food and  Drug Administration.",OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
"These data were processed using  jQuery Slider, and the JMOL applet ( http://www.jmol.or g)  was employed for the visualization of two-dimensional and  three-dimensional compound structures.",OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
Avail - able from: http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.,Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/db/fb/dddt-9-2257.PMC4408954.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/df/59/dddt-9-2277.PMC4408955.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2277–2283Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2277Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8359 2Brentuximab vedotin for treatment of relapsed  or refractory malignant lymphoma: results  of a systematic review and meta-analysis  of prospective studies correspondence: Baoan chen Department of hematology and  Oncology, Zhongda hospital, Medical  school, southeast University, Dingjiaqiao  87, gulou District, nanjing 210009,  Jiangsu Province, People’s republic  of china Tel +86 25 8327 2006 Fax +86 25 8327 2011 email cba8888@hotmail.comrunzhe chen Fei Wang hongming Zhang Baoan chen Department of hematology and  Oncology (Key Department of Jiangsu  Medicine), Zhongda hospital, Medical  school, southeast University, nanjing,   Jiangsu Province, People’s republic  of chinaBackground:  Recently, brentuximab vedotin has become a promising therapeutic approach for  CD30-positive hematological malignancies, but its role in other relapsed or refractory malignant  lymphoma needs to be proven.",Non-OADS,/arxiv_data1/oa_pdf/df/59/dddt-9-2277.PMC4408955.pdf
"Keywords:  clinical studies, monoantibody, lymphoma, clinical studies Introduction Malignant lymphoma is one of the most common cancers among people all over the  world.1 Due to the development of highly active chemotherapy and the optimization  of radiotherapy in recent years, patients with newly diagnosed lymphoma have a very  excellent prognosis, and their 5-year progression-free survival rate can be as high as  greater than 75%.2 Curing patients whose disease are relapsed after transplantation or  refractory after salvage chemotherapy remains a big clinical challenge; such patients  are rarely cured and only have a median overall survival of 2–3 years.2–5 Brentuximab vedotin (SGN-35) is a CD30-directed antibody-drug conjugate  (ADC),  which can induce cell-cycle arrest and apoptosis, with proven efficacy in  patients with CD30-positive malignancies, including Hodgkin lymphoma (HL),  peripheral T-cell lymphoma, diffuse large B-cell lymphoma, and systemic anaplastic Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: Brentuximab vedotin in relapsed/refractory lymphoma DOI: http://dx.doi.org/10.2147/DDDT.S83592",Non-OADS,/arxiv_data1/oa_pdf/df/59/dddt-9-2277.PMC4408955.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/df/59/dddt-9-2277.PMC4408955.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/df/59/dddt-9-2277.PMC4408955.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c9/a9/jpr-8-169.PMC4408956.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 169–174Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  169ORiginal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JPR.S7741 2Tactile, thermal, and electrical thresholds   in patients with and without phantom limb   pain after traumatic lower limb amputation shengai li1,2 Danielle h Melton1,2 sheng li1,2 1Department of Physical Medicine  and Rehabilitation, University of  Texas health science center  at houston, houston, TX, Usa;   2neurorehabilitation Research  laboratory, T iRR Memorial hermann  Research center, houston, TX, Usa correspondence: sheng li   TiRR Memorial hermann hospital,   1333 Moursund street, houston,   TX 77030, Usa   Tel +1 713 7500 5872  email sheng.li@uth.tmc.ed uPurpose:  To examine whether there is central sensitization in patients with phantom limb pain  (PLP) after traumatic limb amputation.",Non-OADS,/arxiv_data1/oa_pdf/c9/a9/jpr-8-169.PMC4408956.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/c9/a9/jpr-8-169.PMC4408956.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c9/a9/jpr-8-169.PMC4408956.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7d/d9/ott-8-893.PMC4408957.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 893–898OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  893Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8183 7comparison of single-agent chemotherapy and  targeted therapy to first-line treatment in patients  aged 80 years and older with advanced non-small- cell lung cancer Qianqian Zhang1 Zhehai Wang2 Jun guo2 liyan liu2 Xiao han2 Minmin li1 shu Fang1 Xiang Bi1 ning Tang1 Yang liu1 1school of Medicine and life sciences,   shandong academy of Medical  sciences, University of Jinan,   2Department of Oncology, shandong  cancer hospital, Jinan, People’s  republic of chinaPurpose:  The aim of this study was to compare single-agent chemotherapy with targeted  therapy in initial treatment and to explore a better choice of treatment for patients aged 80 years  and older with advanced non-small-cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/7d/d9/ott-8-893.PMC4408957.pdf
"Elders present particularity with a variety correspondence: Zhehai Wang Department of Oncology, shandong  cancer hospital, 440 Jiyan road, huaiyin,  Jinan, shandong 250117, People’s  republic of china Tel/fax +86 531 6762 6331 email wzhai8778@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: Treatment comparisons in NSCLC DOI: http://dx.doi.org/10.2147/OTT.S81837",Non-OADS,/arxiv_data1/oa_pdf/7d/d9/ott-8-893.PMC4408957.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7d/d9/ott-8-893.PMC4408957.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7d/d9/ott-8-893.PMC4408957.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpAdvances in Medical Education and Practice 2015:6 279–295Advances in Medical Education and Practice Dove press submit your manuscript | www.dovepress.co m Dove press  279REviEwopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/AMEP .S5617 9T eaching safe prescribing to medical students:  perspectives in the UK Hamde Nazar1 Mahdi Nazar2 Charlotte Rothwell1 Jane Portlock3 Andrew Chaytor1 Andrew Husband1 1School of Medicine, Pharmacy  and Health, Durham University,   UK; 2Cumberland infirmary, North  Cumbria University Hospitals NHS  Trust, UK; 3School of Pharmacy and  Biomedical Sciences, University of  Portsmouth, UK Correspondence: Hamde Nazar   School of Medicine, Pharmacy and Health,  Durham University, Queen’s Campus,  wolfson institute, Stockton-on-Tees,  TS17 6BH, UK   Tel +44 191 334 0250   Email hamde.nazar@durham.ac.u kAbstract:  Prescribing is a characteristic role of a medical practitioner.",Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
Richard Diaz Quotes ; 2014  Available from: https://www.goodreads.com/author/quotes/2490467.,Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
Available from: http://psnet.ahrq.gov/ resource.aspx?resourceID =1726 9.,OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
"Advances in Medical Education and Practice Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/advances-in-medical-education-and-practice-journa lAdvances in Medical Education and Practice is an international, peer- reviewed, open access journal that aims to present and publish research  on Medical Education covering medical, dental, nursing and allied  health care professional education.",Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real  quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
"Available from: http://www.gmcuk.org/06___ National_Licensing_Examination.pdf_57876215.pd f. Accessed  November 12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/70/b3/amep-6-279.PMC4408958.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/85/31/clep-7-295.PMC4408959.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Epidemiology 2015:7 295–303Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  295Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S7385 7Oxaliplatin-based first-line chemotherapy  is associated with improved overall survival  compared to first-line treatment with irinotecan- based chemotherapy in patients with metastatic  colorectal cancer – results from a prospective  cohort study Norbert Marschner1 Dirk arnold2 Erik Engel3 Ulrich Hutzschenreuter4 Jacqueline Rauh5 Werner Freier6 holger hartmann7 Melanie Frank8 Martina Jänicke7 On behalf of the TKK  registry group 1Praxis für Interdisziplinäre Onkologie  und hämatologie, 2Klinik für  T umorbiologie, Freiburg, germany;   3Hämatologisch – Onkologische  Praxis altona, hamburg, germany;   4Hämatologisch – Onkologische  Gemeinschaftspraxis, Nordhorn,   germany; 5Fachinternistische  Gemeinschaftspraxis und  Therapiezentrum, Witten, Germany;   6Onkologische Praxis, Hildesheim,   germany; 7Clinical Epidemiology  and Health Economics, iOMEDICO,   8statistics, iOMEDiCO, Freiburg,   germany Correspondence: Norbert Marschner   Praxis für Interdisziplinäre Onkologie   und Hämatologie, Wirthstr 11c,   79110 Freiburg, germany   Tel +49 761 386 870   Fax +49 761 386 8710   Email norbert.marschner@onkologie- freiburg.d ePurpose:  Several randomized trials investigating the preferable first-line combination che - motherapy regimen for metastatic colorectal cancer have shown inconsistent findings.",Non-OADS,/arxiv_data1/oa_pdf/85/31/clep-7-295.PMC4408959.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access,  online journal focusing on disease and drug epidemiology, identifica - tion of risk factors and screening procedures to develop optimal pre - ventative initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/85/31/clep-7-295.PMC4408959.pdf
"Langversion 1.0, AWMF , 021- 007OL, http://leitlinienprogramm-onkologie.de/Leitlinien.7.0.htm l.  Accessed August 8, 2013.",OADS,/arxiv_data1/oa_pdf/85/31/clep-7-295.PMC4408959.pdf
"Available from: http://www.bundesaerztekammer.de/ downloads/Taetigkeit2010.pd f. Accessed October 21, 2012.",Non-OADS,/arxiv_data1/oa_pdf/85/31/clep-7-295.PMC4408959.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/kfv020.PMC4408961.pdf
"Studies may be preregistered, eg,in the Open Science Framework (https://osf.io) database, to pairexploratory studies with replication studies for subsequent joint publication; such paired studies replace the same number of unrelated studies, potentially reducing Type I error ( Nuzzo, 2014 ).",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/kfv020.PMC4408961.pdf
"In a 2013 policy memorandum, the Office of Science andTechnology Policy in the Executive Office of the President calledfor Federal agencies with over $100 million in research anddevelopment expenditures to develop plans to make research data publicly available to other scientists, regulators, and the general public (http://www.whitehouse.gov/sites/default/files/microsites/ostp/ostp_public_access_memo_2013.pdf) (see http://www.epa.gov/open/ for the EPA plan).",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/kfv020.PMC4408961.pdf
"The experimental guidance document, Supplementary Table S1, has similarities to Nature Publishing Group’s Reporting Checklist for Life Sciences Articles (http://www.nature.com/authors/policies/checklist.pdf) and other previously published checklists ( Hooijmans et al.",Non-OADS,/arxiv_data1/oa_pdf/4c/9f/kfv020.PMC4408961.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/df/dddt-9-2249.PMC4408966.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2249–2256Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2249Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8125 7comparison of reendothelialization  and neointimal formation with stents coated  with antibodies against endoglin and cD34 in a  porcine model song cui1,* Xian-Tao song1 chao Ding2,* li-Jun Meng3 shu-Zheng lv1 Kefeng li4,5 1The Key laboratory of remodeling- related cardiovascular Diseases,   Department of cardiology, anzhen  hospital affiliated to capital  Medical University, Beijing, People’s  republic of china; 2Department  of cardiology, huimin People’s  hospital, Binzhou, People’s  republic of china, 3Department of  cardiology, Binzhou central hospital,   Binzhou, People’s republic of china;   4school of Medicine, University of  california, san Diego, ca, Usa;   5Tianjin sunnyPeak Biotech co, ltd,   Tianjin, People’s republic of china *These authors contributed equally  to this workAbstract:  Anti-CD34 coated stents are the only commercialized antibody-coated stents currently  used for coronary artery diseases with various limitations.",Non-OADS,/arxiv_data1/oa_pdf/e4/df/dddt-9-2249.PMC4408966.pdf
"2, anzhen road,  chaoyang District, Beijing, 100029,  People’s republic of china Tel +86 10 64456981 Fax +86 10 64453756 email songxiantao@medmail.com.c n  li-Jun Meng Department of cardiology, Binzhou  central hospital, Binzhou 251700,  People’s republic of china Tel +86 543 5325877 Fax +86 543 5322880 email zxyymlj@126.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Cui et al Running head recto: Stents coated with anti-endoglin enhance reendothelialization DOI: http://dx.doi.org/10.2147/DDDT.S81257",Non-OADS,/arxiv_data1/oa_pdf/e4/df/dddt-9-2249.PMC4408966.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e4/df/dddt-9-2249.PMC4408966.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/df/dddt-9-2249.PMC4408966.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 69–75Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  69OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S8214 3Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
"Or use: http://youtu.be/2wxTdPXaaj 4Pharmacokinetic equivalence study of two  formulations of the anticonvulsant pregabalin raymond r Tjandrawinata1 effi setiawati2 ratih sofia ika Putri2 Vincent Angga gunawan2 Fenny Ong1 liana W susanto1 Dwi nofiarny1 1Dexa laboratories of Biomolecular  sciences, Cikarang, West Java,  indonesia;  2PT equilab international  Bioavailability and Bioequivalence  laboratory, Jakarta, indonesia Correspondence: raymond r  Tjandrawinata   Dexa laboratories of Biomolecular  sciences, Dexa Medica group, indonesia,  industri selatan V Block PP number  7,  Jababeka industrial estate ii, Cikarang,  West Java  17550, indonesia   Tel +62 21  8984 1901  Fax +62 21  8984 1905  email raymond@dexa-medica.co mPurpose:  The present study was conducted to evaluate whether the bioavailability of  pregabalin capsules  150 mg manufactured by PT Dexa Medica was equivalent to the reference  formulation.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
Available  from: http://www.who.int/mediacentre/factsheets/fs999/en /.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
"Available from: http://www.fda.gov/downloads/Drugs/ Guidances/ ucm070124.pd f. Accessed September  12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
"Available from: http://www.ema.europa.eu/docs/en_GB/ document_library/Scientific_guideline/2010/01/WC500070039.pd f.  Accessed September  12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
Available from: http://www.wma.net/ en/30publications/10policies/b3 /.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
Available from: http://www.ich.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
"Avail - able from: http://www.iuphar.org/pdf/hum_55.pd f. Accessed September   12, 2014.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/94/3c/cpaa-7-069.PMC4408967.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 771–780Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  771OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7356 3Voluntary cognitive screening: characteristics  of participants in an Asian setting Vanda ho1,2 nur hani Zainal1 linda lim1 Aloysius ng1 eveline silva1 nagaendran Kandiah1,3 1Department of n eurology, national  neuroscience Institute, singapore;   2school of Clinical Medicine,   University of Cambridge, Cambridge,   UK; 3Duke- nUs graduate Medical  school, singaporeBackground:  Mild cognitive impairment (MCI) and dementia are reaching epidemic proportions  in Asia.",Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
"MCI is a high-risk Correspondence: nagaendran Kandiah Department of neurology, national  neuroscience Institute, 11 Jalan Tan Tock  seng, singapore 308433 Tel +65 6357 7199 Fax +65 6357 7137 email nagaendran_kandiah@nni.com.s g Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Ho et al Running head recto: Voluntary cognitive screening in Asia DOI: http://dx.doi.org/10.2147/CIA.S73563",Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
"Available from:  http://www.alz.co.uk/adi/pdf/kyotodeclaration.pd f. Accessed June 27,  2014.",Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
Available from: http://www.who.int/mental_health/ mhgap/en /.,Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
Available  from: http://www.hpb.gov.sg/HOPPortal/dandc-article/11890?orginal Id=HPB05302 2.,Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/38/ea/cia-10-771.PMC4408968.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/67/50/dddt-9-2233.PMC4408969.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2233–2247Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2233Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7711 5Promoting endothelial function by  S-nitrosoglutathione through the hiF-1 α/VegF  pathway stimulates neurorepair and functional  recovery following experimental stroke in rats Mushfiquddin Khan1 Tajinder s Dhammu1 Fumiyo Matsuda1,2 Mauhammad Baarine3 T ejbir singh Dhindsa1 inderjit singh1 avtar K singh3,4 1Department of Pediatrics, Medical  University of south carolina,   charleston, sc, Usa; 2school  of health sciences, Kagoshima  University, Kagoshima, Japan;   3Department of Pathology  and laboratory Medicine, Medical  University of south carolina,   charleston, sc, Usa; 4ralph  h Johnson V a Medical center,   charleston, sc, UsaBackground:  For stroke patients, stimulating neurorepair mechanisms is necessary to reduce  morbidity and disability.",Non-OADS,/arxiv_data1/oa_pdf/67/50/dddt-9-2233.PMC4408969.pdf
"Keywords:  GSNO, IR, HIF-1 α, VEGF, motor function, subtle behavior, neuroprotection,  neurorepair, angiogenesis, S-nitrosylation, stroke Introduction Stroke is a leading cause of serious long-term disability and ranks fourth among all  causes of death in the United States.1 Following stroke, direct trauma causes necrotic correspondence: avtar K singh Department of Pathology and laboratory  Medicine, Medical University of south  carolina, 513 children’s research  institute, 173 ashley avenue, charleston,  sc 29425, Usa email singha@musc.ed u  Mushfiquddin Khan Department of Pediatrics, Medical  University of south carolina, 508  children’s research institute, 173 ashley  avenue, charleston, sc 29425, Usa Tel +1 843 792 7991 Fax +1 843 792 3653 email khanm@musc.ed u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Khan et al Running head recto: GSNO stimulates HIF-1 α/VEGF pathway DOI: http://dx.doi.org/10.2147/DDDT.S77115",Non-OADS,/arxiv_data1/oa_pdf/67/50/dddt-9-2233.PMC4408969.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/67/50/dddt-9-2233.PMC4408969.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/67/50/dddt-9-2233.PMC4408969.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 759–770Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  759OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S8212 8Modeling clustered activity increase in amyloid- beta positron emission tomographic images  with statistical descriptors sepideh shokouhi1 Baxter P rogers1 hakmook Kang2 Zhaohua Ding1 Daniel O Claassen3 John W Mckay1 William r riddle1 On behalf of the  Alzheimer’s Disease  neuroimaging Initiative 1Department of radiology and  radiological sciences, Vanderbilt  University Institute of Imaging  science, 2Department of Biostatistics,   3Department of n eurology, Vanderbilt  University, nashville, Tn , UsABackground:  Amyloid-beta (A β) imaging with positron emission tomography (PET) holds  promise for detecting the presence of A β plaques in the cortical gray matter.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
"A β plaques have Correspondence: sepideh shokouhi Vanderbilt University Institute of Imaging  science, 1161 21st Avenue south, Medical  Center north, AA-1105, nashville,  Tn 37232-2310, UsA Tel +1 615 322 6214 Fax +1 615 322 0734 email sepideh.shokouhi@vanderbilt.ed u Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Shokouhi et al Running head recto: Statistical descriptors in A β-PET analysis DOI: http://dx.doi.org/10.2147/CIA.S82128",Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
These  regional gray matter masks were applied to the PiB-PET  images that were coregistered to the subject’s MRI volume  in SPM8 ( http://www.fil.ion.ucl.ac.uk/spm /).,Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
A complete listing of ADNI investigators can be found at:  http://adni.loni.usc.edu/wp- content/uploads/how_to_apply/ ADNI_Acknowledgement _List.pd f. Disclosure The authors report no conflicts of interest in this work.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/49/b7/cia-10-759.PMC4408970.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/99/dddt-9-2265.PMC4408971.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2265–2275Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2265Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8172 2A novel glycyrrhetinic acid-modified oxaliplatin  liposome for liver-targeting and in vitro/vivo  evaluation Jingde chen* hong Jiang* Yin Wu Yandong li Y ong gao Department of Oncology and  hematology, east hospital, T ongji  University school of Medicine,   shanghai, People’s republic of china *These authors contributed equally  to this workAbstract:  In this study, oxaliplatin (OX) liposomes surface-modified with glycyrrhetinic acid  (GA) were developed by the film-dispersion method.",Non-OADS,/arxiv_data1/oa_pdf/57/99/dddt-9-2265.PMC4408971.pdf
"Keywords:  target, drug delivery, modified liposomes, pharmacokinetics, biodistribution Introduction Hepatocellular carcinoma (HCC), the fifth most common cancer worldwide and rarely  detected at an early stage, is usually fatal within months of diagnosis, resulting in  500,000 deaths per year.1,2 It frequently occurs in the setting of chronic liver disease  (hepatitis B or C virus-related) and cirrhosis, and Child–Pugh functional status dictates  the chances of treatment.3 Despite introduction of potentially curative treatments,  such as liver resection and orthotopic liver transplantation, the prognosis is gener - ally poor, as only 10%–37% of patients are suitable surgical candidates because of  advanced tumor or poor hepatic functional reserve.4 Thus, chemotherapy is chosen to  be the first-line treatment for advanced cancer patients, despite the fact that HCC is a  relatively resistant tumor, with response rates ranging from 0% to 29% in randomized  controlled trials.5  Oxaliplatin (OX) is one of the third generation of platinum-based anticancer agents  and displays a wide spectrum of in vitro cytotoxic and in vivo antitumor activities.6–8  As an alkylating agent that causes DNA damage, OX plays an important role in correspondence: Yong gao Department of Oncology  and hematology, east hospital,  Tongji University school of Medicine,  150 Jimo road, shanghai, People’s  republic of china email gaoyon@hotmail.co mJournal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Chen et al Running head recto: A novel glycyrrhetinic acid-modified oxaliplatin liposome DOI: http://dx.doi.org/10.2147/DDDT.S81722",Non-OADS,/arxiv_data1/oa_pdf/57/99/dddt-9-2265.PMC4408971.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/57/99/dddt-9-2265.PMC4408971.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/99/dddt-9-2265.PMC4408971.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8e/ce/mder-8-193.PMC4408972.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 193–199Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  193ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S7964 2consistency and sealing of advanced bipolar  tissue sealers Edward g chekan  Mark a Davison  David W singleton  John Z Mennone Piet hinoul Ethicon, inc., cincinnati, Oh, Usa correspondence: Piet hinoul   Ethicon, inc., Route 22 West,   PO Box 151, somerville, nJ 08876, Usa   Tel +1 908 218 3520   Email phinoul@its.jnj.co mObjectives:  The aim of this study was to evaluate two commonly used advanced bipolar devices  (ENSEAL® G2 Tissue Sealers and LigaSure™ Blunt Tip) for compression uniformity, vessel  sealing strength, and consistency in bench-top analyses.",Non-OADS,/arxiv_data1/oa_pdf/8e/ce/mder-8-193.PMC4408972.pdf
"Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa l Medical Devices: Evidence and Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 199advanced bipolar device sealing with regard to uniformity of jaw compression, reduced tissue  sticking, and increased burst pressures in sealed/transected  vessels.",Non-OADS,/arxiv_data1/oa_pdf/8e/ce/mder-8-193.PMC4408972.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 885–892OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  885Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S6726 2Novel targeted therapies for resistant ALK- rearranged non-small-cell lung cancer: ceritinib  and beyond Zeyad Kanaan1 Goetz H Kloecker1 Ajit Paintal2 Cesar A Perez1 1Division of Medical Oncology  and Hematology, James Graham  Brown Cancer Center, University  of Louisville, Louisville, KY,   2Department of Pathology,   Northwestern University, Feinberg  School of Medicine, Chicago, iL, USAAbstract:  Lung cancer is the leading cause of cancer-related mortality in both sexes, accounting  for over one quarter of cancer deaths.",Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
"The fusion protein formed from the N-terminus  of EML4, a protein which belongs to the family of echinoderm microtubule-associated  protein-like proteins, and the intracellular kinase-containing domain of ALK was the  first fusion protein detected by Soda et al in 2007 in a resected adenocarcinoma specimen  obtained from a 62-year-old male smoker.3 The EML4-ALK fusion protein is the most  common fusion protein and is found in approximately 5% of lung adenocarcinomas.4–9  Its occurrence was more commonly detected in younger patients, non- or light smokers,  tumors with solid histology, and late-stage disease, and considered almost always mutually  exclusive of KRAS and epidermal growth factor receptor (EGFR) mutations.10 Non-EML4- ALK fusion partners also exist, including reported partners as KIF5B and TGF.11,12 T esting for ALK rearrangements in clinical practice At the current time, the only US Food and Drug Administration (FDA)-approved  companion diagnostic test for the detection of ALK rearrangements in metastatic Correspondence: Cesar A Perez Division of Medical Oncology and  Hematology, James Graham Brown  Cancer Center, University of Louisville,  529 South Jackson Street, Suite 426,  Louisville, KY 40202, USA Tel +1 502 562 4369 Fax +1 502 562 6811 email capere06@louisville.ed u Journal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Kanaan et al Running head recto: Novel targeted therapies for resistant ALK-rearranged NSCLC DOI: http://dx.doi.org/10.2147/OTT.S67262",Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
"Available from:  http://www.fda.gov/drugs/informationondrugs/approveddrugs/ ucm395386.ht m. Accessed July 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/51/ott-8-885.PMC4408973.pdf
Preprint at BioRxiv http://dx.doi.org/ 10.1101/006395 (2014).,Non-OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
Preprint at arXiv http://arxiv.org/abs/1410.2801 (2014).,Non-OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
http://www.busi- nesswire.com/news/home/20140127005012/en/Quantum-Biosystems-Demonstrates-Reads-Quantum-Single-Molecule#.,Non-OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
http://www.pacb.com/pdf/TN_Detecting_DNA_Base_Modi ﬁcations.pdf (2012).,OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
http://www.clcsupport.com/clcgenomicsworkbench/ 800/index.php?manual =Trimming_using_Trim_tool.html (2015).,OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
Dryad http://dx.doi.org/10.5061/dryad.6fm1p (2015).,OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
is supported by the BER Plant Microbe Interfaces Scienti ﬁc Focus Area (http://pmi.ornl.,OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
The Department of Energy will provide public access to these results of federally sponsored research in accordance with the DOE Public Access Plan (http://energy.gov/downloads/doe-public-access-plan).,OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
Additional Information Supplementary information accompanies this paper at http://www.nature.com/sdata Competing ﬁnancial interests: LanzaTech has a commercial interest in Clostridium autoethanogenum .,Non-OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc/4.0/ Metadata associated with this Data Descriptor is available at http://www.nature.com/sdata/ and is released under the CC0 waiver to maximize reuse.www.nature.com/sdata/ SCIENTIFIC DATA |2:150014 |DOI: 10.1038/sdata.2015.14 9",Non-OADS,/arxiv_data1/oa_pdf/14/1a/sdata201514.PMC4409012.pdf
Available at: http://arxiv.org/pdf/1010.3303.pdf(accessed on 03 07 2014).,Non-OADS,/arxiv_data1/oa_pdf/61/31/gcb0021-1621.PMC4409026.pdf
"7, 826 –844, http://dx.doi.org/10.1080/02687038.2014.993912 © 2014 The Author(s).",Non-OADS,/arxiv_data1/oa_pdf/ef/e7/paph-29-826.PMC4409036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduc- tion in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.",Non-OADS,/arxiv_data1/oa_pdf/ef/e7/paph-29-826.PMC4409036.pdf
"Retrieved from http://www.sciencedirect.com/science/article/pii/S0093934X06001672 Cicone, M., Wapner, W., Foldi, N., Zurif, E., & Gardner, H. (1979).",OADS,/arxiv_data1/oa_pdf/ef/e7/paph-29-826.PMC4409036.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial- NoDerivatives License ( http://creativecommons.org/Licenses/by-nc-nd/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.Memory, 2015 Vol.",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/pmem-23-633.PMC4409058.pdf
"5, 633 –656, http://dx.doi.org/10.1080/09658211.2015.1010709",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/pmem-23-633.PMC4409058.pdf
"This disconnect between the science of mem- ory and the beliefs held by those involved in judicial processes can lead to fundamental mis-carriages of justice, many of which can be foundon the Innocence Project websites in the USA(http://www.innocenceproject.org/ ) and the UK (http://www.innocencenetwork.org.uk/ ).",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/pmem-23-633.PMC4409058.pdf
"(Taken from: http://law.justia.com/cases/utah/ supreme-court/1999/franklin.html ) Unfortunately, these case examples show that under certain circumstances memories for child- hood experiences can be grotesquely distorted.",Non-OADS,/arxiv_data1/oa_pdf/1d/2a/pmem-23-633.PMC4409058.pdf
"Brain MRI analysis was performed using Jim (v. 5, Xinapse Systems, Northants, UK, www.xinapse.com) and statistical parametric mapping (SPM; v. 8, Wellcome Department of Cognitive Neurology, London, UK, http://www.fil.ion.ucl.ac.uk/spm).",OADS,/arxiv_data1/oa_pdf/93/ae/jon0025-0191.PMC4409073.pdf
"Both DGM and T1 lesion-corrected (dually corrected): cBPF, cGMF, cWMF.Underestimation of DGM structures was corrected by an expert trained observer on uGMM using a drawing tool in 3- dimensional Slicer (v. 3.4, http://www.slicer.org).",Non-OADS,/arxiv_data1/oa_pdf/93/ae/jon0025-0191.PMC4409073.pdf
"All statistical analyses were performed in R (R Development Core Team RR Foundation for Statistical Computing, Vienna, Austria, http://www.R-project.org).",OADS,/arxiv_data1/oa_pdf/93/ae/jon0025-0191.PMC4409073.pdf
"“acupuncture”, last modiﬁed October 27, 2013, http://en.wikipedia.org/wiki/Acupuncture.",Non-OADS,/arxiv_data1/oa_pdf/ae/25/papr0015-0279.PMC4409074.pdf
"Available at: http://www.who.int/mediacentre/factsheets/fs16 4/en/ (Accessed 16 August, 2014) 3 WHO.",Non-OADS,/arxiv_data1/oa_pdf/4d/77/jvh0022-0353.PMC4409077.pdf
"Available at: http://www.who.int/csr/disease/hep-atitis/global_report/en/ (accessed 17 August, 2014) 4 Parker SP, Cubitt WD.",Non-OADS,/arxiv_data1/oa_pdf/4d/77/jvh0022-0353.PMC4409077.pdf
URL: http://www.sf-36.,Non-OADS,/arxiv_data1/oa_pdf/97/34/art0067-0914.PMC4409087.pdf
"Materials and methods Patients and study design Seventy-ﬁve patients participated in a randomized, double- blind, placebo-controlled study to evaluate the efﬁcacy and safety of rhC1INH compared with saline, for the treatmentof acute angioedema attacks in patients with C1-INH-HAE (https://www.clinicaltrials.gov/ct2/results?term=NCT0118856 4&Search=Search; identiﬁer NCT01188564).",Non-OADS,/arxiv_data1/oa_pdf/3e/dd/all0070-0506.PMC4409094.pdf
"Available at: http://www.aerzteblatt.de/ar- chiv/22549/Arzneimittelkommission-der-de- utschen-Aerzteschaft-Schwerwiegende-Thrombenbildung-nach-Berinert-HS.Accessed January 12, 2015.15.",Non-OADS,/arxiv_data1/oa_pdf/3e/dd/all0070-0506.PMC4409094.pdf
Available at: http://www.ema.europa.eu/ docs/en_GB/document_library/EPAR_-_Public_assessment_report/human/001223/WC500098546.pdf.,Non-OADS,/arxiv_data1/oa_pdf/3e/dd/all0070-0506.PMC4409094.pdf
"Br J Midwifery 2009; 17:154–159, doi:http://dx.doi.org./10.1296 8/bjom.2009.17.3.40077 63.",Non-OADS,/arxiv_data1/oa_pdf/ed/30/pon0024-0371.PMC4409098.pdf
Available at: http://faostat3.-fao.org/faostat-gateway/go/to/download/R/RF/E (last accessed 18 August 2014).,Non-OADS,/arxiv_data1/oa_pdf/eb/8a/ismej2014194a.PMC4409153.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Active nitrifying communities in paddy soil B Wang et al 1075 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/eb/8a/ismej2014194a.PMC4409153.pdf
http://www.agroscope.,Non-OADS,/arxiv_data1/oa_pdf/66/3b/ismej2014210a.PMC4409162.pdf
http://www.demeter.ch/ de/pdf/BD_AnbauRiLi_2014.pdf.,Non-OADS,/arxiv_data1/oa_pdf/66/3b/ismej2014210a.PMC4409162.pdf
"To view a copy of this license, visit http://creativecommons.org/ licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on The ISME Journal website (http://www.nature.com/ismej)Microbial diversity of different farming systems M Hartmann et al 1194 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/66/3b/ismej2014210a.PMC4409162.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ Supplementary Information acc ompanies this paper on The ISME Journal web site (http://www.nature.com/ismej)Nitrate assimilation potential in oxygen-deficient-waters Prochlorococcus M Astorga-Eló et al 1267 The ISME Journal",Non-OADS,/arxiv_data1/oa_pdf/26/05/ismej201521a.PMC4409168.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/53/a1/JOMFP-18-349.PMC4409177.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/27/ef/JOMFP-18-386.PMC4409183.pdf
Eyepieces Eyepieces should have the following good features;• The axes of the eyepieces may be straight or inclined at  45° to the optical axis of the apparatus • Features to adjust for the individual’s interocular distance • Must be ﬁ tted with rubber cups • They should have independent focusing elements  adaptable to the individual’s eyesight • Compensation for ametropia from + 7 to − 7 diopters Figure 1:  CS-205 Colpo-Master™ II; A center post mount colposcope  (Available from: http://www.google.co.in.),Non-OADS,/arxiv_data1/oa_pdf/eb/d0/JOMFP-18-403.PMC4409186.pdf
URL: http://www.terapeutica.,Non-OADS,/arxiv_data1/oa_pdf/88/97/JOMFP-18-442.PMC4409194.pdf
"Available from: http://www.expertconsultbook.com/Hybrid  Tumors [Last   accessed on Jan 20, 2015].",Non-OADS,/arxiv_data1/oa_pdf/88/97/JOMFP-18-442.PMC4409194.pdf
Available from: http://rarediseases.info.nih.gov/gard/6880/leiomyosarcoma/resources/1 [Last accessed on 2012 Mar 21].,OADS,/arxiv_data1/oa_pdf/8d/94/JOMFP-18-453.PMC4409196.pdf
"ahttp://genetics.bwh.harvard.edu/pph2/index.shtml bhttp://www.mutationtaster.org chttp://mutationassessor.org dhttp://www.genetics.wustl.edu/jﬂab/lrt_query.html ehttp://sift.jcvi.org fhttp://mendel.stanford.edu/sidowlab/downloads/gerp/index.html ghttp://compgen.bscb.cornell.edu/phast/ hhttp://fathmm.biocompute.org.uk ihttp://cadd.gs.washington.edu/home variants on protein structure or function (e.g., PP2 [Adzhubei et al., 2010]) or to quantify the overall pathogenic potential of a variant based on diverse types of genomic information (e.g., CADD [Kircher et al.",Non-OADS,/arxiv_data1/oa_pdf/43/7e/HUMU-36-513.PMC4409520.pdf
"ahttp://genetics.bwh.harvard.edu/pph2/dokuwiki/overview bhttp://www.plosgenetics.org/article/info%3Adoi%2F10.1371%2Fjournal.pgen.1003143 chttp://structure.bmc.lu.se/VariBench/tolerance_dataset1.php dhttp://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1003440 ehttp://bioinformatics.oxfordjournals.org/content/26/6/851.long fhttp://swissvar.expasy.org/cgi-bin/swissvar/documentation different tools have been trained on different datasets, increasing the likelihood that variants in the evaluation set appear in at least one of these datasets [Gonz ´alez-P ´erez and L ´opez-Bigas, 2011; Capriotti et al., 2013; Li et al., 2013; Bendl et al., 2014].",Non-OADS,/arxiv_data1/oa_pdf/43/7e/HUMU-36-513.PMC4409520.pdf
All data and Python scripts can also be downloaded from: http://www.bsse.ethz.ch/mlcb/research/ bioinformatics-and-computational-biology/pathogenicity-predi- ction.html.,OADS,/arxiv_data1/oa_pdf/43/7e/HUMU-36-513.PMC4409520.pdf
"bChlamydomonas reinhardtii gene IDs, based on the most recent release of Phytozome (http://phytozome.jgi.doe.gov).",OADS,/arxiv_data1/oa_pdf/c6/72/TPJ-82-370.PMC4409525.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f0/05/nihms667648.PMC4409530.pdf
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.matbio.2014.12.002 .,OADS,/arxiv_data1/oa_pdf/f0/05/nihms667648.PMC4409530.pdf
Gelatinolytic bands were quantified with Image J software ( http://imagej.nih.gov ).,OADS,/arxiv_data1/oa_pdf/f0/05/nihms667648.PMC4409530.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commercial use , distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"2 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"Isolates fromCharacteristics of oral Staphylococcus aureus Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"4 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"bIncluding two MRSA strains from Swedish oral infections, and one from a Thai HIV patient.Characteristics of oral Staphylococcus aureus Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"6 (page number not for citation purpose)Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"J Oral Microbiol 2012; 4: 17659, doi: http://dx.doi.org/10.3402/ jom.v4i0.17659 24.",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
"Br Dent J 1999; 186: 345/C17.Characteristics of oral Staphylococcus aureus Citation: Journal of Oral Microbiology 2015, 7: 26250 - http://dx.doi.org/10.3402/jom.v7.26250 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/ce/d0/JOM-7-26250.PMC4409631.pdf
Available from: http://www.aaoms.org/ wisdom_teeth.php.,Non-OADS,/arxiv_data1/oa_pdf/c7/34/JIOH-7-13.PMC4409789.pdf
Available from: http://www.whoindia.org/en/Section20/ Section25_1861.htm.,Non-OADS,/arxiv_data1/oa_pdf/b1/01/JIOH-7-18.PMC4409790.pdf
Available from: http://www.articles.timesofIndia.,Non-OADS,/arxiv_data1/oa_pdf/b1/01/JIOH-7-18.PMC4409790.pdf
Available from: http://www.consang.net/.,Non-OADS,/arxiv_data1/oa_pdf/6b/96/JIOH-7-78.PMC4409803.pdf
Available from: http://www.ineedce.,Non-OADS,/arxiv_data1/oa_pdf/96/09/JIOH-7-96.PMC4409808.pdf
"The DHS has a continuing process of userfeedback through its Questionnaire Review Portal on theDHS user forum (http://userforum.dhsprogram.com/),and the recommendations we present are intended to bepart of such ongoing discussions.",Non-OADS,/arxiv_data1/oa_pdf/40/7c/tmi0020-0589.PMC4409817.pdf
"Measure DHS, 2013 (Available from: http://www.measured- hs.com/Measure) [Accessed November 21, 2013].",OADS,/arxiv_data1/oa_pdf/40/7c/tmi0020-0589.PMC4409817.pdf
"(Available from: http://mdgs.un.org/unsd/mdg/Hos- t.aspx?Content=Indicators/OfﬁcialList.htm) [AccessedDecember 30,2014].",Non-OADS,/arxiv_data1/oa_pdf/40/7c/tmi0020-0589.PMC4409817.pdf
"The Scientiﬁc World Journal, 2013: (Available from: http://dx.doi.org/10.1155/2013/423403).",Non-OADS,/arxiv_data1/oa_pdf/40/7c/tmi0020-0589.PMC4409817.pdf
Available at: http://www.accessdata.fda.gov/ drugsatfda_docs/label/2013/204671s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.ema.europa.eu/docs/en_ GB/document_library/EPAR_-_Product_Information/human/ 002798/ WC500160597.pdf .,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.accessdata.fda.,OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.ema.europa.eu/docs/ en_GB/document_library/EPAR_-_Product_Information/human/003768/ WC500172848.pdf .,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.ema.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.accessdata.fda.gov/drugsatf- da_docs/label/2010/021511s020lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: https://www.clinicaltrials.gov/ct2/show/ NCT02319031.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/205834s000lbl.pdf.,Non-OADS,/arxiv_data1/oa_pdf/83/01/hep0061-1127.PMC4409820.pdf
"6 Global strategy for asthma management and prevention, global initiative for asthma (GINA) 2014. http://www.ginasthma.org/ (last accessed on 22 May 2014).",Non-OADS,/arxiv_data1/oa_pdf/c6/39/bcpt0116-0291.PMC4409821.pdf
"We implemented 3D surface renderings of allmajor neuropils of V. crabro ,Luclia sp., and D. hydei into pdf files using Fiji software (http://fiji.sc/Fiji).",OADS,/arxiv_data1/oa_pdf/17/f8/cne0523-1281.PMC4409823.pdf
"Detailed descriptions of brain neuropils and even individual neurons are available for Drosophila ,a s are virtual standard brain atlases (Vosshall et al., 2000;Rein et al., 2002; Cardona et al., 2010; Peng et al.,2011; Ito et al., 2014) and specific databases (e.g., http://www.virtualflybrain.org).",Non-OADS,/arxiv_data1/oa_pdf/17/f8/cne0523-1281.PMC4409823.pdf
"Available from: http://www.usrds.org/2012/pdf/v2_ch3_12.pdf (accessed date: July 3, 2013).",Non-OADS,/arxiv_data1/oa_pdf/ca/c5/hdi0019-0225.PMC4409831.pdf
"Availablefrom: http://www.medscape.com/viewarticle/738526(accessed date: July 3, 2013).",Non-OADS,/arxiv_data1/oa_pdf/ca/c5/hdi0019-0225.PMC4409831.pdf
"Perimetric testing was performed using the Humphrey Visual Field Analyzer II (Carl Zeiss Meditec, http://www.ze-iss.com/meditec/en_de/home.html), using 24-2 SITA Stan-dard.",OADS,/arxiv_data1/oa_pdf/67/62/opo0035-0186.PMC4409833.pdf
Available at URL: http://www.medtron icdiabetes.com/treatment-and-products/enlite-sensor.Accessed10April2014.,Non-OADS,/arxiv_data1/oa_pdf/8d/b8/dom0017-0343.PMC4409843.pdf
[cited 2014 April] Available from: https://fortress.wa.gov/ecy/gsp/Sitepage.aspx?csid=4213 Anchor QEA.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from: https://fortress.wa.gov/ecy/gsp/ Sitepage.aspx?csid=4213 Beckingham B, Ghosh U.",Non-OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from: http://yosemite.epa.gov/r10/cleanup.nsf/ldw/slip+4+early+action+area Chai Y , Davis J, Currie R, Fishman V, Martin G, Wilken M, Lucas S, Wandor D, Ghosh U.",OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
[cited 2014 November] Available from: http://www.dnrec.delaware.gov/swc/ wa/Documents/Mirror_Lake_plan_02182013.pdf DuPont.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from: http://www.ngi.no/upload/Prosjektweb/opticap/Opticap%20sluttrapport.pdf Ghosh U, Menzie C. 2010.",Non-OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
Available from: http://tools.niehs.nih.gov/srp/programs/Program_detail.cfm?,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from: http://www.serdp.org/Program-Areas/ Environmental-Restoration/Contaminated-Sediments/ER-200835 Murphy P , Marquette A, Reible D, Lowry G. 2006.",Non-OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
Available from: http://www.nap.edu/catalog.php?record_id=11968 [NYSDEC] New York State Department of Environmental Conservation and [USEPA] US Environmental Protection Agency.,Non-OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from:http://www.dec.ny.gov/chemical/34481.html Officer C, Lynch D. 1989.",OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
"Available from: http://www.dec.ny.gov/ chemical/83049.html Patmont C, Nadeau S, McCulloch M. 2013.",OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
Available from: http://www.epa.gov/superfund/health/conmedia/ sediment/pdfs/cover.pdf [USEPA] US Environmental Protection Agency.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
http://www.epa.gov/superfund/health/conmedia/sediment/pdfs/ In_situ_AmendmentReportandAppendix_FinalApril2013.pdf [USEPA] US Environmental Protection Agency.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
Available from: http://www.epa.gov/superfund/cleanup/pdfs/Final_ SPR_Action_Plan-11_26_2013_(2).pdf [USEPA] US Environmental Protection Agency.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
Available from: http://www.epa.gov/region2/superfund/npl/ berryscreek/bcsa_comunityupdate_%20august2013.pdf [WDOE] Washington State Department of Ecology.,OADS,/arxiv_data1/oa_pdf/7c/04/ieam0011-0195.PMC4409844.pdf
DATA ARCHIVING The data from this study has been archived at http://dx.doi.org/10.6084/ m9.figshare.1294876.,OADS,/arxiv_data1/oa_pdf/28/58/evo0069-0788.PMC4409860.pdf
Interface 10:20120997. http://dx.doi.org/10.1098/rsif.2012.0997.,OADS,/arxiv_data1/oa_pdf/28/58/evo0069-0788.PMC4409860.pdf
The microarray analysis was car- ried out using BRB Array Tools software version 3.3.0 (http://linus.nci.nih.gov/BRB-ArrayTools.html).,OADS,/arxiv_data1/oa_pdf/e9/b7/cas0106-0359.PMC4409878.pdf
Data were collected and analyzed bythe CellQuest (http://www.bdbiosciences.com/video/Cell_- Quest.zip) and ModFit Lt (http://www.zedload.com/modﬁt-lt- 3.2-trial-version-crack-serial-download.html) software.,OADS,/arxiv_data1/oa_pdf/da/a2/cas0106-0375.PMC4409880.pdf
The trial was registered with the University Hospital Medical Informa- tion Network (UMIN) Clinical Trials Registry (http://www.u-min.ac.jp/ctr/ number: UMIN-000004855).,Non-OADS,/arxiv_data1/oa_pdf/2e/ea/cas0106-0397.PMC4409883.pdf
"The test assesses English language comprehension and is a standardized, national test,essentially developed for the optional SecondarySchool level (www.skolverket.se/prov-och-bedom,http://www.nafs.gu.se/digitalAssets/1193/1193558_last_ exp.pdf).",Non-OADS,/arxiv_data1/oa_pdf/a9/70/10.1177_2331216515579127.PMC4409938.pdf
"Representatives presented talks on the meth- odologies promoted by a number of diﬀerent initiatives:the COMET (Core Outcome Measures in EﬀectivenessTrials, http://www.comet-initiative.org/about/overview),initiative, the COSMIN (COnsensus-based Standards forthe selection of health Measurement INstruments, http://www.cosmin.nl/cosmin-taxonomy.html) initiative, andthe ICF (International Classiﬁcation of Functioning, Disability and Health, http://www.icf-research-branch.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/10.1177_2331216515580272.PMC4409939.pdf
"For more details, see http://tinnet.tinnitusresearch.net/ Declaration of Conflicting Interests The authors declared no potential conﬂicts of interest with respect to the research, authorship, and/or publication of this article.",Non-OADS,/arxiv_data1/oa_pdf/d2/f8/10.1177_2331216515580272.PMC4409939.pdf
"Furthermore, treatment with embryonic  Received: June 18, 2014 Accepted: November 10, 2014Published online in J-STAGE: January 24, 2015 ©2015 by the Society for Reproduction and Development Correspondence: D-H Kim (e-mail: kimdhhj@korea.kr) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/09/28/jrd-61-090.PMC4410095.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), permitting all non-commer cial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Infection Ecology and Epidemiology 2015, 5: 27708 - http://dx.doi.org/10.3402/iee.v5.27708 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/60/48/IEE-5-27708.PMC4410110.pdf
"2 (page number not for citation purpose)Citation: Infection Ecology and Epidemiology 2015, 5: 27708 - http://dx.doi.org/10.3402/iee.v5.27708",Non-OADS,/arxiv_data1/oa_pdf/60/48/IEE-5-27708.PMC4410110.pdf
Available from: http://www.agriculture.gov.ie/media/migration/agri-foodindustry/foodharvest2020/2020FoodHarvestEng240810.pdf [cited 7 January 2015].,Non-OADS,/arxiv_data1/oa_pdf/60/48/IEE-5-27708.PMC4410110.pdf
"doi: 10.1007/978-94-007-1905-7_3.Letter to the editor Citation: Infection Ecology and Epidemiology 2015, 5: 27708 - http://dx.doi.org/10.3402/iee.v5.27708 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/60/48/IEE-5-27708.PMC4410110.pdf
http://www.1177.se/Om-1177/1177 – Health-care-advice-online-and-on-the-phone1/ (accessed 10 Apr 2014).,Non-OADS,/arxiv_data1/oa_pdf/87/1c/bmjopen-2014-007059.PMC4410112.pdf
http://www.ucr.uu.se/ swedeheart/ 8.,Non-OADS,/arxiv_data1/oa_pdf/87/1c/bmjopen-2014-007059.PMC4410112.pdf
http://www.nhs.uk/annualreport (accessed 21 Jul 2014).,Non-OADS,/arxiv_data1/oa_pdf/87/1c/bmjopen-2014-007059.PMC4410112.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007542).,Non-OADS,/arxiv_data1/oa_pdf/78/da/bmjopen-2014-007542.PMC4410113.pdf
http://www.admin.ch/opc/de/ classified-compilation/19940073/201403010000/832.10.pdf (accessed 4 Nov 2014).,Non-OADS,/arxiv_data1/oa_pdf/11/1f/bmjopen-2014-007443.PMC4410115.pdf
"EQUAM-Stiftung: http://www.equam.ch/de/ (accessed 4 Nov 2014).12. van den Hombergh P, Grol R, van den Hoogen HJM, et al.",Non-OADS,/arxiv_data1/oa_pdf/11/1f/bmjopen-2014-007443.PMC4410115.pdf
doi:10.1136/bmjopen-2014- 007026 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007026).,Non-OADS,/arxiv_data1/oa_pdf/ea/21/bmjopen-2014-007026.PMC4410116.pdf
http://download.tiss.edu/fap/gyurja/gyurja_ reports/mlp_combined_1.pdf 18.,Non-OADS,/arxiv_data1/oa_pdf/ea/21/bmjopen-2014-007026.PMC4410116.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014-007082).,Non-OADS,/arxiv_data1/oa_pdf/a6/43/bmjopen-2014-007082.PMC4410117.pdf
"Randomisation will be performed using an internet-based system for randomisation and data entry(http://www.medscinet.se/laktat, MedSciNet AB, Stockholm, Sweden) via the Guy ’s and St Thomas ’ Biomedical Research Centre and King ’s College London.",Non-OADS,/arxiv_data1/oa_pdf/a6/43/bmjopen-2014-007082.PMC4410117.pdf
"Forthe French sites, sponsorship will be processed in accordance with Comitéde Protection des Personnes (CCP) in Grenoble (http://www.cppsudest5.fr).",Non-OADS,/arxiv_data1/oa_pdf/a6/43/bmjopen-2014-007082.PMC4410117.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007222).,Non-OADS,/arxiv_data1/oa_pdf/6d/57/bmjopen-2014-007222.PMC4410118.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/57/bmjopen-2014-007222.PMC4410118.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007148).,Non-OADS,/arxiv_data1/oa_pdf/7d/31/bmjopen-2014-007148.PMC4410120.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007238).,Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
"” Our systematic review is registered with PROSPERO, registration number CRD42014012940, available at http://www.crd.york.ac.uk/PROSPERO.",Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
"Using no date or lan- guage restrictions, the librarian will use the search strat- egy to search the following databases:▸MEDLINE ▸EMBASE ▸WEB OF SCIENCE (Social Sciences Citation index/ Science Citation Index) ▸Cochrane Library, including CENTRAL register of Controlled Trials ▸CINAHL (Cumulative Index to Nursing and Allied Health Literature) ▸WHO International Clinical Trials Registry Platform (ICTRP; which includes http://www.clinicaltrials.gov) for on-going studies ▸WHO library ▸PsycINFO Farebrother J, et al.BMJ Open 2015; 5:e007238.",Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
"The search terms will be translated into Chinese, and we will search the following databases for records in Chinese, with no date restrictions:▸China Knowledge Resource Integrated Database (http://www.cnki.net), which includes the databases: –China Academic Journals Full-text Database –China Doctoral Dissertations Full-text Database –China Masters Theses Full-text Database –China proceedings of Conferences Full-text Database –International Proceedings of Conferences Full-text Database ▸Wanfang Data (http://www.wanfangdata.com), which includes the databases: –China Online Journals –Dissertations of China.",Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
"38 Quality of evidence using GRADE Quality of evidence will be assessed using Grading ofRecommendations, Assessment, Development and Evaluation (GRADE), via the GRADEpro browser-based platform (http://www.gradepro.org last accessed 12November 2014) 42will be used to create Summary of Findings tables for each comparison using the pre- peciﬁed outcomes.",OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
"TheCochrane Collaboration, 2011. http://www.cochrane-handbook.org.",OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
http://epocoslo.cochrane.,Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
http://epocoslo.cochrane.org/epoc-specific-resources-review-authors 36. Review manager (RevMan) [Computer program].,OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
http://epocoslo.cochrane.org/epoc-specific-resources-review-authors 38.,OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
http://epocoslo.cochrane.,Non-OADS,/arxiv_data1/oa_pdf/7f/36/bmjopen-2014-007238.PMC4410124.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007371).,Non-OADS,/arxiv_data1/oa_pdf/b6/16/bmjopen-2014-007371.PMC4410125.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2014-007215).,Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
http://globocan.iarc.fr 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
http://clinicaltrials.gov/43.,Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
https://www.clinicaltrialsregister.eu/ ctr-search/search 44.,Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
"The GRADE Working Group, 2013. http://www.guidelinedevelopment.org/handbook 51.",Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
"http://www.crd.york.ac.uk/PROSPERO_ REBRANDING/display_record.asp?ID=CRD42014014699 6 Liu Y, et al.BMJ Open 2015; 5:e007215.",Non-OADS,/arxiv_data1/oa_pdf/3a/d4/bmjopen-2014-007215.PMC4410126.pdf
"Zomba, Malawi: National Statistical Office, 2014. http://www.nsomalawi.mw/images/stories/data_on_line/demography/MDGEndline/MalawiMDG EndlineSurveyKeyFindingsReport.pdf (accessed 17 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/bmjopen-2015-007753.PMC4410129.pdf
http://www.health.org.uk/publications/ maikhanda/ (accessed 11 Mar 2015).,Non-OADS,/arxiv_data1/oa_pdf/ad/b1/bmjopen-2015-007753.PMC4410129.pdf
"New Delhi: UNICEF, 2008. http://www.unicef.org/india/MAPEDIR-Maternal_and_Perinatal_Death_Inquiry_and_Response-India.pdf(accessed 17 Dec 2014).",Non-OADS,/arxiv_data1/oa_pdf/ad/b1/bmjopen-2015-007753.PMC4410129.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-006299).,Non-OADS,/arxiv_data1/oa_pdf/0f/b0/bmjopen-2014-006299.PMC4410130.pdf
To view please visitthe journal (http://dx.doi.org/ 10.1136/bmjopen-2014- 007265).,Non-OADS,/arxiv_data1/oa_pdf/4b/2a/bmjopen-2014-007265.PMC4410131.pdf
Available from http://www.crd.york.,Non-OADS,/arxiv_data1/oa_pdf/4b/2a/bmjopen-2014-007265.PMC4410131.pdf
"METHODS AND DESIGN This protocol has been registered on PROSPERO 2014(registration number: CRD42014012961), is available at http://www.crd.york.ac.uk/PROSPERO and is reported according to the PRISMA-P checklist.",OADS,/arxiv_data1/oa_pdf/4b/2a/bmjopen-2014-007265.PMC4410131.pdf
"The Swiss National Sentinel Reporting Network (http://www.sentinella.ch) To apply a supplementary method to gaining insight intosafety hot spots in primary care, we aim to assess 2 Gnädinger M, et al.BMJ Open 2015; 5:e007773.",Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
The questionnaire and the coding plan areavailable at http://www.medication-incidents.ch.,Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
The questionnaire and the coding plan are available at http://www.medication-incidents.ch.,Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
"The study was recorded in http://www.ClinicalTrials.gov: NCT02295371, as well as in our national study registry(http://www.kofam.ch; SNCTP000001207).",Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
"STROBE statement: Where applicable, our publication will follow the general STROBE guidelines (http://www.equator-network.org/).",Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
The questionnaire andthe coding plan are available at http://www.medication-incidents.ch.,Non-OADS,/arxiv_data1/oa_pdf/84/fa/bmjopen-2015-007773.PMC4410132.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2014-007359).,Non-OADS,/arxiv_data1/oa_pdf/8d/92/bmjopen-2014-007359.PMC4410133.pdf
United States Census Bureau/American Factfinder Web site 2011. http://quickfacts.census.gov/qfd/states/12000.html (accessed 23 Jun2014).,OADS,/arxiv_data1/oa_pdf/8d/92/bmjopen-2014-007359.PMC4410133.pdf
To view please visit the journal (http://dx.doi.org/ 10.1136/openhrt-2014- 000190).,Non-OADS,/arxiv_data1/oa_pdf/84/e7/openhrt-2014-000190.PMC4410138.pdf
Nice.org.Uk (http://www.nice.org.uk) 29.,Non-OADS,/arxiv_data1/oa_pdf/84/e7/openhrt-2014-000190.PMC4410138.pdf
http://webappa.cdc.gov/sasweb/ncipc/leadcaus10.html (accessed 17 Nov 2013).,OADS,/arxiv_data1/oa_pdf/06/c7/openhrt-2014-000169.PMC4410139.pdf
2014. http://publications.nice.org.uk/implantable-cardioverter- defibrillators-for-arrhythmias-ta95 11.,Non-OADS,/arxiv_data1/oa_pdf/39/ed/openhrt-2014-000153.PMC4410140.pdf
2014. https://www.nice.org.uk/guidance/TA314/chapter/1-Guidance12.,Non-OADS,/arxiv_data1/oa_pdf/39/ed/openhrt-2014-000153.PMC4410140.pdf
2013. http://www.bsecho.co.uk/home/13.,Non-OADS,/arxiv_data1/oa_pdf/39/ed/openhrt-2014-000153.PMC4410140.pdf
2013. https://nicor4.nicor.org.uk/__802571400070B77E.nsf?,Non-OADS,/arxiv_data1/oa_pdf/39/ed/openhrt-2014-000153.PMC4410140.pdf
"This	is	an	open-access	article	distributed	under	the	terms	of	the	Creative 	 Commons	 Attribution	Non-Commercial	No	Derivatives	(by-nc-nd)	License 	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9d/fd/jrd-61-081.PMC4410306.pdf
"It	has	been	demonstrated	 that	a	 stable	and	high	fertilization	 rate	[15]	and	a	blastocyst	developmental 	 rate	of	about	40%	[16–18]	were	achieved	by	adding	theophylline 	 to	bovine	IVF	medium	at	a	fixed	sperm	concentration	 of	5	×	106 Received:	July	16,	2014 Accepted:	November	17,	2014Published	online	in	J-STAGE:	December	13,	2014 ©2015	by	the	Society	for	Reproduction	and	Development Correspondence:	M	Nagano	(e-mail:	mnaga@vetmed.hokudai.ac.jp) This	is	an	open-access	article	distributed	under	the	terms	of	the	Creative 	 Commons	 Attribution	Non-Commercial	No	Derivatives	(by-nc-nd)	License 	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/67/99/jrd-61-099.PMC4410307.pdf
"It has been shown that fructose can substitute for glucose during  preimplantation embryo development [12] and that fructose can  Received: July 24, 2014 Accepted: November 29, 2014Published online in J-STAGE: January 8, 2015 ©2015 by the Society for Reproduction and Development Correspondence: M Miyake (e-mail: miyake@kobe-u.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a4/a3/jrd-61-106.PMC4410308.pdf
"Moreover, oxidative damage in sperm can  Received: October 17, 2014 Accepted: November 30, 2014Published online in J-STAGE: January 19, 2015 ©2015 by the Society for Reproduction and Development Correspondence: Y Nagao (e-mail: ynagao@cc.utsunomiya-u.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1e/0a/jrd-61-116.PMC4410309.pdf
"Received: June 25, 2014 Accepted: December 3, 2014Published online in J-STAGE: January 2, 2015 ©2015 by the Society for Reproduction and Development Correspondence: D Yu (e-mail: yudebing@njau.edu.cn) and W Du (e-mail: minliyu3356@sina.com) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1b/99/jrd-61-123.PMC4410310.pdf
"Gene ontology analysis was conducted at http://www.geneontology.org, and a pathway analysis was performed with the Kyoto Encyclopedia of Genes and Genomes (KEGG, http:// www.genome.jp/kegg).",OADS,/arxiv_data1/oa_pdf/1b/99/jrd-61-123.PMC4410310.pdf
"Experiment I: Effect of PNMPP on hormone secretion from  the anterior pituitary The anterior pituitaries were placed in cold DMEM medium  containing 10 g/l M5M, 6 g/l HEPES, 10% NaHCO3, and 10 ml/l Received: September 11, 2014 Accepted: December 8, 2014Published online in J-STAGE: January 15, 2015 ©2015 by the Society for Reproduction and Development Correspondence: G Watanabe (e-mail: gen@cc.tuat.ac.jp) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/82/44/jrd-61-134.PMC4410311.pdf
"Northern blotting  Received: August 30, 2014 Accepted: December 16, 2014Published online in J-STAGE: January 26, 2015 ©2015 by the Society for Reproduction and Development Correspondence: P-C Tang (e-mail: pctang@dragon.nchu.edu.tw) This is an open-access article distributed under the terms of the Creative  Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/1e/jrd-61-138.PMC4410312.pdf
"This is an open-access article distributed under the terms of the Creative  Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/40/d8/jrd-61-145.PMC4410313.pdf
"For	miR-224,	 a	vital	role	in	TGF-β-mediated	 cell	Received:	September	30,	2014 Accepted:	December	25,	2014Published	online	in	J-STAGE:	February	3,	2015 ©2015	by	the	Society	for	Reproduction	and	Development Correspondence:	J	Vanselow	(e-mail:	vanselow@fbn-dummerstorf.de),	or	D	Singh	(e-mail:	drdheer.singh@gmail.com) This	is	an	open-access	 article	distributed	 under	the	terms	of	the	Creative	 Commons	 Attribution	 Non-Commercial	 No	Derivatives	 (by-nc-nd)	 License	 <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Journal of Reproduction and Development, Vol.",Non-OADS,/arxiv_data1/oa_pdf/6f/c9/jrd-61-154.PMC4410314.pdf
"Thus, we clustered them on the basis of sequence identityusing CD-HIT-EST ( 41,42) (http://cd-hit.org, version 4.6.1).",OADS,/arxiv_data1/oa_pdf/5f/02/1400234.PMC4410388.pdf
SUPPLEMENTARY MATERIALS Supplementary material for this article is available at http://advances.sciencemag.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/5f/02/1400234.PMC4410388.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31major tissue for energy storage and secreting a different  type of proteins that influence the metabolism of the  body and affect energy and glucose homeostasis.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31was calculated according to the homeostasis model  assessment (HOMA) which is a good index for assessing  insulin sensitivity/resistance.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31one minor allele were associated with higher adiponectin  levels as compared to TG haplotype [Table 2b].",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31DISCUSSION The adipose tissue secretes a variety of molecules having  endocrine, paracrine, and autocrine actions and has a role  in the etiology of the metabolic abnormalities.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31genes associated with obesity may also contribute to the  above association.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/31Received:  16 Jul 14 Accepted:  10 Mar 15   Published:  08 Apr 15 REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:31 http://www.ijpvmjournal.net/content/6/1/3141.",Non-OADS,/arxiv_data1/oa_pdf/56/d4/IJPVM-6-31.PMC4410438.pdf
"International Journal of Preventive Medicine 2015, 6:30 http://www.ijpvmjournal.net/content/6/1/30AVICENNA AND HIS MASTERPIECE Abu‑Ali al‑Husain Ibn Abdullah Ibn‑Sina, more  commonly known as Ibn Sina (or Avicenna) was an  Iranian physician of the tenth and eleventh centuries.",Non-OADS,/arxiv_data1/oa_pdf/db/18/IJPVM-6-30.PMC4410439.pdf
"International Journal of Preventive Medicine 2015, 6:30 http://www.ijpvmjournal.net/content/6/1/30• Heterogeneous, for instance intense cold during the  summer (owing to atmospheric disturbance).",Non-OADS,/arxiv_data1/oa_pdf/db/18/IJPVM-6-30.PMC4410439.pdf
"International Journal of Preventive Medicine 2015, 6:30 http://www.ijpvmjournal.net/content/6/1/30Each of these three kinds of food is either rich or poor in  nutrition:[16] •	Light food, rich in nutrition, such as extract of meat •	Heavy food, poor in nutrition, such as cheese •	Light food, poor in nutrition, such as apples •	Heavy food, rich in nutrition, such as beef.",Non-OADS,/arxiv_data1/oa_pdf/db/18/IJPVM-6-30.PMC4410439.pdf
"International Journal of Preventive Medicine 2015, 6:30 http://www.ijpvmjournal.net/content/6/1/305.",Non-OADS,/arxiv_data1/oa_pdf/db/18/IJPVM-6-30.PMC4410439.pdf
"International Journal of Preventive Medicine 2015, 6:33 http://www.ijpvmjournal.net/content/6/1/33Nasal continuous positive airway pressure (NCPAP) is  a noninvasive method that provides a constant positive  pressure to the airways of spontaneously breathing  infants.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/IJPVM-6-33.PMC4410440.pdf
"International Journal of Preventive Medicine 2015, 6:33 http://www.ijpvmjournal.net/content/6/1/3388 and 95%.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/IJPVM-6-33.PMC4410440.pdf
"International Journal of Preventive Medicine 2015, 6:33 http://www.ijpvmjournal.net/content/6/1/33Eleven infants  (25%) in the non‑HFNC group and  17 infants (38.6%) in the HFNC had significant  apnea, (P = 0.12) and received methylxanthines.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/IJPVM-6-33.PMC4410440.pdf
"International Journal of Preventive Medicine 2015, 6:33 http://www.ijpvmjournal.net/content/6/1/33a predetermined level of pressure is a very useful method  for weaning from NCPAP .",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/IJPVM-6-33.PMC4410440.pdf
"International Journal of Preventive Medicine 2015, 6:33 http://www.ijpvmjournal.net/content/6/1/33ACKNOWLEDGEMENTS The authors are grateful to all staff involved in this study for  their assistance.",Non-OADS,/arxiv_data1/oa_pdf/6e/9f/IJPVM-6-33.PMC4410440.pdf
"International Journal of Preventive Medicine 2015, 6:34 http://www.ijpvmjournal.net/content/6/1/34diabetes T ype II.",Non-OADS,/arxiv_data1/oa_pdf/3f/88/IJPVM-6-34.PMC4410441.pdf
"International Journal of Preventive Medicine 2015, 6:34 http://www.ijpvmjournal.net/content/6/1/34of studies mentioned no significant difference in  body composition when exercise was added to diet  restriction.",Non-OADS,/arxiv_data1/oa_pdf/3f/88/IJPVM-6-34.PMC4410441.pdf
"International Journal of Preventive Medicine 2015, 6:34 http://www.ijpvmjournal.net/content/6/1/34Vasc Health Risk Manag 2007;3:511‑20.",Non-OADS,/arxiv_data1/oa_pdf/3f/88/IJPVM-6-34.PMC4410441.pdf
"International Journal of Preventive Medicine 2015, 6:32 http://www.ijpvmjournal.net/content/6/1/32early diagnosis of such cases is critical in an effort to  reduce the possibility of a seriously affected child.",Non-OADS,/arxiv_data1/oa_pdf/a0/2e/IJPVM-6-32.PMC4410442.pdf
"International Journal of Preventive Medicine 2015, 6:32 http://www.ijpvmjournal.net/content/6/1/32placenta location and gestational age at amniocentesis  between the different groups.",Non-OADS,/arxiv_data1/oa_pdf/a0/2e/IJPVM-6-32.PMC4410442.pdf
"International Journal of Preventive Medicine 2015, 6:32 http://www.ijpvmjournal.net/content/6/1/32prophylactic measure available in order to prevent such  an infection.",Non-OADS,/arxiv_data1/oa_pdf/a0/2e/IJPVM-6-32.PMC4410442.pdf
"International Journal of Preventive Medicine 2015, 6:32 http://www.ijpvmjournal.net/content/6/1/328.",Non-OADS,/arxiv_data1/oa_pdf/a0/2e/IJPVM-6-32.PMC4410442.pdf
"International Journal of Preventive Medicine 2015, 6:29 http://www.ijpvmjournal.net/content/6/1/29two decades ago.",Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
"International Journal of Preventive Medicine 2015, 6:29 http://www.ijpvmjournal.net/content/6/1/29Statistical and data analysis The data bank was produced using SPSS Version 20.0.",Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
"International Journal of Preventive Medicine 2015, 6:29 http://www.ijpvmjournal.net/content/6/1/29case ascertainment; another cause may be decrease in  the proportion of the population with predisposition to  cancer, and hence that those who reach old age have  lower risk.",Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
"International Journal of Preventive Medicine 2015, 6:29 http://www.ijpvmjournal.net/content/6/1/29 Figure 7: Age standardized rate of cancer cases in men/Isfahan province/2006–2010 Figure 6: Age standardized rate of cancer cases in women/Isfahan province/2006–2010 are seeking for medical services in the Isfahan city, give an  address from their relatives who are residence in the city,  this can lead falsely increase in cancer incidence.",Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
"International Journal of Preventive Medicine 2015, 6:29 http://www.ijpvmjournal.net/content/6/1/29County.",Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
Available from: http://www.globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/15/37/IJPVM-6-29.PMC4410443.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28Panel (ATP III), existence of three or more risk factors is  referred to as “metabolic syndrome”.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28So far, the TTM has been successfully applied on  different groups such as students, affected people  by hypertension, diabetes, osteoporosis, and cancer,  but this model has not yet been used in women with  metabolic syndrome in the city of Esfahan.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28flexibility, and balancing, energetic and contraction  exercises were instructed in the first session and the way  to walk properly was also trained to the women.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28Repeated measure ANOVA showed no statistically  significant difference in times ( f = 1.368,   P = 0.266) [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28risking situation.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28questions was too many, it was time‑consuming.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
"International Journal of Preventive Medicine 2015, 6:28 http://www.ijpvmjournal.net/content/6/1/28Heart J 2004;147:106‑12.",Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
Available from: http://www.ipaq.ki.se.,Non-OADS,/arxiv_data1/oa_pdf/78/97/IJPVM-6-28.PMC4410444.pdf
Available from: http://www.shoulderdoc.co.uk/article.asp?article=920&section=609.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/IJSS-9-43.PMC4410470.pdf
Available from: https://www.inkling.com/read/rockwood-matsen-shoulder-4th/chapter-4/special-tests.,Non-OADS,/arxiv_data1/oa_pdf/57/ed/IJSS-9-43.PMC4410470.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/c2/ncomms7859.PMC4410633.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Hu, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/ncomms7859.PMC4410633.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7859 ARTICLE NATURE COMMUNICATIONS | 6:6859 | DOI: 10.1038/ncomms7859 | www.nature.com/naturecommunications 7 &2015 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/67/c2/ncomms7859.PMC4410633.pdf
"Other keyfeatures include an interactive visualization service that illustrates intuitively the evolution of miRNA data, tag clouds summarizing the relevance of publications to particular diseases, cell types or tissues and access to TarBase 6.0 data to oversee genes related to miRNA publications.Availability and Implementation: mirPub is freely available at http://www.microrna.gr/mirpub/.",OADS,/arxiv_data1/oa_pdf/ca/21/btu819.PMC4410649.pdf
"1502 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/21/btu819.PMC4410649.pdf
"To support efficient retrieval of publications that contain each miRNA term, mirPub builds a Lucene (http://lucene.apache.org/core/) inverted index for the titles, the abstracts and the full texts ofMEDLINE articles.",OADS,/arxiv_data1/oa_pdf/ca/21/btu819.PMC4410649.pdf
"1366 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/18/btu833.PMC4410656.pdf
"For known pathway genes, we used pathways at http://www.broadinstitute.org/gsea/index.jsp.",OADS,/arxiv_data1/oa_pdf/5a/18/btu833.PMC4410656.pdf
Availability and implementation: All the datasets and the code used in this study are freely available at https://collaborators.oicr.on.ca/vferretti/borozan_csss/csss.html.Contact: ivan.borozan@gmail.com Supplementary information: Supplementary data are available at Bioinformatics online.,OADS,/arxiv_data1/oa_pdf/01/f3/btv006.PMC4410667.pdf
"1396 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/btv006.PMC4410667.pdf
"The distance calculated using Equation (7) takes val- ues between 0 and 1, with lower values indicating increasing se-quence similarity and higher values decreasing sequence similarity.The compression algorithm used in this study is plzip (http://www.nongnu.org/lzip/plzip.html) a multi-threaded, lossless data compres-sor based on the lzlib compression library that implements a simpli-fied version of the LZMA algorithm.",OADS,/arxiv_data1/oa_pdf/01/f3/btv006.PMC4410667.pdf
This  is  an  open  access  article  under the CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/ac/main.PMC4410735.pdf
"Trichothecenes  can  be  encountered  both  in  food  and  the indoor  environment  and  have  been  structurally  classi- ﬁed  into  several  groups  with  Types  A,  B  and  D  being http://dx.doi.org/10.1016/j.toxrep.2014.12.010 2214-7500/© 2015  The  Authors.",Non-OADS,/arxiv_data1/oa_pdf/a4/ac/main.PMC4410735.pdf
This  is  an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/a4/ac/main.PMC4410735.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use,distribution, and reproduction in any medium, provided the original author(s) and the source are credited.ANTIOXIDANTS & REDOX SIGNALING Volume 22, Number 15, 2015 Mary Ann Liebert, Inc.DOI: 10.1089/ars.2014.6047 1337",Non-OADS,/arxiv_data1/oa_pdf/de/f7/ars.2014.6047.PMC4410756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a4/6c/dmso-8-213.PMC4410820.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 213–218Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  213Original reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DMSO.S8036 4Development of non-alcoholic fatty liver   disease scoring system among adult medical   check-up patients: a large cross-sectional   and prospective validation study cosmas rinaldi a  lesmana1,2 levina S Pakasi1 Sri inggriani3 Maria l aidawati3 laurentius a lesmana1 1Digestive Disease and gi Oncology  centre, Medistra hospital,  2Department of internal Medicine,  hepatobiliary Division, cipto  Mangunkusumo hospital, University  of indonesia, 3radiology Department,  Medistra hospital, Jakarta, indonesia correspondence: cosmas rinaldi a  lesmana   Digestive Disease and gi Oncology  centre, Medistra hospital, Jl Jend gatot  Subroto Kav  59, Jakarta  12950, indonesia   Tel +62 21 5210200 ext 105/106   Fax +62 21 5292 1837  email medicaldr2001id@yahoo.co mBackground:  Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in  the community.",Non-OADS,/arxiv_data1/oa_pdf/a4/6c/dmso-8-213.PMC4410820.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a4/6c/dmso-8-213.PMC4410820.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a4/6c/dmso-8-213.PMC4410820.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 813–822International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  813RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/COPD.S5606 7Role of combined indacaterol and glycopyrronium  bromide (Qv A149) for the treatment of COPD  in Japan Nobuyuki Horita Takeshi Kaneko Department of Pulmonology,   Y okohama City University Graduate  School of Medicine, Y okohama, JapanAbstract:  Once-daily dual-bronchodilator therapy with combined indacaterol and glycopyrronium  bromide in one device (Ultibro, Breezhaler), often called QVA149, was first approved in 2013 in  Japan and Europe.",Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
"The  quick bronchodilation effect and once-daily administration can improve patient  adherence to medical treatment for COPD.6 Currently, the recommended dose for Correspondence: Nobuyuki Horita Department of Pulmonology, Yokohama  City University Graduate School of  Medicine, 3-9 Fukuura, Kanazawa-ku,  Yokohama 236-0004, Japan Tel +81 45 787 2630 Fax +81 45 786 3444 email nobuyuki_horita@yahoo.co.j p Journal name: International Journal of COPD Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Horita and Kaneko Running head recto: QVA149 in Japan: review DOI: http://dx.doi.org/10.2147/COPD.S56067",Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
Available from: http://www.goldcopd.org /.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
Available from: http://www.clinicaltrials.gov/ ct2/show/NCT01285492?term =%28ARISE%29&rank =4.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
Available at:  http://clinicaltrials.gov/ct2/show/NCT01782326?term =COPD+novart is+52&rank=2.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
Available from: http://www.info.pmda.go.jp/ shinyaku/P201300135/300242000_22500AMX01815_A100_5.pdf#s earch=‘%E5%8C%BB%E8%96%AC%E9%A3%9F%E5%93%81%E 5%B1%80%E5%AF%A9%E6%9F%BB%E7%AE%A1%E7%90%8 6%E8%AA%B2 +%E3%82%A6%E3%83%AB%E3%83%86%E3%8 2%A3%E3%83%96%E3%83%A D. Japanese.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/23/0a/copd-10-813.PMC4410821.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 781–793Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  781OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7948 5structural and functional markers of health  depending on lifestyle in elderly women  from Poland Anna skrzek1 Zofia Ignasiak2 T eresa Sławińska2 Jarosław Domaradzki2 Jarosław Fugiel2 Anna sebastjan2 Krystyna Rożek1 1Faculty of Physiotherapy, 2Faculty  of Physical education, University  school of Physical education  in Wroclaw, Wroclaw, PolandObjective:  To comparatively analyze the rate and magnitude of age-related changes between  two groups of elderly women with different lifestyles living in Poland: women attending a  University of the Third Age (active lifestyle) and less-active peers not involved in any seniors  association.",Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
"In this regard, Correspondence: Jarosław Fugiel Faculty of Physical education,  University school of Physical education  in Wroclaw, al Paderewskiego 35,  51–612 Wroclaw, Poland email jaroslaw.fugiel@awf.wroc.p lJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Skrzek et al Running head recto: Markers of health depending on lifestyle in elderly women DOI: http://dx.doi.org/10.2147/CIA.S79485",Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
Available from: http://www.schuhfried.com/viennatestsystem10/ tests-test-sets/all-tests-from-a-z/test/mls-motor-performance-series/.,Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/0c/04/cia-10-781.PMC4410822.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/55/31/dddt-9-2301.PMC4410823.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2301–2309Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2301Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8132 0Preparation, characterization, and in vivo study  of rhein-loaded poly(lactic- co-glycolic acid)  nanoparticles for oral delivery Zheng Yuan Xinhua gu Department of gastrointestinal  surgery, suzhou Municipal hospital,   suzhou, People’s republic of chinaAbstract:  A novel rhein formulation based on poly(lactic- co-glycolic acid) (PLGA)  nanoparticles (NPs) suitable for oral administration was developed in this study.",Non-OADS,/arxiv_data1/oa_pdf/55/31/dddt-9-2301.PMC4410823.pdf
"For the problem of poor solubility of hydrophobic drug in water, the  application of nanotechnology enabled researchers to see hope.15 Recently, a biode - gradable polymer nanoparticle (NP) has shown its increasingly important academic  value and significant clinical applications in cancer therapy.16,17correspondence: Xinhua gu Department of gastrointestinal  surgery, suzhou Municipal hospital,  no 26 Daoqian street, suzhou 215002,  People’s republic of china email xinhua_gu@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Yuan and Gu Running head recto: Rhein-loaded PLGA nanoparticles for oral delivery DOI: http://dx.doi.org/10.2147/DDDT.S81320",Non-OADS,/arxiv_data1/oa_pdf/55/31/dddt-9-2301.PMC4410823.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/55/31/dddt-9-2301.PMC4410823.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/55/31/dddt-9-2301.PMC4410823.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2321–2327Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2321Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6422 7A novel misoprostol delivery system for induction  of labor: clinical utility and patient considerations Megan L Stephenson Deborah A wing Division of Maternal-Fetal Medicine,   Department of Obstetrics and  Gynecology, University of California,   irvine Medical Center, Orange,   CA, USAAbstract:  Induction of labor is one of the most commonly performed obstetric procedures and  will likely become more common as the reproductive population in developed nations changes.",Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
"The rate of labor  induction has increased considerably, with rates more than doubling from 9.5% in 1990  to almost a quarter of US pregnant women undergoing induction in 2012.1 In 2004 and  2005, one in every five deliveries in the UK was induced.2 This rate has consistently  increased in the UK, with rates of induction at around 23% in England, Scotland,  and Wales in 2012, and this trend is predicted to continue.3–5 Although previously  thought to increase the cesarean delivery rate, more recent literature demonstrates that  induction of labor is not associated with increased cesarean rates.6–8 While no large  prospective trials have been conducted to confirm this, some authors of retrospective  reviews comment that induction of labor may be associated with a decreased cesarean  delivery rate, with no difference in perinatal morbidity or mortality.9–11 This includes  a Cochrane review of induction of labor versus expectant management at or beyond  term.12 Bailit et al recently published a retrospective cohort trial comparing expectantly  managed women with women who underwent nonmedically indicated induction with  nonanomalous, singleton, vertex pregnancies between 38 0/7 weeks and 41 6/7 weeks,  and found that the cesarean risk curve was U-shaped with a nadir at 39 weeks.13 This  is similar to the maternal and neonatal morbidity risk curve between these gestational  ages.14 These associations are currently being studied in a large-scale randomized trial  by the US National Institute of Child Health and Human Development Maternal Fetal Correspondence: Megan L Stephenson Division of Maternal-Fetal Medicine,  Department of Obstetrics and  Gynecology, University of California,  irvine Medical Center, 101 The City  Drive South, Building 56, Suite 800,  Orange, CA 92869, USA Tel +1 714 456 5967 email mfm@uci.ed u Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Stephenson and Wing Running head recto: Novel misoprostol delivery system for induction of labor DOI: http://dx.doi.org/10.2147/DDDT.S64227",Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
Available from:  http://www.isdscotland.org/Health-Topics/Maternity-and-Births/Births /.,Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
"Available from: http://wales.gov.uk/docs/statistics/2014/140311-   maternity -method -delivery-2013-en.pd f. Accessed November 17, 2014.",Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/ad/dddt-9-2321.PMC4410824.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2101–2117Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2101Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S6899 4D-cycloserine augmentation in behavioral therapy  for obsessive-compulsive disorder: a meta-analysis Jing Xia1 Yanqiu Du2 Jiyang han1 guo liu1 Xumei Wang1 1Department of Psychiatry,   shengjing hospital of china Medical  University, heping District shenyang,   liaoning, People’s republic of  china; 2Department of Medicine,   shenyang ninth People’s hospital,   Tiexi District, shenyang, liaoning,   People’s republic of chinaObjective:  To evaluate the overall effect of D-cycloserine (DCS) augmentation on exposure  and response prevention (ERP) therapy for obsessive-compulsive disorder (OCD).",Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
"ERP works by facilitating fear extinction correspondence: Xumei Wang Department of Psychiatry, shengjing  hospital of china Medical University, number 36 sanhao street,  heping District shenyang, liaoning,  110004, People’s republic of china Tel +86 24 966 156 6111 email xumeiwang@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Xia et al Running head recto: D-cycloserine augmentation in behavioral therapy for OCD DOI: http://dx.doi.org/10.2147/DDDT.S68994",Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
"Available from:  https://ia600503.us.archive.org/10/items/ecdeuassessmentm1933guyw/ ecdeuassessmentm1933guyw.pd f. Accessed December 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/19/2d/dddt-9-2101.PMC4410826.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/dddt-9-2329.PMC4410827.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2329–2342Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2329Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7621 8Modifying tetramethyl–nitrophenyl–imidazoline  with amino acids: design, synthesis, and 3D-Qsar  for improving inflammatory pain therapy Xueyun Jiang1 Yuji Wang1 haimei Zhu1 Yaonan Wang1 Ming Zhao1,2 shurui Zhao1 Jianhui Wu1 shan li1 shiqi Peng1 1Beijing area Major laboratory  of Peptide and small Molecular Drugs,   engineering research center of  endogenous Prophylactic of Ministry  of education of china, Beijing  laboratory of Biomedical Materials,   college of Pharmaceutical sciences,   capital Medical University, Beijing,   People’s republic of china; 2Faculty  of Biomedical science and   environmental Biology, Kaohsiung  Medical University, Kaohsiung, TaiwanAbstract:  With the help of pharmacophore analysis and docking investigation, 15 novel  1-(4,4,5,5-tetramethyl-2-(3-nitrophenyl)-4,5-dihydroimidazol-1-yl)-oxyacetyl-L-amino acids  (6a–o) were designed, synthesized, and assayed.",Non-OADS,/arxiv_data1/oa_pdf/0c/e3/dddt-9-2329.PMC4410827.pdf
"In this context, here we present the preparation and evaluation of the oral analgesic  and anti-inflammatory activities of 15 novel TMNPIZA on tail-flick and xylene-induced  ear edema mouse models, respectively, as well as analyze their structure–activity  relationship with Discovery Studio 4.0 three-dimensional quantitative structure–activity  relationship (3D-QSAR) module.correspondence: shiqi Peng/Ming Zhao college of Pharmaceutical sciences,  capital University of Medical sciences,   no.10 Xitoutiao, You an Men, Beijing  100069, People’s republic of china Tel +86 10 8391 1528 Fax: +86 10 8280 2482 email shiqipeng@163.co m/ sqpeng@ bjmu.edu.c n; mingzhao@bjmu.edu.c n Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Jiang et al Running head recto: Modifying tetramethyl–nitrophenyl–imidazoline with amino acids DOI: http://dx.doi.org/10.2147/DDDT.S76218",Non-OADS,/arxiv_data1/oa_pdf/0c/e3/dddt-9-2329.PMC4410827.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/0c/e3/dddt-9-2329.PMC4410827.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/e3/dddt-9-2329.PMC4410827.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/dd/4d/dddt-9-2311.PMC4410828.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 2311–2320Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2311Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S6753 6Profile of conbercept in the treatment  of neovascular age-related macular degeneration Correspondence: Xiaodong Sun Department of Ophthalmology, Shanghai  First People’s Hospital, School of  Medicine, Shanghai Jiao Tong University,  No.",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/dddt-9-2311.PMC4410828.pdf
"The incidence of severe vision Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Lu and Sun Running head recto: Conbercept for treatment of neovascular AMD  DOI: http://dx.doi.org/10.2147/DDDT.S67536",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/dddt-9-2311.PMC4410828.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/dd/4d/dddt-9-2311.PMC4410828.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/dd/4d/dddt-9-2311.PMC4410828.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 635–638Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  635Case Repo RTopen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S7554 4a novel missense KIT mutation causing  piebaldism in one Chinese family associated with  café-au-lait macules and intertriginous freckling Wei-Xue Jia1,2 Xue-Min Xiao1,2 Jian-Bing Wu1,2 Yi-ping Ma1,2 Yi-ping Ge1,2 Qi Li1,2 Qiu-Xia Mao1,2 Cheng-Rang Li1,2 1Institute of Dermatology, Chinese  academy of Medical sciences and  peking Union Medical College,   Nanjing, Jiangsu, China; 2Jiangsu Key  Laboratory of Molecular Biology  for skin Diseases and sTIs, Nanjing,   Jiangsu, ChinaAbstract:  Piebaldism is a rare autosomal dominant genodermatosis, manifesting as congenital  and stable depigmentation of the skin and white forelock.",Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
"Here, we report a Correspondence: Cheng-Rang Li  12 Jiangwangmiao street, Nanjing,  Jiangsu, China Tel +86 25 8547 8028 Fax +86 25 8541 4477 email nylcr72@163.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Jia et al Running head recto: Novel mutation piebaldism with CALMs and freckling DOI: http://dx.doi.org/10.2147/TCRM.S75544",Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
submit your manuscript | www.dovepress.co m Dove press Dove press 637Novel mutation piebaldism with C aLMs and freckling analyses were performed using Phred-Phrap-Consed v12.0  program ( http://www.phrap.or g).,Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
Using the tool of PolyPhen-2 ( http://genetics.bwh.,Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ec/33/tcrm-11-635.PMC4410829.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug Design, Development and Therapy 2015:9 2343–2350Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2343Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S8040 7Efficacy and safety of ramosetron versus  ondansetron for postoperative nausea and  vomiting after general anesthesia: a meta-analysis  of randomized clinical trials chengjie gao Bo li lufeng Xu Fubin lv guimao cao huixia Wang Fei Wang guanghan Wu Department of anesthesiology,   general hospital of Jinan Military  command, Jinan, People’s republic  of chinaBackground:  Postoperative nausea and vomiting is a common side effect of general anesthesia.",Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
"Clinical studies show that the anesthesia-related risk  factors for PONV are use of volatile anesthetics and postoperative opioid analgesics.2  However, the mechanism underlying these two primary risk factors is currently not  well understood.3 Non-anesthesia-related risk factors for PONV include female sex, correspondence: chengjie gao Department of anesthesiology, general  hospital of Jinan Military command,  25 shifan road, Jinan, shandong 250031,  People’s republic of china email gaochjmd@yeah.ne t Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gao et al Running head recto: Efficacy and safety of ramosetron after general anesthesia DOI: http://dx.doi.org/10.2147/DDDT.S80407",Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm271913.ht m. Accessed March 18, 2015.",Non-OADS,/arxiv_data1/oa_pdf/6e/d9/dddt-9-2343.PMC4410833.pdf
"This Open Access article is distributed under the terms of the Creative Commons Attribution Noncommercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.JOURNAL OF MEDICINAL FOOD J Med Food 18 (5) 2015, 535–541 Mary Ann Liebert, Inc., and Korean Society of Food Science and Nutrition DOI: 10.1089/jmf.2014.0083 535",Non-OADS,/arxiv_data1/oa_pdf/9e/ed/jmf.2014.0083.PMC4410834.pdf
One of the major problems contributing to treatment failure is a  © 2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/07/b2/nihms680248.PMC4410849.pdf
SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures and three figures and can be found with this article online  at http://dx.doi.org/10.1016/j.celrep.2014.05.036 .,OADS,/arxiv_data1/oa_pdf/07/b2/nihms680248.PMC4410849.pdf
"Published online July 24, 2013 http://dx.doi.org/10.1097/COC.",Non-OADS,/arxiv_data1/oa_pdf/07/b2/nihms680248.PMC4410849.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b5/da/ott-8-939.PMC4410891.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 939–941OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  939STudy Pr OTO cOlopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S8311 4randomized Phase II trial of paclitaxel plus  valproic acid vs paclitaxel alone as second-line  therapy for patients with advanced gastric cancer Sachio Fushida1 Masahide Kaji2 Katsunobu Oyama1 yasuo Hirono3 Hideaki Nezuka4 T oshiya Takeda5 T omoya Tsukada1 daisuke Fujimoto3 Shigekazu Ohyama6 Takashi Fujimura7 T etsuo Ohta1 On behalf of the  digestive disease Support  Organization (ddSO) 1department of Gastroenterological  Surgery, Kanazawa university  Hospital, Kanazawa, 2department  of Surgery, T oyama Prefectural central  Hospital, T oyama, 3First department  of Surgery, Fukui university Hospital,   Fukui, 4department of Surgery,   yatsuo General Hospital, T oyama,   5department of Surgery, Ishikawa  Matto central Hospital, Hakusan,   6department of Surgery, Kanazawa  Medical center, Kanazawa, 7Toyama  city Hospital, T oyama, JapanAbstract:  The standard regimen of second-line chemotherapy for patients with unresectable  gastric cancer has not been established.",Non-OADS,/arxiv_data1/oa_pdf/b5/da/ott-8-939.PMC4410891.pdf
"VPA inhibits both class I and II HDACs,10 and affects tumor growth  by inducing p21WAF1.11,12 However, some reports suggest that HDAC inhibitors also  enhance the acetylation of nonhistone proteins in relation with apoptosis.13–15 Y agi  et al reported that VPA induced dynamic modulation of histone H3 and α-tubulin correspondence: Sachio Fushida department of Gastroenterological  Surgery, Kanazawa university Hospital,  13-1 Takaramachi, Kanazawa 920-8641,  Japan Tel +81 76 265 2365 Fax +81 76 234 4260 Email fushida@staff.kanazawa-u.ac.j p Journal name: OncoTargets and Therapy Article Designation: Study Protocol Y ear: 2015 Volume: 8 Running head verso: Fushida et al Running head recto: Valproic acid in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S83114",Non-OADS,/arxiv_data1/oa_pdf/b5/da/ott-8-939.PMC4410891.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b5/da/ott-8-939.PMC4410891.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b5/da/ott-8-939.PMC4410891.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/33/ott-8-947.PMC4410892.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 947–953OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  947Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8193 6effect of blood type on survival of chinese patients  with esophageal squamous cell carcinoma Jian Qin1,* san-gang Wu2,* Jia-Yuan sun3 huan-Xin lin3 Zhen-Yu he3 Qun li3 1Department of radiation Oncology  of clinical cancer center, the  People’s hospital of guangxi  Zhuang autonomous region,   nanning, People’s republic of china;   2Department of radiation Oncology,   Xiamen cancer center, the First  affiliated hospital of Xiamen  University, Xiamen, People’s republic  of china; 3sun Yat-sen University  cancer center, state Key laboratory  of Oncology in south china,   Department of radiation Oncology,   collaborative innovation center  of cancer Medicine, guangzhou,   People’s  republic of china *These authors contributed equally  to this workBackground:  The aim of this study was to evaluate the prognostic value of ABO blood group  in Chinese patients with esophageal squamous cell carcinoma (ESCC) after esophagectomy.",Non-OADS,/arxiv_data1/oa_pdf/c4/33/ott-8-947.PMC4410892.pdf
"Recently, the association between ABO blood group and survival has been evalu - ated in several malignancies, including pancreatic cancer,4 colon cancer,5 nasopharyn - geal carcinoma,6 and breast cancer.7 Previous studies have suggested that blood type B  was associated with an increased risk of EC.8–10 However, to date, controversy remains correspondences: Zhen-Yu he; Qun li sun Yat-sen University cancer center,  651 Dongfeng east road, guangzhou  510060, People’s republic of china;  state Key laboratory of Oncology in  south china, Department of radiation  Oncology, collaborative innovation  center of cancer Medicine, guangzhou,  People’s republic of china Tel +86 20 87343543 Fax +86 20 87343392 email hezhy@sysucc.org.c n;  liqun0799@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Qin et al Running head recto: Blood type on survival in ESCC DOI: http://dx.doi.org/10.2147/OTT.S81936",Non-OADS,/arxiv_data1/oa_pdf/c4/33/ott-8-947.PMC4410892.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/33/ott-8-947.PMC4410892.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/33/ott-8-947.PMC4410892.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/rmhp-8-045.PMC4410893.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pRisk Management and Healthcare Policy 2015:8 45–54Risk Management and Healthcare Policy Dove press submit your manuscript | www.dovepress.co m Dove press  45Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/RMHP .S5691 1economic evaluation of screening programs   for hepatitis C virus infection: evidence   from literature Silvia Coretti1 Federica Romano1 valentina Orlando2 Paola Codella1 Sabrina Prete1 eugenio Di Brino1 Matteo Ruggeri1 1Post-Graduate School of economics  and Management (ALT eMS),  Università Cattolica del Sacro  Cuore, Rome, italy;  2Center of  Pharmacoeconomics (C iRFF),  Department of Pharmacy, Federico ii  University, Naples, italy Correspondence: Silvia Coretti   Post-Graduate School of economics   and Management (ALTeMS), Università   Cattolica del Sacro Cuore, Largo   Francesco vito  1, Rome  00168, italy   email silvia.coretti@rm.unicatt.i tBackground:  Hepatitis C is a liver infection caused by hepatitis C virus.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/rmhp-8-045.PMC4410893.pdf
"Risk Management and Healthcare Policy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/risk-management-and-healthcare-policy-journa lRisk Management and Healthcare Policy is an international, peer- reviewed, open access journal focusing on all aspects of public health,  policy, and preventative measures to promote good health and improve  morbidity and mortality in the population.",Non-OADS,/arxiv_data1/oa_pdf/ca/1c/rmhp-8-045.PMC4410893.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ca/1c/rmhp-8-045.PMC4410893.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/84/15/sccaa-8-067.PMC4410894.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pStem Cells and Cloning: Advances and Applications 2015:8 67–80Stem Cells and Cloning: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  67Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SCCAA.S8015 7Regulators of pluripotency and their implications  in regenerative medicine Ahmed el-Badawy Nagwa el-Badri Center of excellence for Stem  Cells and Regenerative Medicine,   Zewail  City of Science and  T echnology, Giza, egypt Correspondence: Nagwa el-Badri   Center of excellence For Stem Cells and  Regenerative Medicine (CeSC), Zewail  City of Science and Technology, Sheikh  Zayed District, 12588, 6th of October  City, Giza, egypt   Tel +20 2 3854 0401   email nelbadri@zewailcity.edu.e gAbstract:  The ultimate goal of regenerative medicine is to replace damaged tissues with new  functioning ones.",Non-OADS,/arxiv_data1/oa_pdf/84/15/sccaa-8-067.PMC4410894.pdf
"Stem Cells and Cloning: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/stem-cells-and-cloning-advances-and-applications-journa lStem Cells and Cloning: Advances and Applications is an international,  peer-reviewed, open access journal.",Non-OADS,/arxiv_data1/oa_pdf/84/15/sccaa-8-067.PMC4410894.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/84/15/sccaa-8-067.PMC4410894.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 911–919OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  911Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7108 9Pilot study investigating the prognostic significance  of thymidine phosphorylase expression in patients  with metastatic breast cancer: a single institution  retrospective analysis anna lisa T edeschi1 Zohreh eslami2 evgenia garoufalis1 ramy r saleh3 atilla Omeroglu2 gulbeyaz altinel2 Maria  ait-Tihyaty4 Bertrand Jean-claude4 catalin Mihalcioiu1 1Division of Medical Oncology,   Department of Medicine, Mc gill  University health center, royal  Victoria hospital, 2Department of  Pathology, 3Department of Medicine,   Mcgill University, 4cancer Drug  research laboratory, Department  of Medicine, Mcgill University health  center, royal Victoria hospital,   Montreal, Q c, canada Background:  The thymidine phosphorylase (TP) enzyme is expressed in higher levels in  cancer tissue when compared with normal tissue.",Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
"In 90% of MBC patients, treatment failure is attributed to resistance  to chemotherapeutic agents.4 The use of newer chemotherapeutic regimens in clinical correspondence: catalin Mihalcioiu Department of Medicine, Mcgill  University health center/royal Victoria  hospital, 687 Pine avenue West,  Montreal, Qc, h3a 1a1, canada Fax +1 514 843 1417 email catalin.mihalcioiu@muhc.mcgill.c a Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Tedeschi et al Running head recto: TP expression in metastatic breast cancer DOI: http://dx.doi.org/10.2147/OTT.S71089",Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
Available from:  http://www.cancer.ca/en/cancer-information/cancer-type/breast/ statistics/?region =nb.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e1/77/ott-8-911.PMC4410895.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/tcrm-11-639.PMC4410896.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pTherapeutics and Clinical Risk Management 2015:11 639–647Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  639ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8128 0evaluation of the appropriate use of commonly  prescribed fluoroquinolones and the risk  of dysglycemia Wissam K Kabbara1 Wijdan h Ramadan1 Peggy Rahbany2 souhaila al-n atour3 1Department of Pharmacy Practice,   school of Pharmacy, lebanese  american University, Byblos, lebanon;   2Children’s national Medical Center,   Washington, DC, Usa; 3Medex  Pharmaceutical Company, Beirut,   lebanonBackground:  Fluoroquinolones are among the most widely prescribed antibiotics.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/tcrm-11-639.PMC4410896.pdf
"in 2013.5 Inappropri - ate use of fluoroquinolones is linked to indication, dose, and duration of therapy.Correspondence: Wijdan h Ramadan Department of Pharmacy Practice,  school of Pharmacy, lebanese  american University, PO Box 36 – F 53,  Byblos, lebanon Tel +961 9 547 249 ext 2267 Fax +961 9 547 256 ext 2897 email wramadan@lau.edu.l bJournal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kabbara et al Running head recto: Fluoroquinolones and dysglycemia DOI: http://dx.doi.org/10.2147/TCRM.S81280",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/tcrm-11-639.PMC4410896.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/8a/ab/tcrm-11-639.PMC4410896.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8a/ab/tcrm-11-639.PMC4410896.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/6c/oajsm-6-121.PMC4410897.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 121–127Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  121OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S8097 4The relationship between Taekwondo training  habits and injury: a survey of a collegiate  Taekwondo population natalia covarrubias1 Subir Bhatia2 luis F campos3 Dahn V nguyen2,3 eric Y chang1,4,5 1Department of Physical Medicine and  rehabilitation, University of california  irvine, irvine, cA, USA; 2School of  Medicine, University of california  irvine, irvine, cA, USA; 3institute for  clinical and Translational Science,   irvine, cA, USA; 4Department of  Anesthesiology and Perioperative  care, University of california irvine,   irvine, cA, USA; 5reeve- irvine  research center, irvine, cA, USA correspondence: eric Y chang   Department of Physical Medicine &  rehabilitation, School of Medicine,  University of california irvine Medical  center, room 3226A, gillespie Building,  837 health Science road, irvine, cA  92697, USA   Phone + 714 456 6444   Fax +1 714 456 6557   email ericyaochang@gmail.co mObjective:  To correlate training habits of Taekwondo (TKD) athletes to risk for injury.",Non-OADS,/arxiv_data1/oa_pdf/4d/6c/oajsm-6-121.PMC4410897.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/4d/6c/oajsm-6-121.PMC4410897.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/6c/oajsm-6-121.PMC4410897.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/95/ott-8-943.PMC4410898.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 943–946OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  943Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8388 8a spectrum of cutaneous toxicities from erlotinib  may be a robust clinical marker for non-small-cell  lung therapy: a case report and literature review Feng Jin1 Hui Zhu2 Li Kong2 Jinming Yu2 1Department of radiation Oncology,   shandong Cancer Hospital and  Institute, shandong academy of  Medical sciences, University of Jinan,   Jinan, people’s republic of China;   2Department of radiation Oncology,   shandong Cancer Hospital and  Institute, Jinan, people’s republic  of ChinaAbstract:  Some literature suggests that an EGFR inhibition-induced rash can be used as  a clinical marker, but few studies report the correlation between a spectrum of cutaneous  toxicities from EGFR inhibition and drug efficacy.",Non-OADS,/arxiv_data1/oa_pdf/b9/95/ott-8-943.PMC4410898.pdf
"Because  a genetic test showed exon 19 deletion, she started receiving erlotinib (150 mg) daily  monotherapy.Correspondence: Jinming Yu Department of radiation Oncology,  shandong Cancer Hospital and Institute,  Jinan, shandong province 250117,  people’s republic of China Tel +86 531 8798 4729 Fax +86 531 8798 4079 email sdyujinming@163.co mJournal name: OncoTargets and Therapy Article Designation: Case report Y ear: 2015 Volume: 8 Running head verso: Jin et al Running head recto: Erlotinib for non-small-cell lung cancer DOI: http://dx.doi.org/10.2147/OTT.S83888",Non-OADS,/arxiv_data1/oa_pdf/b9/95/ott-8-943.PMC4410898.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b9/95/ott-8-943.PMC4410898.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/95/ott-8-943.PMC4410898.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 51–60Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  51Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S7880 8Sexual risk behaviors and Hiv risk among  Americans aged 50 years or older: a review Daniel J Pilowsky1,2 Li-Tzy wu3,4 1Columbia University Medical  Center, Department of epidemiology,   Mailman School of Public Health  New Y ork City, NY, USA; 2Division  of epidemiology, New York State  Psychiatric institute, New Y ork City,   NY, USA; 3Department of Psychiatry  and Behavioral Sciences, School of  Medicine, 4Center for Child and  Family Policy, Duke University,   Durham, NC, USA Correspondence: Daniel J Pilowsky   epidemiology, Mailman School of Public  Health, 722 west 168th Street,   New Y ork, NY 10032, USA   email dp14@columbia.ed uAbstract:  Although HIV -related sexual risk behaviors have been studied extensively in ado - lescents and young adults, there is limited information about these behaviors among older   Americans, which make up a growing segment of the US population and an understudied  population.",Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
"Available from: http://www.cdc.gov/hiv/pdf/statistics_2010_Hiv_Surveillance_Report_vol_18_no_3.pd f. Accessed October 27, 2014.8 Keyword = Unsafe sex* Limit to US-based samples#Limit to “Last 10 years” Limit to “English language” Limit to “All aged (65 and older)” 76 references1,379 references 1,335 references 129 references1,380 references Figure 2 Search strategy.",Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
Available from: http://www.cdc.gov/hiv/risk/age/olderamericans /.,Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
"Available from: http://www.cdc.gov/hiv/pdf/statistics_2010_HIV_Sur - veillance_Report_vol_18_no_3.pd f. Accessed October 2 7, 2014.",OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
"Available from:  http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pd f. Accessed  March 27, 2015.",OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
Available from: http://www.cdc.gov/hiv/risk/age/ olderamericans /.,Non-OADS,/arxiv_data1/oa_pdf/52/60/sar-6-051.PMC4410899.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/a7/ott-8-929.PMC4410900.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 929–937OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  929Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5316 4Clinical applications of PD-1-based therapy:  a focus on pembrolizumab (MK-3475) in the  management of melanoma and other tumor types Tara C Gangadhar1 April KS Salama2 1Division of Hematology/Oncology,   Department of Medicine, Abramson  Cancer Center of the University  of Pennsylvania, Philadelphia,   PA, USA; 2Division of Medical  Oncology, Department of Medicine,   Duke University Medical Center,   Durham, NC, USAAbstract:  Preclinical work has led to an increased understanding of the immunomodulatory  mechanisms involved in the regulation of the antitumor response in a variety of tumor types.",Non-OADS,/arxiv_data1/oa_pdf/bc/a7/ott-8-929.PMC4410900.pdf
"The newly realized  possibilities of long-term disease control, improved survival, and, perhaps, even cure  with effective immune-directed therapies highlight the importance of modulating the  immune system in the care of oncology patients.Correspondence: April KS Salama Division of Medical Oncology,  Department of Medicine, Duke University  Medical Center, 1 Trent Drive,   Room 25178, Morris Building,  DUMC 3198, Durham, NC 27710, USA Tel +1 919 681 6932 Fax +1 919 684 5163 email april.salama@duke.ed uJournal name: OncoTargets and Therapy Article Designation: Review Y ear: 2015 Volume: 8 Running head verso: Gangadhar and Salama Running head recto: PD-1-based therapy: pembrolizumab for melanoma and other tumor types DOI: http://dx.doi.org/10.2147/OTT.S53164",Non-OADS,/arxiv_data1/oa_pdf/bc/a7/ott-8-929.PMC4410900.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/bc/a7/ott-8-929.PMC4410900.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/a7/ott-8-929.PMC4410900.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8b/d8/ott-8-905.PMC4410901.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 905–910OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  905Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7898 4comparison of uncommon EGFR exon 21 l858r  compound mutations with single mutation liang Peng1,* Zhigang song2,* shunchang Jiao1 1Department of Oncology, chinese  Pla general hospital, chinese P la  Medical school, Beijing, People’s  republic of china; 2Department  of Pathology, chinese P la general  hospital, Beijing, People’s republic  of china *These authors contributed equally  to this workAbstract:  Non-small-cell lung cancer with epidermal growth factor receptor ( EGFR ) mutation  is sensitive to EGFR  tyrosine kinase inhibitors (TKIs).",Non-OADS,/arxiv_data1/oa_pdf/8b/d8/ott-8-905.PMC4410901.pdf
"The Iressa  Pan-Asia Study (IPASS) showed that significant differences were not found in PFS  and objective response rate (ORR) with gefitinib in the exon 19 deletions and the exon  21 point mutation L858R subgroup.5 However, in the study of Won et al6 although correspondence: shunchang Jiao Department of Oncology, chinese Pla  general hospital, chinese Pla Medical  school, 8th Floor, Zhongliu Building,  28# Fuxing road, Beijing 100853,  People’s republic of china Tel/fax +86 10 6693 7878 email shunchangschjj@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Peng et al Running head recto: Uncommon EGFR  mutations DOI: http://dx.doi.org/10.2147/OTT.S78984",Non-OADS,/arxiv_data1/oa_pdf/8b/d8/ott-8-905.PMC4410901.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8b/d8/ott-8-905.PMC4410901.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8b/d8/ott-8-905.PMC4410901.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/3e/ott-8-899.PMC4410902.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 899–904OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  899Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8351 1hes1 is an independent prognostic factor for  acute myeloid leukemia chen Tian Yingjun Tang T engteng Wang Y ong Yu Xiaofang Wang Yafei Wang Yizhuo Zhang Key laboratory of cancer Prevention  and Therapy, national clinical  research center for cancer, Tianjin  Medical University cancer institute  and hospital, Tianjin, People’s republic  of chinaAbstract:  HES1 is the target of Notch signaling which is reported to affect cell differentia - tion and maintain the cells in G0 phase in various tissues including the hematopoietic tissue.",Non-OADS,/arxiv_data1/oa_pdf/69/3e/ott-8-899.PMC4410902.pdf
"And, we showed that the expression of HES1 was  an independent prognostic factor for overall survival (OS) and relapse-free survival  (RFS) in patients with non-core binding factor (CBF) AML.correspondences: Yizhuo Zhang Department of hematology, Tianjin  Medical University cancer institute  and hospital, national clinical research  center of cancer, Key laboratory of  cancer Prevention and Therapy, Tianjin,  300060, People’s republic of china Tel +86 22 235 9337 Fax +86 22 235 9337 email yizhuozhang111@163.co mJournal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Tian et al Running head recto: HES1 as an independent prognostic factor for acute myeloid leukemia DOI: http://dx.doi.org/10.2147/OTT.S83511",Non-OADS,/arxiv_data1/oa_pdf/69/3e/ott-8-899.PMC4410902.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/69/3e/ott-8-899.PMC4410902.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/3e/ott-8-899.PMC4410902.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 921–928OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  921Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8236 5Progression-free survival as a surrogate endpoint for  overall survival in patients with third-line or later- line chemotherapy for advanced gastric cancer liya liu hao Yu lihong huang Fang shao Jianling Bai Donghua lou Feng chen Department of epidemiology and  Biostatistics, school of Public health,   nanjing Medical University, nanjing,   People’s republic of chinaBackground:  The correlation between overall survival (OS) and progression-free survival (PFS)  has been evaluated in patients with metastatic or advanced gastric cancer who have received  first-line and/or second-line chemotherapy.",Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
"In recent years,  significant achievements have been made in second-line chemotherapy for AGC.7–12  However, after failure of second-line chemotherapy, the results of further treatment are  poor, yielding response rates of 0%–5% with no evidence of prolonged survival.13,14  It should be noted that further active treatments beyond second-line chemotherapy would correspondence: Feng chen Department of epidemiology and  Biostatistics, school of Public health,  nanjing Medical University, 818 east  Tianyuan road, nanjing 210029, People’s republic of china email fengchen@njmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: PFS as a surrogate for OS in advanced gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S82365",Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
Available from: http://www.iarc.fr/en/ publications/pdfs-online/wcr /.,Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
Available from: http://web.mit.edu/r/r_v3.0.1/fullrefman.,Non-OADS,/arxiv_data1/oa_pdf/32/f7/ott-8-921.PMC4410904.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/2d/ppa-9-585.PMC4410905.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 585–588Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  585OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7654 0Application of a three-microneedle device  for the delivery of local anesthetics Kayoko ishikawa1 hidekazu Fukamizu1 T etsuya Takiguchi1 Yusuke Ohta1 Y oshiki T okura2 1Department of Plastic and  reconstructive surgery, hamamatsu  University school of Medicine,   hamamatsu, Japan; 2Department  of Dermatology, hamamatsu  University school of Medicine,   hamamatsu, JapanPurpose:  We investigated the effectiveness of a newly developed device for the delivery  of local anesthetics in the treatment of axillary osmidrosis and hyperhidrosis.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ppa-9-585.PMC4410905.pdf
"In the present study, we investigated the effective - ness of this newly developed TMD for the delivery of local anesthetics for patients  undergoing treatment for axillary osmidrosis and hyperhidrosis.correspondence: hidekazu Fukamizu  Department of Plastic and reconstructive  surgery, hamamatsu University school  of Medicine, 1-20-1 handayama  higashi-ku, hamamatsu, 431-3192, Japan Tel +81 53 435 2111 Fax +81 53 435 2882 email fukamizu@hama-med.ac.j p Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Ishikawa et al Running head recto: Three-microneedle device for local anesthesia DOI: http://dx.doi.org/10.2147/PPA.S76540",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ppa-9-585.PMC4410905.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/de/2d/ppa-9-585.PMC4410905.pdf
"Accession Numbers GSE60358 Nojima et al., 2015, Cell 161, 526–540 April 23, 2015 ª2015 The Authors http://dx.doi.org/10.1016/j.cell.2015.03.027",OADS,/arxiv_data1/oa_pdf/0b/25/main.PMC4410947.pdf
http://dx.doi.org/10.1016/j.cell.2015.03.027 This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0b/25/main.PMC4410947.pdf
"SUPPLEMENTAL INFORMATION Supplemental information includes Extended Experimental Procedures, seven ﬁgures, and one table and can be found with this article online at http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/0b/25/main.PMC4410947.pdf
The NPAC is updated every 3 years and all ambulance nurses receive a hardcopy (NPAC version 7.2 is avaliable at: http://visio.ambulancezorg.nl/LPA7.2/ ).,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/mej-22-199.PMC4410961.pdf
Ethical considerations The recommendations of the Dutch Central Committee on Research Involving Human Subjects were implemented following the step-by-step review plan ( http://www.ccmo-online.,Non-OADS,/arxiv_data1/oa_pdf/fd/8b/mej-22-199.PMC4410961.pdf
"Finally, several in vitro  ©2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/11/5f/nihms678016.PMC4410967.pdf
"*Correspondence: vmylee@upenn.edu.2Present address: Isis Pharmaceuticals, Inc., 2855 Gazelle Court, Carslbad, CA 92010, USA SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, seven figures, and one table and can be found with this  article online at http://dx.doi.org/10.1016/j.celrep.2014.05.033 .",Non-OADS,/arxiv_data1/oa_pdf/11/5f/nihms678016.PMC4410967.pdf
"In December, 2010, JASON, a group of scientific advisors to the military, issued a report entitled ‘The$100Genome:ImplicationsfortheDepartmentofDefense’thatoutlinedanam- bitiousplantoemploygenomictechnologiesto‘enhancemedicalstatusandimprove treatmentoutcomes,’enhance‘health,readiness,andperformanceofmilitaryperson- nel,’ and ‘know the genetic identities of an adversary.’1The report also called for the Department of Defense (DoD) to take advantage of its ‘large, well-defined popula- tioningenerallygoodhealth,togetherwiththeirmedicalrecords’to‘facilitatevaluable 1JASON, The Mitre Corporation, The$100 Genome: Implications for the DoD (Dec. 2010), http://www.fas.org/irp/agency/dod/jason/hundred.pdf (accessed May 2, 2014) [hereinafter, JASON Report].",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"C/circlecopyrtTheAuthor2014.PublishedbyDukeUniversitySchoolofLaw,HarvardLawSchool,OxfordUniversityPress, andStanfordLawSchool.ThisisanOpenAccessarticledistributedunderthetermsoftheCreativeCommons Attribution-NonCommercial-NoDerivs licence ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permitsnon-commercialreproductionanddistributionofthework,inanymedium,providedtheoriginalworkis notalteredortransformedinanyway,andthattheworkisproperlycited.Forcommercialre-use,pleasecontact journals.permissions@oup.com",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"See NationalInstitutesofHealth,NationalHumanGenomeResearchInstitute, TalkingGlossaryofGeneticTerms , http://www.genome.gov/glossary/index.cfm?id=532 (accessedMay2,2014).Theremainderofthispaper usesthetermsinterchangeablyunlessthediscussionrequiresthateithergeneticorgenomictechnologiesbe addressedspecifically.",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"One component of the research,theNewSoldierStudywhichstartedinFebruary,2011,asksnewenlisteesto volunteertocompletesurveysandtoundergoneurologicalandDNAtestingtoiden- tifygeneticandotherriskfactors.9AsofNovember,2012,34,851bloodsampleshave beenobtained.10In2012,theU.S.AirForceOfficeoftheSurgeonGeneralestablished the‘Patient-CenteredPrecisionCareResearch(PC2-Z)Program,’whichcollectsand sequencesDNAfromsalivasamplesprovidedbyvolunteersfromtheAirForceMedi- calServiceandmatchestheresultswiththeirmedicalinformationandfamilyhistory.11 Thepurposeoftheprojectistocreatea‘personalizedmedicineprofile’thatidentifies genomicrisksfor‘clinicallyactionable,commoncomplexdiseasesthataretraditionally treatedintheprimarycaresetting,’andtodeterminetheimpactofthisinformationon thehealthofthevolunteers.12Finally,in2011,theUSDepartmentofVeteransAffairs (VA)establishedtheMillionVeteranProgram,ageno–phenobankthatcollectsDNA 7Donna Miles, DNA Registry Unlocks Key to Fallen Servicemembers’ Identities , U.S. Army (Jan. 25, 2007),http://www.army.mil/article/1508/DNA RegistryUnlocksKeytoFallenServicemembers 039 Identities/ (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"9TheNationalInstituteofMentalHealth, ArmySTARRSNewSoldierStudy(NSS):TheFirstDaysofService , http://www.nimh.nih.gov/health/topics/suicide-prevention/suicide-prevention-studies/army-starrs-new- soldier-study-nss-the-first-days-of-service.shtml (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"10Army STARRS, Army STARRS by the Numbers: Quarter 4, 2013 ,http://www.armystarrs.org/ sites/default/files/By%20the%20numbers%20Web%2020130Q4%20.pdf (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"11Christopher E. Bradburne et al., Implementing Genome-Informed Personalized Medicine in the U.S. Air Force Medical Service via the Patient-Centered Precision Care Research (PC2-Z) Program ,3 1JOHNSHOPKINS APL T ECHNICAL DIGEST4, 333 (2013), http://techdigest.jhuapl.edu/TD/td3104/31 04-Bradburne.pdf (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"5, 2014), http://www.research.va.gov/MVP/media.cfm (accessed May 2, 2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"15PRWeb, Genevolve to Launch Military Grade DNA Test for Color Blindness (May 4, 2012), http://www.prweb.com/releases/2012/5/prweb9471028.htm (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Genomictestingformentalaswellasphysicaltraitswillattractthemilitary’satten- tion.Aconsiderableamountofresearchongeneticvariantsassociatedwithmentalill- nessalreadyisunderway.Forexample,geneticistsaresearchingformutationsthatpre- disposewarfighterstoorprotectthemfrompost-traumaticstressdisorder(PTSD)and haveidentifiedseveralgenes,suchas FKBP5,PACAP,TLL1,rs263232inADCY8,and 17National Cancer Institute, Cancer Genetics Risk Assessment and Counseling ,http://www.cancer.gov/ cancertopics/pdq/genetics/risk-assessment-and-counseling/HealthProfessional/page6 (accessed May 2, 2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"18Genetics and Public Policy Center, Genetics Perspectives on Policy Seminar—Genes in Uniform: Don’t Test, Don’tTell (Jan.10,2006), http://www.dnapolicy.org/news.past.php?action=detail&past eventid=25(ac- cessedMay2,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"S .N EWS&WORLDREPORT(Nov. 20, 2009), http://www.usnews.",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"25Mauro Costa-Mattioli et al., eIF2alpha Phosphorylation Bidirectionally Regulates the Switch from Short- to Long-Term Synaptic Plasticity and Memory , 129 C ELL195 (2007); Julie M. Miwa & Andreas Walz,Enhancement in Motor Learning through Genetic Manipulation of the Lynx1 gene ,7P LOSONE e43302 (2012), http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043302 (ac- cessedMay2,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"26Jos´e A. Apud et al., Tolcapone Improves Cognition and Cortical Information Processing in Normal Human Subjects,3 2NEUROPSYCHOPHARMACOLOGY 1011 (2007); Kristin M. Pearson-Fuhrhop et al., Genetic Varia- tionintheHumanBrainDopamineSystem Influences MotorLearningandItsModulationbyL-Dopa ,8PLOS ONEe61197 (2013), http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0061197 (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"2008), 76, https://www.fas.org/irp/agency/ dod/jason/human.pdf (accessedMay2,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"The second is 37See, eg,National Human Genome Research Institute, Genetic Discrimination ,http://www.genome.gov/ 10002077 (accessedMay2,2014);KathyL.Hudsonetal., KeepingPacewiththeTimes—TheGeneticInforma- tionNondiscriminationActof2008 ,358NEWENG.J.MED.2661(2008);SusannahBaruch&KathyHudson, Civilian and Military Genetics: Nondiscrimination Policy in a Post-GINA World ,8 3AM.J .HUM.GENET.",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"42U.S.DepartmentofDefense,DepartmentofDefenseInstruction(DoDI)No.3216.02, ProtectionofHuman Subjects and Adherence to Ethical Standards in DoD-Supported Research , Glossary at 38 (2011) (hereinafter DoDI.3216.02), http://www.dtic.mil/whs/directives/corres/pdf/321602p.pdf (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Informed consent is a central focus in the government’s ef- fortstoprotecthumansubjectsingeneticandgenomicresearch.49Indeed,ithasbeen argued that genomic research requires even stronger protections for subjects than many other types of human experimentation because of the sensitive nature of per- sonal genomic information that a study may uncover, such as predictive data about future illnesses for which the subject or the subject’s family members are at risk50or 47TroopsinCubawhoparticipatedinWalterReed’syellowfeverexperimentssignedformsindicatingthatthey understoodtheriskandfreelyconsentedtobeenrolledassubjects.RadiationReport, supranote44,at97; ArthurO.Anderson, ABriefHistoryofMilitaryContributionstoEthicalStandardsforResearchInvolvingHu- manSubjects ,http://artnscience.us/Med Ethics/index.html (accessedMay4,2014)(hereinafterAnderson History).In1953,theSecretaryofDefense,CharlesE.Wilson,distributedamemorandumthroughoutthe militarythatpermittedArmedServicespersonneltoserveasresearchsubjectsonlyiftheygavetheirvoluntary consent.RadiationReport, supranote44,at105;AndersonHistory,at11.AlthoughtheWilsonMemoran- dumwasclassifiedtopsecretuntil 1975forreasonsthatarenotentirelyclear( seeRadiationReport, supra note44,at107),theArmychiefofstaffissuedanon-classifiedversionofthememorandumin1954asArmy DirectiveCS:35( seeRadiationReport, supranote44,at107)andincorporatedCS:35intoArmyregulations as AR 70–25 in 1962.",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"49See,eg, National Human Genome Research Institute, Informed Consent for Genomics Research , http://www.genome.gov/27026588 (accessed May 2, 2014); National Human Genome Research In- stitute,ELSIResearchPrioritiesandPossibleResearchTopics ,http://www.genome.gov/27543732 (accessed May2,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"50National Human Genome Research Institute, Protecting Human Research Subjects, National Institutes of Health Office for Protection from Research Risks (OPRR) 1993 Institutional Review Board Guidebook , http://www.genome.gov/10001752 (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"81NationalInstituteonAging, Alzheimer’sDiseaseFactSheet ,http://www.nia.nih.gov/alzheimers/publication/ alzheimers-disease-genetics-fact-sheet (accessedMay2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"GENET.474(1998), http://www.ashg.org/pdf/pol-29%20.pdf (accessedMay5,2014);RuthMacklin, Pri- vacyControlofGeneticInformation ,inGENEMAPPING:USINGLAW ANDETHICS ASGUIDES157–72,(George J. Annas & Sherman Elias eds., 1992); Kenneth Offit et al., The “Duty to Warn” a Patient’s Family Mem- bers About Hereditary Disease Risks , 292 JAMA 1469 (2004); Dorothy C. Wertz, John C. Fletcher & Kare Berg,ReviewofEthicalIssuesinMedicalGenetics ,WorldHealthOrganizationHumanGeneticsProgramme (2003),http://www.who.int/genomics/publications/en/ethical issuesinmedgenetics%20report.pdf (ac- cessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"87See,eg,MarkE.Robsonetal., AmericanSocietyofClinicalOncologyPolicyStatementUpdate:GeneticTestingfor CancerSusceptibility ,21J .C LINICALONCOLOLGY 2397(2003);AmericanMedicalAssociation,Proceedings ofthe2013AnnualMeetingoftheHouseofDelegates, ReportsoftheCouncilonScienceandPublicHealth (ap- provedNov.17,2013), http://www.ama-assn.org/assets/meeting/2013a/a13-csaph-reports.pdf (accessed May5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"88SeePRESIDENTIAL COMMISSION FOR THE STUDY OF BIOETHICAL ISSUES,ANTICIPATE AND COM- MUNICATE :ETHICALMANAGEMENT OF INCIDENTAL AND SECONDARY FINDINGS IN THE CLINICAL, RESEARCH,ANDDIRECT-TO-CONSUMER CONTEXTS (2013),http://bioethics.gov/sites/default/files/ FINALAnticipateCommunicate PCSBI0.pdf(accessedJuly2,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"97U.S.DepartmentofHealthandHumanServices, WhenDoesCompensatingSubjectsUndermineInformedCon- sentorParentalPermission ?http://answers.hhs.gov/ohrp/questions/7251 (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"100CBS News, Troops’ New Bionic Leg Now for Civilians, Too ,http://www.cbsnews.com/news/troops-new- bionic-leg-now-for-civilians-too/ (June16,2011)(accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"101See,eg,TomA.Peter, MilitaryInventionsHittheCivilianMarket ,THECHRISTIANSCIENCEMONITOR(June19, 2008),http://www.csmonitor.com/Innovation/Tech-Culture/2008/0619/built-for-battle-but-perfect-in- peacetime (accessed May 5, 2014); Josh Kulla, FLIR Introduces Products for the Civilian Market,PAMPLINMEDIAGROUP(Jan. 22, 2014), http://www.pamplinmedia.com/wsp/139-business/ 207955-63820-flir-introduces-products-for-the-civilian-market (accessedMay5,2014);MatthewPeach, IR ImagingMarketShiftingfromMilitarytoCivilian (Sep.13,2013), http://optics.org/news/4/9/16 (accessed May5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Department of Health and Human Services, Office for Human Research Protection, Institutional Re- viewBoardGuidebook ,c.3(1993), http://www.hhs.gov/ohrp/archive/irb/irb chapter3.htm (accessedMay 5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Equal Employment Opportunity Commission, Rehabilitation Act/GINA: Confidentiality of Medi- cal/GeneticInformation (Dec.12,2012), http://www.eeoc.gov/eeoc/foia/letters/2012/gina confidentiality ofmedicalgenetic information 2.html(accessedMay5,2014);SusannahBaruch&KathyHudson, Civilian andMilitaryGenetics:NondiscriminationPolicyinaPost-GINAWorld ,83AM.J .HUM.GENET.435(2008).It isnotclear,however,atwhatpointenlisteeslosetheprotectionofGINA.",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"117U.S.DepartmentofDefense,RevisedDoDInstructionE3.P4.5.2.2(2008),on‘Hereditaryand/orGenetic Diseases.’ 118Lt.Col.PaulDean&Lt.Col.JeffreyMcNeil, BreakingtheStigmaofBehavioralHealthcare ,25SPECIALWARFARE 6(2012), http://static.dvidshub.net/media/pubs/pdf 10170.pdf (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Geno–phenobankresearchraisesmanyofthesametypesofethical,legal,andpolicy concernsasclinicalresearch,includingtheneedtoobtainconsentfromDNAcontrib- utors to use their DNA for research, return of results and incidental findings, shared 132Joel Kupersmith, The Million Veterans Program: Building VA’s Mega-Database for Genomic Medicine (Nov. 19, 2012), http://healthaffairs.org/blog/2012/11/19/the-million-veteran-program-building-vas-mega- database-for-genomic-medicine/print/ (accessedMay5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"134Ronald Przygodski, Genomic Medicine Program ,http://www.cdc.gov/genomics/translation/GAPPNet/ meeting/file/print/slides/Przygodzki.pdf (accessedMay5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Department of Veterans Affairs, Veterans Health Administration, Veterans Health Administration Research and Development Program (July 9, 2009), http://www.va.gov/vhapublications/ ViewPublication.asp?pub ID=2043(accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"Department of Veterans Affairs Office of Research and Development, Volunteering in Research— HereAreSomeThingsYouNeedToKnow ,http://www.research.va.gov/programs/pride/veterans/trifold.pdf (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"151ArmySTARRS, http://www.armystarrs.org (accessedMay5,2014);CoriellPersonalizedMedicineCollab- orative,InformedConsentSession—U.S.AirForceMedicalServicePC2-ZStudy ,http://www.cpmc.coriell.org/ Sections/Membership/EnrollmentConsent.aspx?CoriellReg =Y&PgId =9&id=38(accessedMay5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"153MarkWicclair&MichaelDeVita, OversightofResearchInvolvingtheDead ,14KENNEDYINST.ETHICSJ.143 (2004).SeealsoWorldHealthOrganization(WHO),GeneticDatabases:AssessingtheBenefitsandtheIm- pactonHumanandPatientRights,Geneva(2003)(‘Thedeathofanindividualwhohasprovidedagenetic sampleorgeneticinformationdoesnotrepresenttheendoftheethicalresponsibilitiesthatareowedinre- spectofthesamplesorinformation.’) 154United Nations Educational, Scientific and Cultural Organization (UNESCO), Human Genetic Data: Pre- liminaryStudybytheIBConItsCollection,Processing,StorageandUse ,18,http://portal.unesco.org/shs/en/ files/2138/10563744931Rapfinal gendataen.pdf/Rapfinal gendataen.pdf(accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"155U.S.DepartmentofVeteransAffairs, MillionVeteranProgram ,http://www.research.va.gov/mvp/ (accessed May5,2014).",OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"156Joel Kupersmith, The Million Veterans Program: Building VA’s Mega-Database for Genomic Medicine (Nov. 19, 2012), http://healthaffairs.org/blog/2012/11/19/the-million-veteran-program-building-vas-mega- database-for-genomic-medicine/print/ (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"159See,eg, American Medical Association, AMA Code of Medical Ethics, Genetic Testing by Employers , Opinion 2.132(2)(e), 2.132, http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/ code-medical-ethics/opinion2132.page ,Ethical Issues in Carrier Screening of Genetic Disorders , Opinion 2.137, http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics/ opinion2137.page ,a n dMultiplex Genetic Testing , Opinion 2.139, http://www.ama-assn.org/ama/ pub/physician-resources/medical-ethics/code-medical-ethics/opinion2139.page (accessed May 5, 2014);LoisSnyder,AmericanCollegeofPhysiciansEthics,Professionalism,andHumanRightsCommittee, American College of Physicians Ethics Manual: Sixth Edition , 156 A NNALSINT.MED.",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"17, 1998), http://www.fda.gov/NewsEvents/Testimony/ucm115125.htm (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"176According to the package insert, Factor VII, brand-name NovoSeven, is produced by cloning the gene for human Factor VII, expressing it in baby hamster kidney cells, secreting it into a culture media containing newborn calf serum in its single-chain form, and then proteolytically converting it by auto- catalysistotheactivetwo-chainformduringachromatographicpurificationprocess, http://www.fda.gov/ downloads/biologicsbloodvaccines/bloodbloodproducts/approvedproducts/licensedproductsblas/ fractionatedplasmaproducts/ucm056915.pdf (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"T IMES, Nov. 6, 2007, http://www.nytimes.com/2007/11/06/health/06prof.html?pagewanted=all (accessedJuly4,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"178RobertLittle, ArmyMedicine:UntestedinBattle ,BALT.SUN,Mar.29,2009, http://www.baltimoresun.com/ news/nation-world/bal-te.militarymed29mar29,0,7320913,full.story (accessedJuly4,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"In the de- bate about the ethics and legality of human genomic engineering, one technology thatcausesparticularconcern,forexample,isintermixinghumanandanimalDNA.183 Critics object that even using this technology to combat disease, let alone for 180U.S.DepartmentofHealthandHumanServices, Shortstature:CriteriaforDeterminingDisabilityinInfants andChildren ,http://www.ahrq.gov/clinic/epcsums/shortsum.htm (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"181TimJohnson, Whatis20/20vision ?https://www.uihealthcare.org/2column.aspx?id=225702 (accessedMay 5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"182AmericanPsychiatricAssociation, Let’sTalkFactsBrochures:SexualOrientation ,http://www.psychiatry.org/ mental-health/people/lgbt-sexual-orientation (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"183SeePublic Broadcasting Network, Frontline: Organ Farms ,http://www.pbs.org/wgbh/pages/frontline/ shows/organfarm/etc/faqs.html (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
"186See,eg, Mark Frankel, Audrey Chapman & American Association for the Advancement of Science, Human Inheritable Genetic Modifications: Assessing Scientific, Ethical, Religious, and Policy Issues (2000), http://www.aaas.org/sites/default/files/migrate/uploads/germline.pdf (accessedMay5,2014).",Non-OADS,/arxiv_data1/oa_pdf/ba/ef/lsu021.PMC4410969.pdf
More information about the NIfTI ﬁle format is available from the Neuroimaging Informatics Technology Initiative webpage at http://nifti.nimh.nih.gov/.,OADS,/arxiv_data1/oa_pdf/9c/10/sdata201437.PMC4411010.pdf
Data processing All 3D volumes were processed using FreeSurfer6–8(freely available online at http://surfer.nmr.mgh.,OADS,/arxiv_data1/oa_pdf/9c/10/sdata201437.PMC4411010.pdf
"Maclaren, J., Han, Z., Vos, S. B., Fischbein, N. & Bammer, R. FigShare http://dx.doi.org/10.6084/m9.",Non-OADS,/arxiv_data1/oa_pdf/9c/10/sdata201437.PMC4411010.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/sdata.,Non-OADS,/arxiv_data1/oa_pdf/9c/10/sdata201437.PMC4411010.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc/4.0/ Metadata associated with this Data Descriptor is available at http://www.nature.com/sdata/ and is released under the CC0 waiver to maximize reuse.www.nature.com/sdata/ SCIENTIFIC DATA |1:140037 |DOI: 10.1038/sdata.2014.37 9",Non-OADS,/arxiv_data1/oa_pdf/9c/10/sdata201437.PMC4411010.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/00/ijwh-7-403.PMC4411013.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/eb/00/ijwh-7-403.PMC4411013.pdf
"Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.Dove pres s International Journal of Women’s Health 2015:7 403International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  403CorrIgendumopen access to scientific and medical research open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S8588 9Eribulin for the treatment of metastatic breast cancer: an update on its  safety and efficacy [Corrigendum] Doherty MK, Morris PG.",Non-OADS,/arxiv_data1/oa_pdf/eb/00/ijwh-7-403.PMC4411013.pdf
"On page 54, Future directions heading, 1st paragraph,  “For HER2-positive MBC, taxanes combined with trastu - zumab have yielded ORRs of 69%–76% and median PFS  rates of 9–12 months.”41,42 Should have been “For HER2- positive MBC, taxanes combined with trastuzumab have  yielded ORRs of 69%–76% and median TTP rates of 9–12  months.”41,42Journal name: International Journal of Women’s Health Article Designation: Corrigendum Y ear: 2015 Volume: 7 Running head verso: Doherty and Morris Running head recto: Corrigendum DOI: http://dx.doi.org/10.2147/IJWH.S85889",Non-OADS,/arxiv_data1/oa_pdf/eb/00/ijwh-7-403.PMC4411013.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/eb/58/ndt-11-1111.PMC4411014.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNeuropsychiatric Disease and Treatment 2015:11 1111–1114Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1111Case repor Topen access to scientific and medical research open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8401 0posterior reversible encephalopathy syndrome in  a woman with focal segmental glomerulosclerosis Mudit Chowdhary1 ahmad a Kabbani1 Devon T obey1 Thomas D Hope2 1Department of Internal Medicine,   Mercer University school of Medicine,   Macon, Ga, Usa; 2Department of  Neurology, Mercer University school  of Medicine, Macon, Ga, UsaAbstract:  Posterior reversible encephalopathy syndrome (PRES) is a rare syndrome character - ized by reversible vasogenic edema in the posterior hemispheres.",Non-OADS,/arxiv_data1/oa_pdf/eb/58/ndt-11-1111.PMC4411014.pdf
"Here we report a rare case of a young adult female with FSGS who presented with  an acute onset seizure with concurrent subarachnoid hemorrhage (SAH) and nephrotic  syndrome that was subsequently discovered to be PRES.Correspondence: Mudit Chowdhary Department of Internal Medicine,  Mercer University school of Medicine,  707 pine street, Macon, Ga 31201, Usa Tel +1 478 301 5820 Fax +1 478 301 5825 email mu.chowdhary@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Case report Y ear: 2015 Volume: 11 Running head verso: Chowdhary et al Running head recto: PRES secondary to FSGS DOI: http://dx.doi.org/10.2147/NDT.S84010",Non-OADS,/arxiv_data1/oa_pdf/eb/58/ndt-11-1111.PMC4411014.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/eb/58/ndt-11-1111.PMC4411014.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/eb/58/ndt-11-1111.PMC4411014.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6a/61/jmdh-8-205.PMC4411015.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 205–208Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  205CoMMentaryopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/JMDH.S7412 9reducing health disparities in underserved  communities via interprofessional collaboration  across health care professions allison a Vanderbilt1,2 Michael D Dail3 Parham Jaberi4 1Center on Health Disparities, 2School  of Medicine, Virginia Commonwealth  University, richmond, V a, USa; 3Family  Health Clinic, McDonald army Health  Center, Fort eustis, V a, USa; 4Virginia  Department of Health, Chesterfield  Health District, Chesterfield, V a, USa Correspondence: allison a Vanderbilt   School of Medicine, Virginia  Commonwealth University,   730 east Broad Street, Suite 4116,  richmond, Va 23298, USa   email avanderbilt@vcu.ed uAbstract:  Health disparities can negatively impact subsets of the population who have system - atically experienced greater socioeconomic obstacles to health.",Non-OADS,/arxiv_data1/oa_pdf/6a/61/jmdh-8-205.PMC4411015.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/6a/61/jmdh-8-205.PMC4411015.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/6a/61/jmdh-8-205.PMC4411015.pdf
"Available from: http://www.lcme.org/standard.ht m. Accessed  February 3, 2015.",OADS,/arxiv_data1/oa_pdf/6a/61/jmdh-8-205.PMC4411015.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1121–1130Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1121OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7771 0association between anxiety and hypertension:  a systematic review and meta-analysis  of epidemiological studies Yu Pan1,2,* Wenpeng cai1,* Qi cheng3,* Wei Dong1 Ting an4 Jin Yan1 1Department of Psychology and  Mental health, second Military  Medical University, shanghai,   2Department of Psychology,   Peoples liberation army general  hospital, Beijing, 3Department of  child and adolescent Behavioral  Medicine, The 102 hospital of P la,   changzhou, 4Department of internal  Medicine, The  Pla second  artillery  Force general hospital, Beijing,   People’s republic of china *These authors contributed equally  to this workBackground:  Epidemiological studies have repeatedly investigated the association between  anxiety and hypertension.",Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
"Hypertension has a multifactorial etiology, where genetic as well as psychosocial  and environmental factors appear to be of importance.3,4 However, there are complex  physiological processes involved and the linkage among psychosocial factors and  hypertension is not fully understood.5–7 Anxiety is one of the most common psychiatric  illnesses in adults and is a major public health problem in many countries,8,9 damaging  the affected individual’s health and quality of life.10 Because both hypertension and correspondence: Jin Yan Department of Psychology and Mental  health, second Military Medical  University, 800 Xiangyin road, shanghai,  200433, People’s republic of china Tel +86 136 6166 5500 email yanjingk@qq.comJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Pan et al Running head recto: Association between anxiety and hypertension DOI: http://dx.doi.org/10.2147/NDT.S77710",Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
Available from: http://www.ohri.ca/programs/ clinical_epidemiology / oxford.asp .,Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c1/6c/ndt-11-1121.PMC4411016.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/38/idr-8-075.PMC4411017.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 75–82Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  75RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IDR.S5669 1Profile of tedizolid phosphate and its potential   in the treatment of acute bacterial skin   and skin structure infections Ronald G Hall 2nd Heidi N Michaels Texas Tech University Health   Sciences Center, Dallas, TX, USA Correspondence: Ronald G Hall 2nd   T exas T ech University Health Sciences  Center, 5920 Forest Park Road, Suite  400,   Dallas, TX  75235, USA   Tel +1 214 358 9009  email ronald.hall@ttuhsc.ed uAbstract:  Tedizolid phosphate is the first once-daily oxazolidinone approved by the United  States Food and Drug Administration for the treatment of acute bacterial skin and skin structure  infections (ABSSSI).",Non-OADS,/arxiv_data1/oa_pdf/3b/38/idr-8-075.PMC4411017.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/3b/38/idr-8-075.PMC4411017.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/38/idr-8-075.PMC4411017.pdf
Available from: https://www.clinicaltrials.gov/ct2/ show/NCT02342418?term =tedizolid&rank =3.,Non-OADS,/arxiv_data1/oa_pdf/3b/38/idr-8-075.PMC4411017.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ce/d9/ndt-11-1115.PMC4411018.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 1115–1120Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1115ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S7476 0Dietary patterns and schizophrenia: a comparison  with healthy controls Koji Tsuruga1 Norio Sugawara1 Yasushi Sato1 Manabu Saito1 Hanako Furukori2 Taku Nakagami3 Kazuhiko Nakamura1 Ippei Takahashi4 Shigeyuki Nakaji4 Norio Yasui-Furukori1 1Department of Neuropsychiatry,   Hirosaki University School  of Medicine, Hirosaki, Japan;   2Department of Psychiatry, Kuroishi- Akebono Hospital, Kuroishi, Japan;   3Department of Neuropsychiatry,   Odate Municipal General Hospital,   Odate, Japan; 4Department of Social  Medicine, Hirosaki University School  of Medicine, Hirosaki, JapanBackground:  It has been reported that the onset of schizophrenia and the physical complications  after its onset are related to diet.",Non-OADS,/arxiv_data1/oa_pdf/ce/d9/ndt-11-1115.PMC4411018.pdf
"Correspondence: Koji Tsuruga Department of Neuropsychiatry, Hirosaki  University School of Medicine, 5 Zaifu-cho,   Hirosaki City, Aomori 036-8562, Japan  Tel +81 172 39 5066 Fax +81 172 34 5067 Email cranehappiness@yahoo.co.j p Journal name: Neuropsychiatric Disease and Treatment Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 11 Running head verso: Tsuruga et al Running head recto: Dietary patterns and schizophrenia DOI: http://dx.doi.org/10.2147/NDT.S74760",Non-OADS,/arxiv_data1/oa_pdf/ce/d9/ndt-11-1115.PMC4411018.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/ce/d9/ndt-11-1115.PMC4411018.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ce/d9/ndt-11-1115.PMC4411018.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a7/da/ijn-10-3065.PMC4411019.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nanomedicine 2015:10 3065–3080International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3065OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8219 9Nitric oxide-releasing poly(lactic- co-glycolic acid)- polyethylenimine nanoparticles for prolonged  nitric oxide release, antibacterial efficacy,  and in vivo wound healing activity correspondence: Jin-Wook Yoo college of Pharmacy, Pusan National  University, geumjeong-gu, Busan  609-735, south Korea Tel +82 51 510 2807 Fax +82 51 513 6754 email jinwook@pusan.ac.k r hasan Nurhasni1 Jiafu cao1 Moonjeong choi1 Il Kim2 Bok luel lee1 Yunjin Jung1 Jin-Wook Y oo1 1college of Pharmacy, Pusan National  University, Busan, south Korea;   2Department of Polymer science  and engineering, Pusan National  University, Busan, south KoreaAbstract:  Nitric oxide (NO)-releasing nanoparticles (NPs) have emerged as a wound healing  enhancer and a novel antibacterial agent that can circumvent antibiotic resistance.",Non-OADS,/arxiv_data1/oa_pdf/a7/da/ijn-10-3065.PMC4411019.pdf
Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Nurhasni et al Running head recto: Nitric oxide-releasing PLGA nanoparticles DOI: http://dx.doi.org/10.2147/IJN.S82199,Non-OADS,/arxiv_data1/oa_pdf/a7/da/ijn-10-3065.PMC4411019.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/a7/da/ijn-10-3065.PMC4411019.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a7/da/ijn-10-3065.PMC4411019.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f9/d6/ijn-10-3081.PMC4411020.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3081–3095International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3081OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7955 0Delivery of vincristine sulfate-conjugated gold  nanoparticles using liposomes: a light-responsive  nanocarrier with enhanced antitumor efficiency Ying liu1,* Man he1,* Mengmeng Niu1 Yiqing Zhao1 Yuanzhang Zhu1 Zhenhua li2 Nianping Feng1 1Department of Pharmaceutical  sciences, school of Pharmacy,   shanghai University of Traditional  chinese Medicine, shanghai, People’s  republic of china; 2cedars- sinai  Medical center, los angeles, ca, Usa *These authors contributed equally  to this workAbstract:  Rapid drug release at the specific site of action is still a challenge for antitumor  therapy.",Non-OADS,/arxiv_data1/oa_pdf/f9/d6/ijn-10-3081.PMC4411020.pdf
"Gold nanoparticles have the  unique features of strong light absorption and distinct surface plasmon resonance, and correspondence: Nianping Feng Department of Pharmaceutical sciences,  school of Pharmacy, shanghai University  of Traditional chinese Medicine, 1200  cailun road, Zhangjiang hi-Tech Park,  Pudong New District, shanghai 201203,  People’s republic of china Tel +86 21 5132 2198 Fax +86 21 5132 2198 email npfeng@hotmail.co m;   npfeng@shutcm.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Liu et al Running head recto: VCR-gold nanoparticle conjugates incorporated liposomes DOI: http://dx.doi.org/10.2147/IJN.S79550",Non-OADS,/arxiv_data1/oa_pdf/f9/d6/ijn-10-3081.PMC4411020.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f9/d6/ijn-10-3081.PMC4411020.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/d6/ijn-10-3081.PMC4411020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Women’s Health 2015:7 415–427International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  415RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5459 9Smoking cessation in pregnancy: psychosocial  interventions and patient-focused perspectives Yukiko Miyazaki1 Kunihiko Hayashi2 Setsuko Imazeki1 1Faculty of Health Care, Takasaki  University of Health and Welfare,   Takasaki, 2School of Health Sciences,   Faculty of Medicine, Gunma  University, Maebashi, JapanBackground:  Smoking during pregnancy causes obstetric and fetal complications, and smoking  cessation may have great benefits for the mother and the child.",Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
"Smoking cessation  reduces the risk of complications during delivery and of health problems for the baby,  and furthermore, benefits a woman’s long-term health.Correspondence: Yukiko Miyazaki Faculty of Health Care, Takasaki  University of Health and Welfare,  501 Nakaorui-Machi, Takasaki 370-0033,  Gunma, Japan Tel +81 27 352 1291 Fax +81 27 352 1985 email yukiko@takasaki-u.ac.j p Journal name: International Journal of Women’s Health Article Designation: Review Y ear: 2015 Volume: 7 Running head verso: Miyazaki et al Running head recto: Psychosocial interventions for smoking cessation in pregnancy DOI: http://dx.doi.org/10.2147/IJWH.S54599",Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
"Available  from: http://www.ncbi.nlm.nih.gov/books/NBK190304/pdf/TOC.pd f.  Accessed December 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
"2011 Feb. Avail - able from: http://ash.org.uk/files/documents/ASH_112.pd f. Accessed  June 4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
Available  from: http://www.who.int/tobacco/global_report/2013/appendix_xi/en.,Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0a/71/ijwh-7-415.PMC4411022.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/de/a6/mder-8-185.PMC4411023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pMedical Devices: Evidence and Research 2015:8 185–192Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  185ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/MDER.S7696 0An in vitro comparison of tracheostomy   tube cuffs Seamus Maguire1 Frances Haury2 Korinne Jew2 1Research and Development, Covidien  Respiratory and Monitoring Solutions,   Athlone, Ireland; 2Medical Affairs,   Covidien Respiratory and Monitoring  Solutions, Boulder, CO, USA Correspondence: Korinne Jew   Medical Affairs, Covidien Respiratory and  Monitoring Solutions,  6135 Gunbarrel  Avenue, Boulder, CO 80304, USA   Tel +1 303 305 2509   Fax +1 303 305 2246   Email k ori.jew@covidien.co mIntroduction:  The Shiley™ Flexible adult tracheostomy tube with TaperGuard™ cuff has  been designed through its geometry, materials, diameter, and wall thickness to minimize micro- aspiration of fluids past the cuff and to provide an effective air seal in the trachea while also  minimizing the risk of excessive contact pressure on the tracheal mucosa.",Non-OADS,/arxiv_data1/oa_pdf/de/a6/mder-8-185.PMC4411023.pdf
Available from:  http://www.fda.gov/downloads/MedicalDevices/.../UCM080457.pdf.,Non-OADS,/arxiv_data1/oa_pdf/de/a6/mder-8-185.PMC4411023.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/de/a6/mder-8-185.PMC4411023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 3097–3114International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  3097REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7048 8Magnetic particle imaging: current developments  and future directions Nikolaos Panagiotopoulos1 Robert L Duschka1 Mandy Ahlborg2 Gael Bringout2 Christina Debbeler2 Matthias Graeser2 Christian Kaethner2 Kerstin Lüdtke-Buzug2 Hanne Medimagh2 Jan Stelzner2 Thorsten M Buzug2 Jörg Barkhausen1 Florian M Vogt1 Julian Haegele1 1Clinic for Radiology and Nuclear  Medicine, University Hospital  Schleswig Holstein, Campus Lübeck,   2Institute of Medical Engineering,   University of Lübeck, Lübeck,   GermanyAbstract:  Magnetic particle imaging (MPI) is a novel imaging method that was first proposed  by Gleich and Weizenecker in 2005.",Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
"In 2005, Gleich and Weizenecker wrote a pivotal paper Correspondence: Nikolaos  Panagiotopoulos  Clinic for Radiology and Nuclear  Medicine, University Hospital Schleswig  Holstein, Campus Lübeck, Ratzeburger  Allee 160, 23538 Lübeck, Germany   Email nikolaos.panagiotopoulos@uksh.d eJournal name: International Journal of Nanomedicine Article Designation: REVIEW Y ear: 2015 Volume: 10 Running head verso: Panagiotopoulos et al Running head recto: MPI: developments and future directions DOI: http://dx.doi.org/10.2147/IJN.S70488",Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
Available from: http://www.bruker.com/news- records/single-view/article/bruker-announces-the-worlds-first- preclinical-magnetic-particle-imaging-mpi-system.html.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
Available  from: http://dfg.de/foerderung/info_wissenschaft/archiv/2011/ info_wissenschaft_11_65/index.html.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
Available from: http://www.bruker.com/ de/news-records/single-view/article/bruker-announces-first-customer- installation-of-its-preclinical-magnetic-particle-imaging-mpi-scan.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bc/34/ijn-10-3097.PMC4411024.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/4b/afu146.PMC4411219.pdf
"The City of Rikuzentakata, 2014. http://www.city.",Non-OADS,/arxiv_data1/oa_pdf/fb/4b/afu146.PMC4411219.pdf
"Archive of Recovery Support Survey [cited 2014 3.10].http://fukkou.csis.u-tokyo.ac.jp/ (10 March 2014, date last accessed).",OADS,/arxiv_data1/oa_pdf/fb/4b/afu146.PMC4411219.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/52/afu165.PMC4411221.pdf
"This term is often used  by plant researchers, but it is entirely possible that me- chanical stimuli caused by change in membrane ten - sion, cell wall damage, or the disruption of plasma  membrane–cell wall connections are relevant factors   in osmosensing, in addition to or instead of altered Perspectives on: The response to osmotic challenges The ongoing search for the molecular basis of plant osmosensing Elizabeth S. Haswell1 and Paul E. Verslues2 1Department of Biology, Washington University in Saint Louis, Saint Louis, MO 63130 2Institute of Plant and Microbial Biology, Academia Sinica, Taipei 11529, Taiwan © 2015 Haswell and Verslues  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1146/annurev-phyto-073009-114436 Boudsocq, M., M.J. droillard, H. Barbier-Brygoo, and C. Laurière.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1007/s11103-006-9103-1 Boyer, J.S., and P.J.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1046/j.1365-313x .1998.00276.x Cazale, A.C., M.J. droillard, C. Wilson, E. Heberle-Bors, H. Barbier- Brygoo, and C. Lauriere.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1046/ j.1365-313X.1999.00528.x Cheung, A. y., and H.M. Wu.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1016/j.pbi.2011.09.001 Christmann, A., E. grill, and J. Huang.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1146/ annurev-arplant-042809-112122 Hamann, T. 2012.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
3:77. http://dx.doi.org/10.3389/fpls.2012.00077known.,Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1152/physrev.00038.2011 Hou, C., W. Tian, T. Kleist, K. He, v. garcia, F. Bai, y. Hao, S. Luan,  and L. Li.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1038/cr.2014.14 Knepper, C., E.A.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1104/pp.112.209791 Kurusu, T., K. Kuchitsu, M. nakano, y. nakayama, and H. Iida.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1016/j.tplants.2012.12.002 Long, S.P., and d.r.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1111/ j.1469-8137.2011.03664.x Marshall, A., r.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi .org/10.1105/tpc.112.096677 Monshausen, g.B., and E.S.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1093/jxb/ert204 Parsegian, v.A., r.P.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"259:43– 94. http://dx.doi.org/10.1016/0076-6879(95)59039-0 Pritchard, J.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1093/ emboj/20.20.5556 Saito, H., and F. Posas.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1534/genetics.112.140863 Tran, L.S., T. Urao, F. Qin, K. Maruyama, T. Kakimoto, K. Shinozaki,  and K. yamaguchi-Shinozaki.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1073/ pnas.0706547105 verslues, P.E., and T.E.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1016/j.pbi.2011.04 .006 verslues, P.E., M. Agarwal, S. Katiyar-Agarwal, J. Zhu, and J.K. Zhu.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1111/j.1365-313X.2005 .02593.x verslues, P.E., J.r. Lasky, T.E.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1104/pp.113.224014 Wilson, M.E., M. r. Basu, g.B.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi .org/10.1104/pp.114.236620 Wohlbach, d.J., B.F. Quirino, and M.r.",Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"http://dx.doi.org/10.1105/tpc.107.055871 yoshida, T., J. Mogami, and K. yamaguchi-Shinozaki.",OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
http://dx.doi.org/10.1038/ nature13593,Non-OADS,/arxiv_data1/oa_pdf/bc/3c/JGP_201411295.PMC4411250.pdf
"Water diffuses (or initially flows) into a sponge Perspectives on: The response to osmotic challenges Cell volume control in three dimensions: Water movement without  solute movement Frederick Sachs1 and Mettupalayam V. Sivaselvan2 1Department of Physiology and Biophysics and 2Department of Civil, Structural and Environmental Engineering,  University at Buffalo, The State University of New York, Buffalo, NY 14260 © 2015 Sachs and Sivaselvan  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1021/bi200770q Beyder, A., and F. Sachs.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1063/1 .1712886 Borle, A.B., C.C.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"24:1628– 1635. http://dx.doi.org/10.1016/j.cub.2014.05.069 Bowman, C.L., P.A.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/j.toxicon .2006.09.030 Chamberlin, M.E., and K. Strange.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/ 10.1115/1.1688774 Charras, G.T., J.C. Yarrow, M.A.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1038/ nature03550 Charras, G.T., T.J. Mitchison, and L. Mahadevan.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1242/ jcs.049262 Cheng, A.H.-D., T. Badmus, and D.E.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
http://dx.doi.org/10.1061/ (ASCE)0733-9399(1991)117:5(1136) Tr m mv = − =σεε 2 3; .,OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1152/ajpcell.00503.2009 Huang, H., C. Bae, F. Sachs, and T.M.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1371/journal.pone.0072894 Johnson, K.L.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"317:663– 666. http://dx.doi.org/10.1126/science.1139857 Kim, K.M., Y.J.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1371/journal.pone .0092427 Kregenow, F.M.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1146/annurev.ph.43.030181  .002425 Kung, C. 2005.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1038/nature03896 Kung, C., B. Martinac, and S. Sukharev.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/ S0006-3495(81)84817-5 Lang, F., and E.K.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1113/jphysiol.2013.258632 Lauritzen, I., J. Chemin, E. Honoré, M. Jodar, N. Guy, M. Lazdunski,  and A. Jane Patel.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1038/sj.embor.7400449 Lieber, A.D., S. Yehudai-Resheff, E.L. Barnhart, J.A.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/j.febslet .2009.01.027 MacGillivray, A.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1063/1.1669549 Maneshi, M.M., F. Sachs, and S.Z.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/j.bbamem.2013.07.015 Martinac, B., T. Nomura, G. Chi, E. Petrov, P.R.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1126/science .7973655 Evans, E., and D. Needham.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1039/dc9868100267 Evans, E., and D. Needham.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1371/journal.pone.0002327 Guharay, F., and F. Sachs.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
http://dx.doi.org/10.1113/jphysiol.1984.,OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.163550 Heo, J., F. Sachs, J. Wang, and S.Z.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1159/000339033 Herant, M., W.A.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/S0006-3495(03)70062-9 Hill, T.L.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/S0021-9290(99) 00175-X Hodgkin, A.L., and P. Horowicz.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1113/jphysiol .1959.sp006278 Hoffman, B.D., and J.C. Crocker.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1146/annurev.bioeng.10.061807  .160511 Hoffmann, E.K., I.H.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1152/physrev.00037.2007 Hoffmann, E.K., N.B.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
http://dx.doi.org/10.1002/iub.1266,Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/ j.neulet.2014.03.072 Savitz, D., V.W.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi .org/10.1085/jgp.48.1.79 Spagnoli, C., A. Beyder, S. Besch, and F. Sachs.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"78:031916. http://dx.doi.org/10.1103/ PhysRevE.78.031916 Stewart, M.P., J. Helenius, Y. Toyoda, S.P.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/j.bpj.2009.05.018 Taber, L.A., Y. Shi, L. Yang, and P.V.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.2140/jomms.2011.6.569 Trombetta, G., C. Di Bona, and E. Grazi.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/ j.ijbiomac.2004.11.002 Wan, X., J.A.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1007/BF00233304 Wang, H.F. 2000a.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1007/s10254-003-0009-x Whitaker, S. 1986.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi .org/10.1007/BF01036523 Williams, R., H. Meryman, M.S.J.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1007/978-94-011-5716-2_79 Xu, K., H.P.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1038/ nmeth.1841 Zou, S., R. Chisholm, J.S.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1111/j.1742- 4658.2008.06461.x Mills, J.W., and D.J.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1038/nmat3517 Mohandas, N., and E. Evans.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1126/ science.1706535 Nieto, A., D. Salvatori, M. Castro, and S. Alzamora.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1016/S0260-8774 (03)00108-0 Odijk, T. 1979.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/ 10.1021/ma60070a028 Parsegian, V.A., R.P.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"359:1277– 1285. http://dx.doi.org/10.1098/rstb.2004.1504 Rey, J., and M. Vandamme.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"80:020908.  http://dx.doi.org/10.1115/1.4007906 Rice, J.R. 1998.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"Available at http://esag.harvard.edu/rice/e2_Poroelasticity  .pdf (accessed March 30, 2015).",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"http://dx.doi.org/10.1029/ RG014i002p00227 Ricka, J., and T. Tanaka.",OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"17:2916– 2921. http://dx.doi.org/10.1021/ma00142a081 Sachs, F. 2015.",Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
http://dx.doi.org/10.1007/BFb0004985,Non-OADS,/arxiv_data1/oa_pdf/65/f4/JGP_201411297.PMC4411252.pdf
"However, in the ABCC family (and  certain other transporters), CS1 contains modifications  in certain key residues that prevent this “degenerate” site New structural insights into the gating movements of CFTR Michael C. Puljung Department of Physiology, Anatomy & Genetics, University of Oxford, Oxford OX1 3PT, England, UK © 2015 Puljung  This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1085/jgp .200308798 Carson, M.R., S.M.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1074/ jbc.270.4.1711 Chaves, L.A.P., and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi .org/10.1085/jgp.201411347 Csanády, L., K.W.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"125:43– 55. http://dx.doi.org/10.1085/jgp.200409174 Csanády, L., P. Vergani, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10 .1038/nature05155 Eckford, P.D., C. Li, M. Ramjeesingh, and C.E.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1074/ jbc.M112.393637 Gunderson, K.L., and R.R.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1016/0092-8674 (95)90310-0 Hohl, M., C. Briand, M.G.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi .org/10.1038/nsmb.2267 Hohl, M., L.M.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"23:282– 293. http://dx.doi.org/10.1038/sj.emboj.7600040 Li, J., K.F.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1002/ pro.2387 Mense, M., P. Vergani, D.M.",Non-OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1038/sj.emboj .7601373 ter Beek, J., A. Guskov, and D.J.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
http://dx.doi .org/10.1085/jgp.201411164MTS-rhodamine.,OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1085/jgp .201010399 Vergani, P., A.C. Nairn, and D.C. Gadsby.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"http://dx.doi.org/10.1085/jgp .20028673Vergani, P., S.W.",OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
http://dx.doi .org/10.1073/pnas.0709388104,Non-OADS,/arxiv_data1/oa_pdf/23/b7/JGP_201511399.PMC4411253.pdf
"4 becomes  Π = − ⋅ −( ) { } − − ( ) { } ( ) ≈ ⋅ ( )−( ) ( )≈ ⋅RT Vx i x e RT Vx i x e RT CWS S WS S Sln ln 1 1 ii C e ( )−( ) ( ) S ,  (5)Perspectives on: The response to osmotic challenges Olaf S. Andersen Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065 © 2015 Andersen  This article is distributed under the terms of an Attribution–Noncommer­ cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"After six months it is available under a Creative Com­ mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by ­nc­sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
Letters should be prepared ac - cording to The Journal’s Instructions and submitted at http://www.jgp.org.,Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"http://dx.doi.org/10.1152/physrev.00037.2007 Hunter, F.T.",Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"http://dx.doi.org/10.1172/JCI101172 Luby-Phelps, K. 1999.",OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"http://dx.doi.org/10.1016/S0074- 7696(08)60527-6 Mauro, A.",OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"http://dx.doi.org/10.1126/science.149.3686.867 Mauro, A.",Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"22:117– 126. http://dx.doi.org/10.1016/j.copbio.2010.09.009 Solomon, A.K., M.R.",OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"http://dx.doi.org/ 10.1007/BF01868819 Stoddard, J.S., J.H.",Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
http://dx.doi.org/10.1007/BF00233304which is the Van ’t Hoff expression.,Non-OADS,/arxiv_data1/oa_pdf/6b/72/JGP_201511397.PMC4411254.pdf
"Bernhard E. Flucher Section of Physiology, Medical University Innsbruck, 6020 Innsbruck, Austria © 2015 Flucher  This article is distributed under the terms of an Attribution–Noncommercial–  Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1074/jbc .274.31.21913 Hidalgo, C., M.A.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1016/0014-5793(86)80651-2 Hille, B., E.J.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1016/j.bbalip.2014.09.010 Kobayashi, M., A. Muroyama, and Y. Ohizumi.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1016/0006-291X(89) 91147-9 Kurokawa, T., S. Takasuga, S. Sakata, S. Yamaguchi, S. Horie, K.J.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10 .1016/0304-4157(94)00014-5 Ogawa, Y., and H. Harafuji.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1139/y99-017 Okamura, Y., Y. Murata, and H. Iwasaki.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/ 10.1152/ajpcell.00008.2010 Ríos, E., G. Pizarro, and E. Stefani.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi .org/10.1146/annurev.ph.54.030192.000545 Rousset, M., T. Cens, A. Gouin-Charnet, F. Scamps, and P. Charnet.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"279:14619– 14630. http://dx.doi.org/10.1074/jbc.M313284200 Schredelseker, J., V. Di Biase, G.J.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1016/j .neuron.2010.07.001 Weiss, R.G., K.M.S.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10 .1152/ajpcell.00173.2004According to the regulation in space hypothesis, PI(4,5) P2 interactions could stabilize normal channel function  in the appropriate membrane compartment, whereas, in membrane compartments lacking PI(4,5)P 2, channel  function would be inhibited.",Non-OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1073/ pnas.1313364111 Berthier, C., C. Kutchukian, C. Bouvard, Y. Okamura, and V.  Jacquemond.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
"http://dx.doi.org/10.1085/jgp .201411309 Chu, A., and E. Stefani.",OADS,/arxiv_data1/oa_pdf/cc/e9/JGP_201511395.PMC4411255.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
The  online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201511361/DC1.,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1007/ s00424­012­1195­7 Giordanetto, F., L. Knerr, and A. Wållberg.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"21:85– 101. http://dx.doi.org/10.1517/13543776.2011.536532 Godfraind, T. 2014.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1006/ jtbi.2000.2113 Harraz, O.F., and D.G.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1242/jcs.128363 Harraz, O.F., R.R.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi .org/10.1038/sj.bjp.0705841 Knot, H.J., and M.T.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi .org/10.1111/j.1469­7793.1998.199br.x Kumar, S., and R.J. Hall.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.2165/ 00002512­200320110­00002 Kuo, I.Y., A. Ellis, V.A.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"30:1226– 1239. http://dx.doi.org/10.1038/jcbfm.2010.11 Lee, J.H., J.C. Gomora, L.L.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1016/S0006­3495(99)77134­1 Li, Z., X. Wang, G. Gao, D. Qu, B. Yu, C. Huang, K.S.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1007/ s00232­009­9221­1 Liao, P., D. Yu, G. Li, T.F.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"282:35133– 35142. http://dx.doi.org/10.1074/jbc.M705478200 Monteil, A., J. Chemin, V. Leuranguer, C. Altier, G. Mennessier,  E. Bourinet, P. Lory, and J. Nargeot.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1074/ jbc.C000090200 Moosmang, S., V. Schulla, A. Welling, R. Feil, S. Feil, J.W.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1093/emboj/cdg583 Navedo, M.F., G.C.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1152/ajpheart.00476.2012 Bayliss, W.M.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi .org/10.1113/jphysiol.1902.sp000911 Beltrame, J.F., S.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1016/j.jacc.2004.03.055 Björling, K., H. Morita, M.F.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1111/apha.12066 Bowles, D.K., K.K.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1101/csh­perspect.a003947 Chemin, J., A. Monteil, E. Perez­Reyes, E. Bourinet, J. Nargeot, and  P. Lory.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1113/ jphysiol.2001.013269 Chen, C.C., K.G.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1016/j.abb.2011.02.024 Cui, W., D.D.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1093/nar/gkl767 Faraci, F.M., and D.D.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1161/01.RES.66.1.8 Filosa, J.A., A.D. Bonev, S.V.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1038/nn1779 Frazier, C.J., J.R. Serrano, E.G.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1371/journal.pone.0088975 Furchgott, R.F., and J.V.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1038/288373a0 Gallagher, P.J., B.P.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
http://dx.doi.org/ 10.1023/A:1018616814417,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi .org/10.1152/physrev.00018.2002 Pries, A.R., T.W.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1161/01.RES.67.4.826 Pries, A.R., T.W.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1161/01 .RES.75.5.904 Segal, S.S. 2000.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1046/j.1365­201x.2000.00703.x Sugano, N., K. Hayashi, T. Hosoya, and T. Yokoo.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.2174/15734021 0903140415124048 Thuesen, A.D., H. Andersen, M. Cardel, A. Toft, S. Walter, N. Marcussen,  B.L.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1152/ajprenal.00016.2014 Ullrich, N.D., A. Koschak, and K.T.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1016/j.bbrc.2007.07.054 Welsh, D.G., M.T.",OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
"http://dx.doi.org/10.1111/ j.1469­7793.2000.t01­1­00139.x Welsh, D.G., A.D. Morielli, M.T.",Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
http://dx.doi.org/10 .1161/hh0302.105662,Non-OADS,/arxiv_data1/oa_pdf/1c/fc/JGP_201511361.PMC4411256.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
The online supplemental material is available at http://www.jgp.org/cgi/content/full/jgp.201411288/DC1.,Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"The control parameters in the I Ca,L formulation were determined  by fitting formulated current to experimental nifedipine-sensitive I Ca,L records (Madhvani et al., 2011) using Berkeley Madonna and  then implemented for dynamic clamp in RTXI (http://www.rtxi .org; Lin et al., 2010).",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/01.RES.69.6.1427 Asano, Y., J.M.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/S0735-1097(96)00588-8 Bapat, A., T.P.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1152/ ajpheart.00094.2012 Catterall, W.A.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10 .1146/annurev.cellbio.16.1.521 Chang, M.G., D. Sato, E. de Lange, J.H.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/j.hrthm.2011.08.014 Chen, P.S., T.J. Wu, C.T.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/01.CIR.0000094404.26004.07 Choi, B.R., F. Burton, and G. Salama.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/ 01.RES.79.3.474 Gotoh, Y., Y. Imaizumi, M. Watanabe, E.F. Shibata, R.B.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10 .1016/j.yjmcc.2009.09.019 January, C.T., and J.M.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/01.RES.64.5.977 January, C.T., J.M.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/01.RES.62.3.563 Karwatowska-Prokopczuk, E., W. Wang, M.L.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"15:429– 436. http://dx.doi.org/10.1093/europace/eus400 Lin, R.J., J. Bettencourt, J. Wha Ite, D.J.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"589:6081– 6092. http://dx.doi.org/10.1113/jphysiol.2011.219600 Mahajan, A., Y. Shiferaw, D. Sato, A. Baher, R. Olcese, L.H.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
http://dx.doi.org/10.1529/ biophysj.106.98160Off-target effects of nifedipine.,Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1093/europace/eum166 Antzelevitch, C., and S. Sicouri.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/0735-1097(94)90529-0 Antzelevitch, C., S. Sicouri, S.H.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1371/ journal.pone.0043587 Qu, Z., L.H.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1093/cvr/cvt104 Rose, W.C., C.W.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/0002-9149(88)90735-7 Sato, D., L.H.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/S0006- 3495(03)74784-5 Song, Y., J.C. Shryock, S. Wagner, L.S.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1124/ jpet.106.101832 Tohse, N. 1990.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"102:258103. http://dx.doi.org/10 .1103/PhysRevLett.102.258103 Verkerk, A.O., A. Baartscheer, J.R. de Groot, R. Wilders, and R.  Coronel.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi .org/10.1016/j.ijcard.2009.10.047Wagner, S., H.M. Ruff, S.L.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/ CIRCRESAHA.110.221911 Ward, C.A., and W.R. Giles.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"500:631– 642. http://dx.doi.org/10.1113/jphysiol.1997.sp022048 Weber, C.R., V. Piacentino III, K.S.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/j.hrthm.2010 .09.017 Wit, A.L., and M.R.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi .org/10.1016/0002-8703(83)90003-0 Wu, J., J. Wu, and D.P.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10 .1161/CIRCRESAHA.108.183475 Xie, Y., D. Sato, A. Garfinkel, Z. Qu, and J.N.",Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1016/ j.bpj.2010.06.042 Yan, G.X., Y. Wu, T. Liu, J. Wang, R.A. Marinchak, and P.R.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/01 .CIR.103.23.2851 Yang, P.C., J. Kurokawa, T. Furukawa, and C.E.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1371/journal.pcbi.1000658 Yang, T., T.C.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.112.265173 Zeng, J., and Y. Rudy.",OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
68:949– 964. http://dx.doi.org/10.1016/S0006-3495(95)80271-7,Non-OADS,/arxiv_data1/oa_pdf/25/a9/JGP_201411288.PMC4411259.pdf
This article is distributed under the terms of an Attribution–Noncom- mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
The online supplemental material is available  at http://www.jgp.org/cgi/content/full/jgp.201511377/DC1.,Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"1594:127– 135. http://dx.doi.org/10.1016/S0167-4838(01)00296-5 Malavasi, F., S. Deaglio, A. Funaro, E. Ferrero, A.L.",Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1152/ physrev.00035.2007 McHugh, D., R. Flemming, S.Z.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1074/jbc.M210810200 Moreau, C., T. Kirchberger, J.M.",Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"56:10079– 10102. http://dx.doi.org/10.1021/jm401497a Nagamine, K., J. Kudoh, S. Minoshima, K. Kawasaki, S. Asakawa, F.  Ito, and N. Shimizu.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1006/geno.1998.5551 Olah, M.E., M.F.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1113/jphysiol.2008.162289 Perraud, A.L., A. Fleig, C.A.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1016/S0143- 4160(03)00057-5 Perraud, A.L., B. Shen, C.A.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1074/jbc.M205601200 Perraud, A.L., C.L.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"280:6138– 6148. http://dx.doi.org/10.1074/jbc.M411446200 Sano, Y., K. Inamura, A. Miyake, S. Mochizuki, H. Yokoi, H.  Matsushime, and K. Furuichi.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10 .1126/science.1062473 Schmid, F., S. Bruhn, K. Weber, H.W.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"585:3544– 3548. http://dx.doi.org/10.1016/j.febslet.2011.10.017 Togashi, K., Y. Hara, T. Tominaga, T. Higashi, Y. Konishi, Y. Mori,  and M. Tominaga.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601083 Tóth, B., and L. Csanády.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1073/ pnas.1204702109 Tóth, B., I. Iordanov, and L. Csanády.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"270:30327– 30333. http://dx.doi.org/10.1074/jbc.270.51.30327 Beck, A., M. Kolisek, L.A. Bagley, A. Fleig, and R. Penner.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1096/fj.05-5538fje Brailoiu, E., D. Churamani, X. Cai, M.G.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1038/nature08030 Churamani, D., E.A.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10 .1042/BJ20031754 Csanády, L., and B. Törocsik.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi .org/10.1085/jgp.200810109 Fliegert, R., A. Gasser, and A.H. Guse.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1042/BST0350109 Fonfria, E., I.C.",Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1111/j.1471- 4159.2005.03396.x Hara, Y., M. Wakamori, M. Ishii, E. Maeno, M. Nishida, T. Yoshida, H.  Yamada, S. Shimizu, E. Mori, J. Kudoh, et al.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/ 10.1016/S1097-2765(01)00438-5 Hermosura, M.C., A.M. Cui, R.C.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi .org/10.1073/pnas.0808218105 Kaneko, S., S. Kawakami, Y. Hara, M. Wakamori, E. Itoh, T. Minami,  Y. Takada, T. Kume, H. Katsuki, Y. Mori, and A. Akaike.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1254/ jphs.FP0060128 Koch-Nolte, F., F. Haag, A.H. Guse, F. Lund, and M. Ziegler.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1126/scisignal.257mr1 Kolisek, M., A. Beck, A. Fleig, and R. Penner.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10 .1016/j.molcel.2005.02.033 Lange, I., R. Penner, A. Fleig, and A. Beck.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1073/ pnas.1412449111 Uchida, K., K. Dezaki, B. Damdindorj, H. Inada, T. Shiuchi, Y. Mori,  T. Yada, Y. Minokoshi, and M. Tominaga.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.2337/db10-0276 Wang, X., X. Zhang, X.P.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10 .1016/j.cell.2012.08.036Wehage, E., J. Eisfeld, I. Heiner, E. Jüngling, C. Zitt, and A. Lückhoff.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
"http://dx.doi.org/10.1074/jbc.M112096200 Yamamoto, S., S. Shimizu, S. Kiyonaka, N. Takahashi, T. Wajima,  Y. Hara, T. Negoro, T. Hiroi, Y. Kiuchi, T. Okada, et al.",OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
http://dx.doi.org/10.1038/nm1758,Non-OADS,/arxiv_data1/oa_pdf/b2/3c/JGP_201511377.PMC4411260.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201408118/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/   journal.pgen.100466 6 Byers, B., and L. Goetsch.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/journal.pgen.100093 5 Chen, J., C.J.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.20130704 3 Chu, S., and I. Herskowitz.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/   jcb.20110800 6 Miller, M.P., E. Unal, G.A.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.50.2.34 4 Newnham, L., P.W.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/journal.pone.008398 2 Niepel, M., C. Strambio-de-Castillia, J. Fasolo, B.T.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.20050414 0 Nigg, E.A., and T. Stearns.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1038/ncb234 5 Nishikawa, S., Y .",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.04 4 Padmore, R., L. Cao, and N. Kleckner.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/0092-   8674(91)90046- 2 Rock, J.M., D. Lim, L. Stach, R.W.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1126/   science.123582 2 Shirk, K., H. Jin, T.H.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi   .org/10.1242/jcs.08665 2 Sosa, B.A., A. Rothballer, U. Kutay, and T.U.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/j   .cell.2012.03.04 6 Sourirajan, A., and M. Lichten.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1101/gad.171140 8 Spang, A., I. Courtney, K. Grein, M. Matzner, and E. Schiebel.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10   .1083/jcb.128.5.86 3 Tapley, E.C., and D.A.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 4 Vallen, E.A., W. Ho, M. Winey, and M.D.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/journal.pgen.100018 8 Wang, W., Z. Shi, S. Jiao, C. Chen, H. Wang, G. Liu, Q. Wang, Y .",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi   .org/10.1038/cr.2012.12 6 Winey, M., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1534/genetics.111.12871 0 Wu, H.Y ., and S.M.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"26:3683– 3694. http://dx.doi.org/10.1128/MCB.26.10.3683-3694.200 6 Xu, L., M. Ajimura, R. Padmore, C. Klein, and N. Kleckner.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1126/   science.276.5316.125 2 Conrad, M.N., C.Y .",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.04.04 7 Crasta, K., H.H.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1038/ncb172 9 Elserafy, M., M. Šari ć, A. Neuner, T.C.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/j.cub.2014.05.03 2 Friederichs, J.M., S. Ghosh, C.J.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/journal.pgen.100236 5 Haase, S.B., M. Winey, and S.I.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1038/3505054 3 Hiraoka, Y ., and A.F.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1016/j.devcel.2009   .10.01 4 Jaspersen, S.L., and M. Winey.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.20.022003.11410 6 Jaspersen, S.L., T.H.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi   .org/10.1083/jcb.20020816 9 Jaspersen, S.L., A.E.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.20060106 2 Jin, H., V .",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.20081010 7 Kilmartin, J.V .",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1083/jcb.20030706 4 Kim, S., R. Meyer, H. Chuong, and D.S.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1101/gad.227454.11 3 Knop, M., G. Pereira, S. Geissler, K. Grein, and E. Schiebel.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi   .org/10.1093/emboj/16.7.155 0 Kosaka, H., M. Shinohara, and A. Shinohara.",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1371/journal.pgen.100019 6 Lee, B.H., and A. Amon.",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi   .org/10.1126/science.108184 6 Li, S., A.M. Sandercock, P. Conduit, C.V .",OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"http://dx.doi.org/10.1007/s10577-011-9253- 0 Lim, H.H., P.Y .",Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2- U,Non-OADS,/arxiv_data1/oa_pdf/66/98/JCB_201408118.PMC4411264.pdf
"Since then, our production team Reproducibility and cell biology Kenneth M. Yamada1,3 and Alan Hall2,4 1Academic Editor and 2Editor-in-Chief, The Journal of Cell Biology 3Laboratory of Cell and Developmental Biology, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892 4Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065 Correspondence to Kenneth M. Yamada: kenneth   .yamada@nih.gov; or Alan Hall: halla@mskcc.org© 2015 Yamada and Hall  This article is distributed  under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"Experiments  should include a sufficient number of  independent replications when practi - cal, sufficiently large sample sizes with  convincing magnitudes of effects (or  no effect), and, when appropriate, other   best-practice approaches including ran - domization, observer blinding, validation   of cell lines, and appropriate statistical  analysis as described in recent guidelines   from journal editors (http://www.nih.gov/   about/reporting-preclinical-research.htm).",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"The National Institutes of   Health is holding workshops on research   reproducibility (e.g., http://videocast.nih   .gov/summary.asp?Live=15277&bhcp=1)   and is supporting research toward this  aim through the R25 funding mecha - nism.",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"http://dx.doi.org/10.1038/   505612 a Hines, W.C., Y. Su, I. Kuhn, K. Polyak, and M.J.  Bissell.",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"http://dx.doi.org/10.1038/nature1155 6 Madsen, D.H., and T.H.",OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"10:712. http://dx.doi   .org/10.1038/nrd3439-c 1 Rossner, M. 2002.",OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"158:1151.  http://dx.doi.org/10.1083/jcb.20020908 4 Schultz, N., D.R.",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"2:3. http://dx.doi.org/   10.1186/1758-907X-2- 3 Tschaharganeh, D., V. Ehemann, T. Nussbaum,  P. Schirmacher, and K. Breuhahn.",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"http://dx.doi.org/10   .1007/BF0289348 2 Williams, E.H., P. Carpentier, and T. Misteli.",Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
"http://dx.doi.org/10.1083/jcb   .20120711 7 Wolf, K., M. Te Lindert, M. Krause, S. Alexander,  J. Te Riet, A.L.",OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
http://dx.doi   .org/10.1083/jcb.20121015 2,Non-OADS,/arxiv_data1/oa_pdf/89/32/JCB_201503036.PMC4411270.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1242/   jcs.14438 6 Bartee, E., M. Mansouri, B.T.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1128/JVI.78.3.1109-1120.200 4 Bays, N.W., R.G.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1038/3505052 4 Becker, T., S. Bhushan, A. Jarasch, J.P. Armache, S. Funes, F. Jossinet, J.  Gumbart, T. Mielke, O. Berninghausen, K. Schulten, et al.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1126/   science.117853 5 Biederer, T., C. Volkwein, and T. Sommer.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1083/jcb.109.1.7 3 Bonifacino, J.S., C.K.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1126/science.229459 5 Brodsky, J.L., and W.R. Skach.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10   .1016/j.ceb.2011.05.00 4 Carvalho, P., V. Goder, and T.A.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1016/j.cell.2006.05.04 3 Christianson, J.C., and Y. Ye.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi   .org/10.1038/nsmb.279 3 Corcoran, K., M. Jabbour, C. Bhagwandin, M.J. Deymier, D.L.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1074/ jbc.M110.20404 0 Coscoy, L., and D. Ganem.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1172/JCI1243 2 Deak, P.M., and D.H. Wolf.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10   .1074/jbc.M00860820 0 Deng, M., and M. Hochstrasser.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1038/nature0517 0 Feige, M.J., and L.M.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"51:297– 309. http://dx.doi.org/10.1016/j.molcel.2013.07.01 3 Feng, D., X. Zhao, C. Soromani, J. Toikkanen, K. Römisch, S.S. Vembar, J.L.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi   .org/10.1074/jbc.M70184020 0 Finke, K., K. Plath, S. Panzner, S. Prehn, T.A.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201408088/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi   .org/10.1016/j.molcel.2009.03.01 0 Schuldiner, M., J. Metz, V. Schmid, V. Denic, M. Rakwalska, H.D.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"134:634– 645. http://dx.doi.org/10.1016/j.cell.2008.06.02 5 Shao, S., and R.S.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1146/annurev-cellbio-092910-15412 5 Stolz, A., S. Besser, H. Hottmann, and D.H. Wolf.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1371/ journal.pone.004519 4 Swanson, R., M. Locher, and M. Hochstrasser.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1101/gad.93330 1 Toikkanen, J., E. Gatti, K. Takei, M. Saloheimo, V.M.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(199604)12:5<425::AID-YEA924>3.0.CO;2- B Van den Berg, B., W.M.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/nature0221 8 Varshavsky, A.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1016/0092-8674(91)90202- A Vashist, S., and D.T.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1083/jcb.20030913 2 Vembar, S.S., and J.L.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1093/emboj/20.12.312 4 Wang, X., L. Lybarger, R. Connors, M.R.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1128/JVI   .78.16.8673-8686.200 4 Wang, X., R.A. Herr, and T. Hansen.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1016/j.semcancer.2008.09.00 2 Ye, Y., H.H.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/414652 a Zattas, D., and M. Hochstrasser.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.3109/10409238.2014.95988 9 Zhao, X., and J. Jäntti.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"10:76. http://dx.doi.org/10.1186/1471-2121-10-7 6Foresti, O., A. Ruggiano, H.K.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/nrm322 6 Hegde, R.S., and H.L.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10   .1016/j.ceb.2010.05.00 5 Hill, K., and A.A. Cooper.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"19:550– 561. http://dx.doi.org/10.1093/emboj/19.4.55 0 Hirsch, C., R. Gauss, S.C. Horn, O. Neuber, and T. Sommer.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/nature0796 2 Hochstrasser, M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/nature0795 8 Huyer, G., W.F.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1074/jbc.M40246820 0 Kinch, L.N., M.H.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1016/S0968-0004(01)02055- 2 Kreft, S.G., and M. Hochstrasser.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi   .org/10.1074/jbc.M110.19636 0 Kreft, S.G., L. Wang, and M. Hochstrasser.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1074/jbc.M51221520 0 Lee, D.H., and A.L.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10   .1016/S0962-8924(98)01346- 4 Leroux, A., and L.A. Rokeach.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1371/journal.pone.000388 0 Loayza, D., A. Tam, W.K.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1091/mbc.9.10.276 7 Mandon, E.C., S.F.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1101/cshperspect.a01334 2 Mehnert, M., T. Sommer, and E. Jarosch.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/ncb288 2 Nakatsukasa, K., G. Huyer, S. Michaelis, and J.L.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.02 3 Nathan, J.A., and P.J.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1016/j.yexcr.2008.10.02 6 Panzner, S., L. Dreier, E. Hartmann, S. Kostka, and T.A.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/   10.1016/0092-8674(95)90077- 2 Park, E., and T.A.",OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
"http://dx.doi.org/10.1038/sj.emboj.760094 6 Rubenstein, E.M., S.G. Kreft, W. Greenblatt, R. Swanson, and M. Hochstrasser.",Non-OADS,/arxiv_data1/oa_pdf/c4/03/JCB_201408088.PMC4411271.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201501090/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"102:817– 826. http://dx.doi.org/10.1016/S0092-8674(00)00070- 2 Asai, K., C. Platt, and A. Cochrane.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/   10.1016/S0042-6822(03)00400- 8 Basilico, F., S. Maffini, J.R. Weir, D. Prumbaum, A.M. Rojas, T. Zimniak, A.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.7554/eLife.0297 8 Bassik, M.C., M. Kampmann, R.J. Lebbink, S. Wang, M.Y .",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi   .org/10.1016/j.devcel.2008.11.00 5 Liu, D., X. Ding, J.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1074/ jbc.M60902620 0 Liu, S.T., J.C. Hittle, S.A. Jablonski, M.S.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"5:341– 345. http://dx.doi.org/10.1038/ncb95 3 Lynch-Day, M.A., D. Bhandari, S. Menon, J. Huang, H. Cai, C.R.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/j.febslet.2006   .03.08 1 Mayya, V., D.H. Lundgren, S.I.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1126/scisignal.200000 7 McEwen, B.F., G.K. Chan, B. Zubrowski, M.S.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi   .org/10.1091/mbc.12.9.277 6 Meraldi, P., and P.K.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi   .org/10.1038/sj.emboj.760064 1 Ohta, S., J.C. Bukowski-Wills, L. Sanchez-Pulido, F.L.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/   10.1016/j.cell.2010.07.04 7 Pines, J., and T. Hunter.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/0092-   8674(89)90936- 7 Putkey, F.R., T. Cramer, M.K.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/S1534-5807(02)00255- 1 Robinson, M.S., D.A.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.12.01 5 Royle, S.J.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1111/j.1600-0854.2011   .01184. x Sacher, M., Y. Jiang, J. Barrowman, A. Scarpa, J. Burston, L. Zhang, D.  Schieltz, J.R. Yates III, H. Abeliovich, and S. Ferro-Novick.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10   .1093/emboj/17.9.249 4 Sacher, M., J. Barrowman, W. Wang, J. Horecka, Y. Zhang, M. Pypaert, and  S. Ferro-Novick.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10   .1016/S1097-2765(01)00190- 3 Sacher, M., Y.G.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
http://dx.doi.org/10.1111/j.1600-0854.2008.00833.,Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1038/emboj.2009.17 3 Schaar, B.T., G.K. Chan, P. Maddox, E.D.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/jcb.139.6.137 3 Scrivens, P.J., B. Noueihed, N. Shahrzad, S. Hul, S. Brunet, and M. Sacher.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1091/mbc.E10-11-087 3 Shevchenko, A., H. Tomas, J. Havliš, J.V.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
http://dx.doi.org/10.1038/nprot   .2006.46 8mammalian genetic interaction map reveals pathways underlying ricin sus - ceptibility.,OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/j.cell.2013.01.03 0 Cai, H., Y. Zhang, M. Pypaert, L. Walker, and S. Ferro-Novick.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/jcb.20050514 5 Cheeseman, I.M.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1101/cshperspect.a01582 6 Cheeseman, I.M., and A. Desai.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi   .org/10.1038/nrm231 0 Cheeseman, I.M., J.S.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/j.cell   .2006.09.03 9 Cleveland, D.W., Y. Mao, and K.F.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"112:407– 421. http://dx.doi.org/10.1016/S0092-8674(03)00115- 6 Clute, P., and J. Pines.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1038/   1004 9 Corda, D., M.L.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1002/iub.105 4 Dephoure, N., C. Zhou, J. Villén, S.A. Beausoleil, C.E.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1073/   pnas.080513910 5 Ditchfield, C., V.L.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/jcb   .20020809 1 Errico, A., K. Deshmukh, Y. Tanaka, A. Pozniakovsky, and T. Hunt.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1016/j.advenzreg.2009.12.00 1 Gascoigne, K.E., and I.M.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/   10.1016/j.ceb.2010.07.00 7 Gascoigne, K.E., and I.M.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/jcb.20130100 6 Ghosh, A.K., M. Majumder, R. Steele, R.A. White, and R.B.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1128/MCB.21.2.655-662.200 1 Ghosh, A.K., R. Steele, and R.B.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"278:24033– 24038. http://dx.doi.org/10.1074/jbc.M21198220 0 Hendzel, M.J., Y. Wei, M.A.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10   .1007/s00412005025 6 Hornung, P., P. Troc, F. Malvezzi, M. Maier, Z. Demianova, T. Zimniak, G.  Litos, F. Lampert, A. Schleiffer, M. Brunner, et al.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/jcb   .20140308 1 Huang, Y., W. Wang, P. Yao, X. Wang, X. Liu, X. Zhuang, F. Yan, J. Zhou, J.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1074/jbc.M111.27719 4 Johnson, V .L., M.I.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1126/scisignal.200149 7 Kulukian, A., J.S.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1091/mbc.E03-07-048 2 Thingholm, T.E., T.J. Jørgensen, O.N.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1038/nprot.2006.18 5 Tipton, A.R., K. Wang, P. Oladimeji, S. Sufi, Z. Gu, and S.T.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"13:15.  http://dx.doi.org/10.1186/1471-2121-13-1 5 Varma, D., and E.D.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi   .org/10.1242/jcs.09372 4 Weaver, B.A., Z.Q.",OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1083/   jcb.20030316 7 Yao, X., K.L.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"http://dx.doi.org/10.1038/359536a 0 Zhang, X.D., J. Goeres, H. Zhang, T.J.",Non-OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
http://dx.doi.org/10.1016/j.molcel.2008.01.01 3,OADS,/arxiv_data1/oa_pdf/da/58/JCB_201501090.PMC4411272.pdf
"Nap1 glutamylation increased the deposi - tion of H1M on sperm nuclei and chromatin-coated beads,  indicating that charge-shifting posttranslational modifica - tion of Nap1 contributes to H1M dynamics that are essen - tial for higher order chromosome architecture.Glutamylation of Nap1 modulates histone H1  dynamics and chromosome condensation in Xenopus Kelly E. Miller and Rebecca Heald Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA 94720 © 2015 Miller and Heald  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1093/bfgp/ell02 0 Avvakumov, N., A. Nourani, and J. Côté.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/   10.1016/j.molcel.2011.02.01 3 Banaszynski, L.A., C.D.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/j.ymeth.2009.12.01 4 Campos, E.I., J. Fillingham, G. Li, H. Zheng, P. Voigt, W.-H.W.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1038/nsmb.191 1 Chang, L., S.S. Loranger, C. Mizzen, S.G. Ernst, C.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1021/bi962069 i Cociorva, D., D. L Tabb, and J.R. Yates.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1038/nsmb131 8 Dworkin-Rastl, E., H. Kandolf, and R.C.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1006/dbio.1994.104 2 Eddé, B., J. Rossier, J.P.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1126/science.196719 4 Eitoku, M., L. Sato, T. Senda, and M. Horikoshi.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1007/s00018-007-7305- 6 Elsässer, S.J., and S. D’Arcy.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
http://dx.doi.org/   10.1016/j.bbagrm.2011.07.00 7,OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10   .1073/pnas.050800210 3 Peng, J., J.E.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1021/pr025556 v Regnard, C., E. Desbruyères, J.C. Huet, C. Beauvallet, J.C. Pernollet, and B.  Eddé.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1074/jbc.M00004520 0 Saeki, H., K. Ohsumi, H. Aihara, T. Ito, S. Hirose, K. Ura, and Y. Kaneda.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1073/pnas.040982410 2 Shintomi, K., M. Iwabuchi, H. Saeki, K. Ura, T. Kishimoto, and K. Ohsumi.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1073/pnas.050082210 2 Spano, A.J., and A. Frankfurter.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/   S0091-679X(10)95003- 6 Tabb, D.L., W.H.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1021/   pr015504 q Thoma, F., and T. Koller.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/0092-8674(77)90188- X Thoma, F., T. Koller, and A. Klug.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1083/jcb.83.2.40 3 van Dijk, J., K. Rogowski, J. Miro, B. Lacroix, B. Eddé, and C. Janke.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/ 10.1016/   j.molcel.2007.04.01 2 Wang, H., Z. Ge, S.T.R.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/   10.1093/nar/gkr78 1 Wilhelm, F.X., M.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"5:505– 521. http://dx.doi.org/10.1093/nar/5.2.50 5 Xu, T., J.D.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1128/MCB.23.13.4559-4572.200 3 Freedman, B.S., and R. Heald.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/j.cub.2010.04.02 5 Freedman, B.S., K.E.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1371/journal.pone.001311 1 Hannak, E., and R. Heald.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"1:2305– 2314. http://dx.doi.org/10.1038/nprot.2006.39 6 Happel, N., and D. Doenecke.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1016/j.gene.2008.11.00 3 Harshman, S.W., N.L.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"41:9593– 9609. http://dx.doi.org/10.1093/nar/gkt70 0 Hondele, M., and A.G. Ladurner.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/j.sbi.2011.10.00 3 Ishimi, Y., and A. Kikuchi.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
http://dx.doi.org/10.1111/j.1432- 1033.1984.tb08305.,Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"124:3254– 3265. http://dx.doi.org/10.1242/jcs.08313 9 Kellogg, D.R., A. Kikuchi, T. Fujii-Nakata, C.W.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1083/   jcb.130.3.66 1 Kepert, J.F., J. Mazurkiewicz, G.L.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"280:34063– 34072. http://dx.doi.org/10.1074/jbc.M50732220 0 Korolev, N., O.V.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi   .org/10.1016/j.pbiomolbio.2006.11.00 3 Lacroix, B., J. van Dijk, N.D. Gold, J. Guizetti, G. Aldrian-Herrada, K. Rogowski,  D.W. Gerlich, and C. Janke.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1038/3504860 3 Loyola, A., and G. Almouzni.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1016/j   .bbaexp.2003.09.01 2 Machida, S., M. Takaku, M. Ikura, J.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"4:4863. http://dx.doi   .org/10.1038/srep0486 3 Maresca, T.J., and R. Heald.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1007/978-1-59745-000-3_3 3 Maresca, T.J., B.S.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1083/   jcb.20050303 1 McDonald, W.H., D.L.",Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
"http://dx.doi.org/10.1002/rcm.160 3 Misteli, T., A. Gunjan, R. Hock, M. Bustin, and D.T.",OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
http://dx.doi.org/10.1038/3504861 0,Non-OADS,/arxiv_data1/oa_pdf/a7/9a/JCB_201412097.PMC4411273.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201409024/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201409024.d v. We thank Professor H. Green and Japan Tissue Engineering Co., Ltd. for  providing 3T3-J2 cells; Drs.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1016/0092-8674(87)90179- 6 Barrandon, Y., and H. Green.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1038/nrm263 6 Cavani, A., G. Zambruno, A. Marconi, V. Manca, M. Marchetti, and A. Giannetti.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10   .1073/pnas.050725010 2 Clayton, E., D.P.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1038/nature0557 4 De Luca, M., G. Pellegrini, and H. Green.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1242/dev.0083 7 Li, A., P.J.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1073/   pnas.95.7.390 2 Lowell, S., P. Jones, I.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1016/S0960-9822(00)00451- 6 Marchisio, P.C., S. Bondanza, O. Cremona, R. Cancedda, and M. De Luca.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/   j.ceb.2008.05.00 1 Mascré, G., S. Dekoninck, B. Drogat, K.K.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1371/journal.pone.005508 2 Matsushita, N., S. Matsushita, S. Hirakawa, and S. Higashiyama.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"77:776– 781. http://dx.doi.org/10.1271/bbb.12091 7 Mavilio, F., G. Pellegrini, S. Ferrari, F. Di Nunzio, E. Di Iorio, A. Recchia,  G. Maruggi, G. Ferrari, E. Provasi, C. Bonini, et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/   10.1038/nm150 4 Metallo, C.M., L. Ji, J.J. de Pablo, and S.P.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1634/stemcells.2007-050 1 Nanba, D., N. Matsushita, F. Toki, and S. Higashiyama.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"4:127. http://dx.doi.org/   10.1186/scrt33 8 Nanba, D., F. Toki, N. Matsushita, S. Matsushita, S. Higashiyama, and Y.  Barrandon.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1002   /emmm.20120183 9 Oshima, H., A. Rochat, C. Kedzia, K. Kobayashi, and Y. Barrandon.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/S0092-   8674(01)00208- 2 Pellegrini, G., C.E.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1097/00007890-199909270-0002 1 Pellegrini, G., E. Dellambra, O. Golisano, E. Martinelli, I. Fantozzi, S. Bondanza,  D. Ponzin, F. McKeon, and M. De Luca.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1073/pnas.06103209 8 Pellegrini, G., P. Rama, S. Matuska, A. Lambiase, S. Bonini, A. Pocobelli,   R.G.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.2217/   rme.13.4 3 Rabinovitz, I., A. Toker, and A.M. Mercurio.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1083/jcb.146.5.114 7De Rosa, L., S. Carulli, F. Cocchiarella, D. Quaglino, E. Enzo, E. Franchini, A.  Giannetti, G. De Santis, A. Recchia, G. Pellegrini, and M. De Luca.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/j.stemcr.2013.11.00 1 Erdmann, G., C. Volz, and M. Boutros.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1002/biot.20120011 7 Fortunel, N.O., E. Cadio, P. Vaigot, L. Chadli, S. Moratille, S. Bouet, P.H.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
http://dx.doi.org/10.1111/j.1600-0625.2009.01046.,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/j.stem.2012.03.01 0 Gallico, G.G., III, N.E.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1056/NEJM19840816311070 6 Green, H. 2008.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1002/bies.2079 7 Green, H., K. Easley, and S. Iuchi.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1016/S0140-6736(09)61496- 3 Hashimoto, K., S. Higashiyama, H. Asada, E. Hashimura, T. Kobayashi,  K. Sudo, T. Nakagawa, D. Damm, K. Yoshikawa, and N. Taniguchi.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1007/s10616-005-3749- 4 Ito, M., Y. Liu, Z. Yang, J. Nguyen, F. Liang, R.J. Morris, and G. Cotsarelis.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/   0092-8674(93)90251- K Jones, P.H., S. Harper, and F.M.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/0092-   8674(95)90453- 0 Jones, P.H., B.D.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1371/journal.pone.002767 2 Kino-oka, M., Y. Agatahama, N. Hata, and M. Taya.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"107:544– 551. http://dx.doi.org/10.1016/j.jbiosc.2008.12.01 8 Krawczyk, W.S., and G.F. Wilgram.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/S0022-5320(73)90035- X Legg, J., U.B.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10   .1097/00007890-200111150-0000 2 Rama, P., S. Matuska, G. Paganoni, A. Spinelli, M. De Luca, and G.  Pellegrini.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1056/   NEJMoa090595 5 Rheinwald, J.G., and H. Green.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/S0092-8674(75)   80001- 8 Rochat, A., K. Kobayashi, and Y. Barrandon.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi   .org/10.1016/0092-8674(94)90383- 2 Rochat, A., N. Grasset, F. Gorostidi, S. Lathion, and Y. Barrandon.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1097/00007890-   200012150-0000 9 Schlüter, H., S. Paquet-Fifield, P. Gangatirkar, J. Li, and P. Kaur.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1002/stem.67 5 Schneider, A., D. Spitkovsky, P. Riess, M. Molcanyi, N. Kamisetti, M. Maegele,  J. Hescheler, and U. Schaefer.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1371/journal.pone.000378 8 Seiler, C., A. Gazdhar, M. Reyes, L.M.",Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)00050- 7 Terunuma, A., K.L.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
"http://dx.doi.org/10.1046/j.1523- 1747.2003.12531. x Watt, F.M., and H. Green.",OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
http://dx.doi   .org/10.1083/jcb.90.3.73 8,Non-OADS,/arxiv_data1/oa_pdf/ae/0b/JCB_201409024.PMC4411274.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1039/c0mb00317 d Alikhani, M., Z. Alikhani, C. Boyd, C.M.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1023/A:102139922839 5 Ashcroft, G.S., M.J. Jeong, J.J. Ashworth, M. Hardman, W. Jin, N. Moutsopoulos,  T. Wild, N. McCartney-Francis, D. Sim, G. McGrady, et al.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi   .org/10.1111/j.1524-475X.2011.00748.,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10   .1172/JCI6032 9 Behl, Y., P. Krothapalli, T. Desta, S. Roy, and D.T.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.2337/db08-053 7 Bos, D.C., W.L.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1089/dia.2011.003 4 Coulombe, P.A.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1046/j.1523- 1747.2003.12387. x Dasu, M.R., and I. Jialal.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/j.jdiacomp.2013.05.00 2 Decline, F., and P. Rousselle.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1111/1523-1747   .ep1239317 6 Gary Sibbald, R., and K.Y.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1002/dmrr.84 7 Gkogkolou, P., and M. Böhm.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/   10.4161/derm.2202 8 Glasser, J., and A. Barth.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10   .1016/S0002-9440(10)61723- 3 Goren, I., E. Müller, D. Schiefelbein, U. Christen, J. Pfeilschifter, H. Mühl,  and S. Frank.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1038/sj.jid.570084 2SERPINB2  (forward, 5 -GAAGCAGGAAAGCAGAAAGAAG-3 ; and  reverse, 5 -ACTGCCACACAGGAAGATATAC-3 ); and CCL20  (forward,  5-TCTGATATAGGCATCACCAACTC-3 ; and reverse, 5 -GAACTCTCCA- CTAGACCCAAATAG-3 ).",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1172/JCI11019 8 Shimizu, T., K. Sato, T. Suzuki, K. Tachibana, and K. Takeda.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/   10.1016/j.bbrc.2003.08.00 4 Siqueira, M.F., J. Li, L. Chehab, T. Desta, T. Chino, N. Krothpali, Y .",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1007/s00125-009-1529- y Stojadinovic, O., H. Brem, C. Vouthounis, B. Lee, J. Fallon, M. Stallcup, A.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)62953- 7 Sun, T., S. Adra, R. Smallwood, M. Holcombe, and S. MacNeil.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1371/journal.pone.000851 5 Tarcic, G., R. Avraham, G. Pines, I. Amit, T. Shay, Y. Lu, Y. Zwang, M. Katz,  N. Ben-Chetrit, J. Jacob-Hirsch, et al.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1096/fj.11-19465 4 Tredget, E.B., J. Demare, G. Chandran, E.E.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi.org/10.1111/j.1067-1927.2005.130108.,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/j.cmet   .2012.01.01 8 Usui, M.L., J.N.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1369/jhc.2008.95119 4 Xu, F., C. Zhang, and D.T.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"2013:754802.  http://dx.doi.org/10.1155/2013/75480 2 Yamazaki, T., X.O.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.4049/jimmunol.181.12.839 1 Yarosh, D., D. Both, J. Kibitel, C. Anderson, C. Elmets, D. Brash, and D. Brown.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1034/j.1600- 0781.2000.160606. x Zhang, C., C.K.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10   .1152/ajpcell.00179.201 1Hardman, M.J., E. Emmerson, L. Campbell, and G.S.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/   10.1210/en.2007-104 2 Huang, H., and D.J.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1242/jcs.00122 2 Jacobsen, J.N., B. Steffensen, L. Häkkinen, K.A.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi.org/10.1111/j.1600-0463.2010.02654.,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1002/jbmr.5 9 Lan, C.C., I.H.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1038/nprot.2007.3 0 Lima, M.H., A.M. Caricilli, L.L.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1371/journal   .pone.003697 4 Lohwasser, C., D. Neureiter, B. Weigle, T. Kirchner, and D. Schuppan.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/   10.1038/sj.jid.570007 0 Lund, L.R., K.A.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1038/sj.emboj   .760117 3 Moulik, P.K., R. Mtonga, and G.V.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.2337/diacare.26.2.49 1 Ni, Y.G., N. Wang, D.J.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/j.cell.2006.12.02 9 Paul, T.N.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/S0140-   6736(66)93041- 8 Peppa, M., P. Stavroulakis, and S.A. Raptis.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi.org/10.1111/j.1524-475X.2009.00518.,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"2012:939751. http://dx.doi.org/10.1155/2012/93975 1 Ponugoti, B., F. Xu, C. Zhang, C. Tian, S. Pacios, and D.T.",Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10   .1038/sj.gt.330080 2 Raja, K. Sivamani, M.S.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.2741/227 7 Reinke, J.M., and H. Sorg.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1159/00033961 3 Rittié, L., and G.J.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"http://dx.doi.org/10.1016/S1568-   1637(02)00024- 7 Schnider, S.L., and R.R.",OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
http://dx.doi.org/10   .1172/JCI10995 0,Non-OADS,/arxiv_data1/oa_pdf/73/29/JCB_201409032.PMC4411275.pdf
"Current understanding of the structural organization and  the cellular and molecular basis of renal filtration draws  from studies of human glomerular diseases and animal  models of glomerular dysfunction.Beyond the cell The cell biology of renal filtration Rizaldy P. Scott and Susan E. Quaggin Feinberg School of Medicine, Northwestern University, Chicago, IL 60611 © 2015 Scott and Quaggin  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub­ lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"After six months it is available under  a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by ­nc­sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10   .1016/j.semnephrol.2012.06.00 5 Abrahamson, D.R., B.G.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/   10.1681/ASN.200810108 6 Akilesh, S., T.B.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1172/JCI4645 8more restricted with increasing glomerular pressure is congru - ent with an electrokinetic model of the GFB (Lund et al., 2003).",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1016/j.ydbio.2009.04.01 7 Ebarasi, L., S. Ashraf, A. Bierzynska, H.Y.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1016/j.ajhg.2014.11.01 4 El-Aouni, C., N. Herbach, S.M.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200509092 1 Eremina, V., M. Sood, J. Haigh, A. Nagy, G. Lajoie, N. Ferrara, H.P.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1172/JCI1742 3 Eremina, V., S. Cui, H. Gerber, N. Ferrara, J. Haigh, A. Nagy, M. Ema, J.  Rossant, S. Jothy, J.H.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200508081 0 Eremina, V., J.A.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1056/NEJMoa070733 0 Eyre, J., K. Ioannou, B.D.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1152/ajprenal.00272.200 6 Fan, X., Q. Li, A. Pisarek-Horowitz, H.M. Rasouly, X. Wang, R.G.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi   .org/10.1016/j.celrep.2012.06.00 2 Fissell, W.H., C.L.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1152/ajprenal.00162.200 9 Fridén, V ., E. Oveland, O. Tenstad, K. Ebefors, J. Nyström, U.A.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10   .1038/ki.2011.5 8 Fu, B.M., and J.M.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1002/wsbm.121 1 Fukasawa, H., S. Bornheimer, K. Kudlicka, and M.G.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"20:1491– 1503. http://dx.doi.org/10.1681/ASN.200810111 7 Garg, P., R. Verma, L. Cook, A. Soofi, M. Venkatareddy, B. George, K. Mizuno,   C. Gurniak, W. Witke, and L.B.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1074/jbc.M110.12292 9 Gbadegesin, R.A., G. Hall, A. Adeyemo, N. Hanke, I. Tossidou, J. Burchette, G.  Wu, A. Homstad, M.A.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1172/JCI6913 4 Gelberg, H., L. Healy, H. Whiteley, L.A. Miller, and E. Vimr.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1371/journal.pone.001783 8 Gerke, P., T.B.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1093/ndt/gfn75 8Ashraf, S., H.Y .",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1172/JCI6900 0 Ashworth, S., B. Teng, J. Kaufeld, E. Miller, I. Tossidou, C. Englert, F. Bollig,  L. Staggs, I.S.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1371/journal.pone.001262 6 Augustin, H.G., G.Y.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1038/nrm263 9 Blattner, S.M., J.B. Hodgin, M. Nishio, S.A. Wylie, J. Saha, A.A. Soofi, C.  Vining, A. Randolph, N. Herbach, R. Wanke, et al.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1038/ki.2013.17 5 Boute, N., O. Gribouval, S. Roselli, F. Benessy, H. Lee, A. Fuchshuber, K.  Dahan, M.C.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"42:361)  http://dx.doi.org/10.1038/ng.50 5 Byron, A., M.J. Randles, J.D.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.201307079 5 Candiello, J., G.J.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1016/j.matbio.2010.03.00 4 Chang, R.L., W.M.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1038/ki.1975.10 4 Chen, S., D.J.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
http://dx.doi.org/10.1046/ j.1464-5491.2000.00350.,Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1128/MCB.23.10.3575-3582.200 3 Cui, Z., and M.H.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10   .1038/nrneph.2011.8 9 Curry, F.E., and R.H. Adamson.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi   .org/10.1007/s10439-011-0429- 8 Dai, C., D.B.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200601003 3 Dane, M.J., B.M.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/   10.1016/j.ajpath.2013.01.04 9 Diomedi-Camassei, F., S. Di Giandomenico, F.M.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"18:2773– 2780. http://dx.doi.org/10.1681/ASN.200608083 3 Donoviel, D.B., D.D.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
12:308– 319. http://dx.doi.org/10.1038/nrm311 2,Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
http://dx.doi.org/10.1046/ j.1523-1755.2000.07504.,Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"12:3397– 3405. http://dx.doi.org/10.1093/hmg/ddg36 0 Huber, T.B., B. Schermer, and T. Benzing.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10   .1159/00010178 9 Huber, T.B., B. Hartleben, K. Winkelmann, L. Schneider, J.U.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200808087 1 Ichimura, K., H. Kurihara, and T. Sakai.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1177/00221554030510120 3 Inoue, T., E. Yaoita, H. Kurihara, F. Shimizu, T. Sakai, T. Kobayashi, K.  Ohshiro, H. Kawachi, H. Okada, H. Suzuki, et al.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1371/journal.pone.010662 1 Jeansson, M., and B. Haraldsson.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1097/01.ASN   .0000072742.02714.6 E Jeansson, M., and B. Haraldsson.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi   .org/10.1152/ajprenal.00173.200 5 Jeansson, M., K. Björck, O. Tenstad, and B. Haraldsson.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200711120 5 Jeansson, M., A. Gawlik, G. Anderson, C. Li, D. Kerjaschki, M. Henkelman,  and S.E.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"121:2278– 2289. http://dx.doi.org/10.1172/JCI4632 2 Jin, J., K. Sison, C. Li, R. Tian, M. Wnuk, H.K.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.03 7 Jones, N., I.M.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1038/nature0466 2 Jones, N., L.A. New, M.A.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200901005 6 Kaplan, J.M., S.H.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/   10.1038/7345 6 Karamatic Crew, V., N. Burton, A. Kagan, C.A.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1182/blood-2004-04-151 2 Kestilä, M., U. Lenkkeri, M. Männikkö, J. Lamerdin, P. McCready, H. Putaala,   V. Ruotsalainen, T. Morita, M. Nissinen, R. Herva, et al.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/   10.1016/S1097-2765(00)80057- X Khoshnoodi, J., K. Sigmundsson, L.G.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1016/S0002-9440(10)63590- 0 Kikkawa, Y., and J.H.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10   .1016/j.ydbio.2006.04.46 3 Kim, J.M., H. Wu, G. Green, C.A.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200909100 4 Gross, O., B. Beirowski, S.J.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
http://dx.doi   .org/10.1111/j.1523-1755.2004.00712.,Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"50:330– 338. http://dx.doi.org/10.1136/jmedgenet-2012-10144 2 Haege, S., C. Einer, S. Thiele, W. Mueller, S. Nietzsche, A. Lupp, F. Mackay,  S. Schulz, and R. Stumm.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1371/journal   .pone.004281 4 Hamano, Y., T. Okude, R. Shirai, I. Sato, R. Kimura, M. Ogawa, Y. Ueda, O.  Yokosuka, R. Kalluri, and S. Ueda.",OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
"http://dx.doi.org/10.1681/ASN.200905049 2 Hartleben, B., H. Schweizer, P. Lübben, M.P.",Non-OADS,/arxiv_data1/oa_pdf/17/dc/JCB_201410017.PMC4411276.pdf
